The Erasmus Immunology Publications
PUBLICATIONS 2022
| 1 | Aarts P, van Huijstee JC, Ragamin A, Reeves JL, van Montfrans C, van der Zee HH, et al. Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa. Dermatology. 2022:1-10. |
| 2 | Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T, Tresoldi C, Davis Z, Giudicelli V, et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia. 2022;36(8):1961-8. |
| 3 | Agathangelidis A, Vlachonikola E, Davi F, Langerak AW, Chatzidimitriou A. High-Throughput immunogenetics for precision medicine in cancer. Semin Cancer Biol. 2022;84:80-8. |
| 4 | Aichholzer M, Gangadin SS, Sommer IEC, Wijkhuis A, de Witte LD, Kahn RS, et al. Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial. Brain Behav Immun Health. 2022;26:100551. |
| 5 | Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden RDM, Islam B, et al. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clin Neurophysiol. 2022;138:231-40. |
| 6 | Arends S, Drenthen J, Van den Bergh PYK, Hadden RDM, Shahrizaila N, Dimachkie MM, et al. Electrodiagnostic subtyping in Guillain-Barre syndrome: Use of criteria in practice based on a survey study in IGOS. J Peripher Nerv Syst. 2022;27(3):197-205. |
| 7 | Assmann J, Kolijn PM, Schrijver B, van Gammeren AJ, Loth DW, Ermens T, et al. TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients. J Leukoc Biol. 2022;111(1):283-9. |
| 8 | Assmann J, Leon LG, Stavast CJ, van den Bogaerdt SE, Schilperoord-Vermeulen J, Sandberg Y, et al. miR-181a is a novel player in the STAT3-mediated survival network of TCRalphabeta+ CD8+ T large granular lymphocyte leukemia. Leukemia. 2022;36(4):983-93. |
| 9 | Ataei Ataabadi E, Golshiri K, Juttner AA, de Vries R, Van den Berg-Garrelds I, Nagtzaam NMA, et al. Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse model. Aging Cell. 2022;21(9):e13683. |
| 10 | Baars AE, Kuitwaard K, de Koning LC, Luijten LWG, Kok WM, Eftimov F, et al. SARS-CoV-2 Vaccination Safety in Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropath. Neurology. 2022. |
| 11 | Basak EA, de Joode K, Uyl TJJ, van der Wal R, Schreurs MWJ, van den Berg SAA, et al. The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy. Biomed Pharmacother. 2022;156:113839. |
| 12 | Basak EA, Vermeer NS, de Joode K, Hurkmans DP, Velthuis DEM, Oomen-de Hoop E, et al. Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study. Eur J Cancer. 2022;174:113-20. |
| 13 | Bastiaansen AEM, de Bruijn M, Schuller SL, Martinez-Hernandez E, Brenner J, Paunovic M, et al. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy. Neurol Neuroimmunol Neuroinflamm. 2022;9(2). |
| 14 | Bik L, Wolkerstorfer A, Bekkers V, Prens EP, Haedersdal M, Bonn D, et al. Needle-free jet injection-induced small-droplet aerosol formation during intralesional bleomycin therapy. Lasers Surg Med. 2022;54(4):572-9. |
| 15 | Bisoendial R, Lubberts E. A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases. Mediators Inflamm. 2022;2022:6600264. |
| 16 | Boekesteijn R, Smolders J, Busch V, Keijsers N, Geurts A, Smulders K. Objective monitoring of functional recovery after total knee and hip arthroplasty using sensor-derived gait measures. PeerJ. 2022;10:e14054. |
| 17 | Bottcher S, Engelmann R, Grigore G, Fernandez P, Caetano J, Flores-Montero J, et al. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Adv. 2022;6(3):976-92. |
| 18 | Bras AE, Matarraz S, Nierkens S, Fernandez P, Philippe J, Aanei CM, et al. Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients-A EuroFlow Study. Cancers (Basel). 2022;14(8). |
| 19 | Broekhuizen M, de Vries R, Smits MAW, Dik WA, Schoenmakers S, Koch BCP, et al. Pentoxifylline as a therapeutic option for pre-eclampsia: a study on its placental effects. Br J Pharmacol. 2022;179(22):5074-88. |
| 20 | Broers MC, de Wilde M, Lingsma HF, van der Lei J, Verhamme KMC, Jacobs BC. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands. J Peripher Nerv Syst. 2022;27(3):182-8. |
| 21 | Broijl A, de Jong ACM, van Duin M, Sonneveld P, Kuhnau J, van der Velden VHJ. VS38c and CD38-Multiepitope Antibodies Provide Highly Comparable Minimal Residual Disease Data in Patients With Multiple Myeloma. Am J Clin Pathol. 2022;157(4):494-7. |
| 22 | Brouwer N, Matarraz S, Nierkens S, Hofmans M, Novakova M, da Costa ES, et al. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study. Cancers (Basel). 2022;14(6). |
| 23 | Bus SRM, Broers MC, Lucke IM, Bunschoten C, van Lieverloo GGA, Adrichem ME, et al. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study. J Neurol. 2022;269(2):945-55. |
| 24 | Buters TP, Hameeteman PW, Jansen IME, van Hindevoort FC, Ten Voorde W, Florencia E, et al. Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers. Br J Clin Pharmacol. 2022;88(2):680-90. |
| 25 | Cassidy BR, Sonntag WE, Leenen PJM, Drevets DA. Systemic Listeria monocytogenes infection in aged mice induces long-term neuroinflammation: the role of miR-155. Immun Ageing. 2022;19(1):25. |
| 26 | Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szabo L, Gaspar K, et al. Primary alterations during the development of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2022;36(3):462-71. |
| 27 | Damoiseaux M, Damoiseaux J, Pico-Knijnenburg I, van der Burg M, Bredius R, van Well G. Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II. Clin Immunol. 2022;235:108932. |
| 28 | de Jong NW, van Splunter ME, Emons JAM, Hettinga KA, Gerth van Wijk R, Wichers HJ, et al. Introduction of Heated Cow’s Milk Protein in Challenge-Proven Cow’s Milk Allergic Children: The iAGE Study. Nutrients. 2022;14(3). |
| 29 | de Mol CL, van Luijn MM, Kreft KL, Looman KIM, van Zelm MC, White T, et al. Multiple sclerosis risk variants influence the peripheral B-cell compartment early in life in the general population. Eur J Neurol. 2022. |
| 30 | de Vries M, Schreurs MWJ, Ahsmann EJM, Spee-Dropkova M, Karim F. A Case of Anti-SAE1 Dermatomyositis. Case Reports Immunol. 2022;2022:9000608. |
| 31 | den Braanker H, Razawy W, Wervers K, Mus AC, Davelaar N, Kok MR, et al. Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm. Arthritis Res Ther. 2022;24(1):28. |
| 32 | den Otter AAS, van der Houwen TB, van Hagen PM, van Laar JAM. Clinical course of COVID-19 infections in patients with Behcet’s disease in The Netherlands. Clin Exp Rheumatol. 2022;40(8):1504-9. |
| 33 | Detiger SE, Paridaens D, van Hagen M, Karim F, van Laar JAM, Verdijk RM. Tissue IgG2/IgG4 Ratio as an Additional Tool to Distinguish IgG4-Related Disease From Other Fibroinflammatory Disorders. Appl Immunohistochem Mol Morphol. 2022;30(7):517-25. |
| 34 | Detiger SE, Paridaens D, Verdijk RM, van Laar JAM, Dammers R, Monserez DA, et al. Vision loss caused by immunoglobulin G4-related disease of the skull base complicated by a mucocele of the sphenoid sinus. Int Forum Allergy Rhinol. 2022;12(9):1216-20. |
| 35 | Doets AY, Lingsma HF, Walgaard C, Islam B, Papri N, Davidson A, et al. Predicting Outcome in Guillain-Barre Syndrome: International Validation of the Modified Erasmus GBS Outcome Score. Neurology. 2022;98(5):e518-e32. |
| 36 | Doets AY, Walgaard C, Lingsma HF, Islam B, Papri N, Yamagishi Y, et al. International Validation of the Erasmus Guillain-Barre Syndrome Respiratory Insufficiency Score. Ann Neurol. 2022;91(4):521-31. |
| 37 | Dudink K, Aarts P, Ardon CB, Vossen A, Koster SBL, Van den Bosch JF, et al. Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch Cohort. Dermatology. 2022;238(3):600-2. |
| 38 | Duizendstra AA, De Knegt RJ, Nagtzaam NMA, Betjes MGH, Dik WA, Litjens NHR, et al. Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation. Transplant Proc. 2022;54(7):1874-80. |
| 39 | Edomskis PP, Dik WA, Sparreboom CL, Nagtzaam NMA, van Oudenaren A, Lambrichts DPV, et al. Monocyte response after colorectal surgery: A prospective cohort study. Front Immunol. 2022;13:1031216. |
| 40 | Erkeland SJ, Stavast CJ, Schilperoord-Vermeulen J, Dal Collo G, Van de Werken HJG, Leon LG, et al. The miR-200c/141-ZEB2-TGFbeta axis is aberrant in human T-cell prolymphocytic leukemia. Haematologica. 2022;107(1):143-53. |
| 41 | Eurelings LEM, Missotten T, van Velthoven MEJ, van Daele PLA, van Laar JAM, van Hagen PM, et al. Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy. Am J Ophthalmol. 2022;240:194-204. |
| 42 | Ferrao Blanco MN, Bastiaansen Jenniskens YM, Kops N, Chavli A, Narcisi R, Botter SM, et al. Intra-articular injection of triamcinolone acetonide sustains macrophage levels and aggravates osteophytosis during degenerative joint disease in mice. Br J Pharmacol. 2022;179(11):2771-84. |
| 43 | Feyen J, Ernst MPT, van der Velden VHJ, Valk PJM, Broeders L, Touw IP, et al. A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factor. Pediatr Blood Cancer. 2022:e30039. |
| 44 | Flessa CM, Zampeli E, Evangelopoulos ME, Natsis V, Bodewes ILA, Huijser E, et al. Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjogren’s Syndrome. Front Immunol. 2022;13:836824. |
| 45 | Fokkink WJR, van Tilburg SJ, de Winter BCM, Sassen SDT, van Doorn PA, Koch BCP, et al. Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barre Syndrome. Clin Pharmacokinet. 2022;61(9):1285-96. |
| 46 | Framme JL, Lundqvist C, Lundell AC, van Schouwenburg PA, Lemarquis AL, Thorn K, et al. Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs. J Clin Immunol. 2022;42(3):618-33. |
| 47 | Ghuijs W, Kemps PG, Capala ME, Verdijk RM, van Halteren AGS, van der Wal RJP, et al. Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report. Radiat Oncol. 2022;17(1):137. |
| 48 | Govert F, Abrante L, Becktepe J, Balint B, Ganos C, Hofstadt-van Oy U, et al. Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis. Brain. 2022. |
| 49 | Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022;139(17):2601-21. |
| 50 | Hagedoorn NN, Boeddha NP, Kohlfuerst DS, Anderson S, Carrol ED, Agapow P, et al. Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study. Pediatr Crit Care Med. 2022. |
| 51 | Hagedoorn NN, Kolukirik P, Nagtzaam NMA, Nieboer D, Verbruggen S, Joosten KF, et al. Association of monocyte HLA-DR expression over time with secondary infection in critically ill children: a prospective observational study. Eur J Pediatr. 2022;181(3):1133-42. |
| 52 | Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, et al. Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19. JAMA Oncol. 2022;8(10):1477-83. |
| 53 | Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, et al. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients. Blood Adv. 2022;6(5):1537-46. |
| 54 | Haimel M, Pazmandi J, Heredia RJ, Dmytrus J, Bal SK, Zoghi S, et al. Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity. J Allergy Clin Immunol. 2022;149(1):369-78. |
| 55 | Helfferich J, de Lange MM, Benschop KS, Jacobs BC, Van Leer-Buter CC, Meijer A, et al. Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019. Euro Surveill. 2022;27(42). |
| 56 | Helfferich J, Roodbol J, de Wit MC, Brouwer OF, Jacobs BC, Enterovirus DAFMWG, et al. Acute flaccid myelitis and Guillain-Barre syndrome in children: A comparative study with evaluation of diagnostic criteria. Eur J Neurol. 2022;29(2):593-604. |
| 57 | Hengeveld PJ, Ertem YE, Dubois JMN, Mellink CHM, van der Kevie-Kersemaekers AM, Evers LM, et al. Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110). Leukemia. 2022;36(7):1935-8. |
| 58 | Hengeveld PJ, van der Klift MY, Kolijn PM, Davi F, Kavelaars FG, de Jonge E, et al. Detecting measurable residual disease beyond 10-4 through an IGHV leader-based NGS approach improves prognostic stratification in CLL. Blood. 2022. |
| 59 | Hensgens MPM, Delemarre EM, Drylewicz J, Voortman M, Krol RM, Dalm V, et al. Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients. Rheumatology (Oxford). 2022;61(10):4087-96. |
| 60 | Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm V, et al. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. PLoS Med. 2022;19(10):e1003979. |
| 61 | Hermans MAW, Heeringa JJ, Swagemakers SGA, Schrijver B, van Daele PLA, van der Spek PJ, et al. Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis. J Allergy Clin Immunol. 2022;150(1):146-56 e10. |
| 62 | Hermans MAW, Pasmans S, Arends NJT, van den Bosch TPP, van Daele PLA, van Doorn MBA, et al. Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children. Clin Exp Dermatol. 2022;47(9):1694-702. |
| 63 | Hines MR, von Bahr Greenwood T, Beutel G, Beutel K, Hays JA, Horne A, et al. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Crit Care Med. 2022;50(5):860-72. |
| 64 | Hofste Op Bruinink D, Kuiper R, van Duin M, Cupedo T, van der Velden VHJ, Hoogenboezem R, et al. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. J Clin Oncol. 2022;40(27):3132-50. |
| 65 | Hope JL, Zhao M, Stairiker CJ, Kiernan CH, Carey AJ, Mueller YM, et al. MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8(+) T Cell Responses. J Immunol. 2022;208(3):603-17. |
| 66 | Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, et al. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjogren’s syndrome. Rheumatology (Oxford). 2022;61(8):3491-6. |
| 67 | Huijser E, Gopfert J, Brkic Z, van Helden-Meeuwsen CG, Jansen S, Mandl T, et al. Serum interferon-alpha2 measured by single-molecule array associates with systemic disease manifestations in Sjogren’s syndrome. Rheumatology (Oxford). 2022;61(5):2156-66. |
| 68 | Huijser E, van Helden-Meeuwsen CG, Grashof DGB, Tarn JR, Brkic Z, Huisman JMA, et al. Trained Immunity in Primary Sjogren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype. Front Immunol. 2022;13:840751. |
| 69 | Huisman EJ, Brooimans AR, Mayer S, Joosten M, de Bont L, Dekker M, et al. Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes. J Clin Immunol. 2022;42(7):1521-34. |
| 70 | Iaccarino L, Talarico R, Bozzalla-Cassione E, Burmester GR, Culver EL, Doria A, et al. Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners. Clin Exp Rheumatol. 2022;40 Suppl 134(5):71-80. |
| 71 | Ishigaki K, Sakaue S, Terao C, Luo Y, Sonehara K, Yamaguchi K, et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat Genet. 2022;54(11):1640-51. |
| 72 | Israni M, Nicholson B, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, et al. Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey. J Clin Immunol. 2022. |
| 73 | Jabbour AJ, van Straalen KR, Colvin A, Prens EP, Petukhova L. Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration. Br J Dermatol. 2022;186(1):183-5. |
| 74 | Jahan I, Hayat S, Khalid MM, Ahammad RU, Asad A, Islam B, et al. Association of mannose-binding lectin 2 gene polymorphisms with Guillain-Barre syndrome. Sci Rep. 2022;12(1):5791. |
| 75 | Jemec GBE, Del Marmol V, Bettoli V, Augustin M, Prens EP, Zouboulis CC. Registries, multicentre and genome-wide association studies in hidradenitis suppurativa. Exp Dermatol. 2022;31 Suppl 1:22-8. |
| 76 | Jongkees MJ, Geers D, Hensley KS, Huisman W, GeurtsvanKessel CH, Bogers S, et al. Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination. J Infect Dis. 2022. |
| 77 | Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, et al. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial. Gut. 2022;71(1):34-42. |
| 78 | Kaiser FMP, Gruenbacher S, Oyaga MR, Nio E, Jaritz M, Sun Q, et al. Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder. J Exp Med. 2022;219(9). |
| 79 | Karu N, Kindt A, Lamont L, van Gammeren AJ, Ermens AAM, Harms AC, et al. Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites. 2022;12(7). |
| 80 | Karu N, Kindt A, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, et al. Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress. Metabolites. 2022;12(7). |
| 81 | Kaufman M, Yan XJ, Li W, Ghia EM, Langerak AW, Rassenti LZ, et al. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia. Front Oncol. 2022;12:897280. |
| 82 | Keij FM, Kornelisse RF, Hartwig NG, van der Sluijs-Bens J, van Beek RHT, van Driel A, et al. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial. Lancet Child Adolesc Health. 2022;6(11):799-809. |
| 83 | Kemps PG, Picarsic J, Durham BH, Helias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-80. |
| 84 | Khan SR, Peeters RP, van Hagen PM, Dalm V, Chaker L. Determinants and Clinical Implications of Thyroid Peroxidase Antibodies in Middle-Aged and Elderly Individuals: The Rotterdam Study. Thyroid. 2022;32(1):78-89. |
| 85 | Khan SR, Vanoverschelde A, Lahousse L, Peeters RP, van Hagen PM, Brusselle G, et al. Serum Immunoglobulins, Pneumonia Risk, and Lung Function in Middle-Aged and Older Individuals: A Population-Based Cohort Study. Front Immunol. 2022;13:868973. |
| 86 | Khan SR, Yaqub A, Ikram MK, van Hagen PM, Peeters RP, Dalm V, et al. The association of serum immunoglobulins with cognition and dementia: the Rotterdam Study. J Neurol. 2022. |
| 87 | Kimball AB, Loesche C, Prens EP, Bechara FG, Weisman J, Rozenberg I, et al. IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study. Exp Dermatol. 2022;31(10):1522-32. |
| 88 | Knijff JM, Houdijk E, van der Kaay DCM, van Berkel Y, Filippini L, Stuurman FE, et al. Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity. Digit Biomark. 2022;6(1):19-29. |
| 89 | Koetzier SC, van Langelaar J, Melief MJ, Wierenga-Wolf AF, Corsten CEA, Blok KM, et al. Distinct Effector Programs of Brain-Homing CD8(+) T Cells in Multiple Sclerosis. Cells. 2022;11(10). |
| 90 | Koetzier SC, van Langelaar J, Wierenga-Wolf AF, Melief MJ, Pol K, Musters S, et al. Improving Glucocorticoid Sensitivity of Brain-Homing CD4(+) T Helper Cells by Steroid Hormone Crosstalk. Front Immunol. 2022;13:893702. |
| 91 | Kolijn PM, Hosnijeh FS, Spath F, Hengeveld PJ, Agathangelidis A, Saleh M, et al. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 2022;139(10):1557-63. |
| 92 | Kruizinga MD, Essers E, Stuurman FE, Yavuz Y, de Kam ML, Zhuparris A, et al. Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care. Eur Respir J. 2022;59(6). |
| 93 | Kruizinga MD, Zhuparris A, Dessing E, Krol FJ, Sprij AJ, Doll RJ, et al. Development and technical validation of a smartphone-based pediatric cough detection algorithm. Pediatr Pulmonol. 2022;57(3):761-7. |
| 94 | Kulis J, Wawrowski L, Sedek L, Wrobel L, Slota L, van der Velden VHJ, et al. Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia. J Clin Med. 2022;11(9). |
| 95 | Kumova OK, Galani IE, Rao A, Johnson H, Triantafyllia V, Matt SM, et al. Severity of neonatal influenza infection is driven by type I interferon and oxidative stress. Mucosal Immunol. 2022. |
| 96 | Laman JD, Huizinga R, Boons GJ, Jacobs BC. Guillain-Barre syndrome: expanding the concept of molecular mimicry. Trends Immunol. 2022;43(4):296-308. |
| 97 | Langerak AW. The Advent of Precision Immunology: Immunogenetics at the Center of Immune Cell Analysis in Health and Disease. Methods Mol Biol. 2022;2453:1-5. |
| 98 | Leonhard SE, van der Eijk AA, Andersen H, Antonini G, Arends S, Attarian S, et al. An International Perspective on Preceding Infections in Guillain-Barre Syndrome: The IGOS-1000 Cohort. Neurology. 2022;99(12):e1299-e313. |
| 99 | Litjens NHR, Langerak AW, Azmani Z, den Dekker X, Betjes MGH, Brouwer RWW, et al. Combined Analysis of Transcriptome and T-Cell Receptor Alpha and Beta (TRA /TRB ) Repertoire in Paucicellular Samples at the Single-Cell Level. Methods Mol Biol. 2022;2453:231-59. |
| 100 | Lubberts E. [Vitamin D like one of few prevention possibilities for autoimmune diseases?] |
| Hoe helpt vitamine D auto-immuunziekten voorkomen? Ned Tijdschr Geneeskd. 2022;166. | |
| 101 | Lubberts E, Scher JU, FitzGerald O. Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis. J Rheumatol. 2022;49(6 Suppl 1):16-9. |
| 102 | Macchiarella G, Cornacchione V, Cojean C, Riker J, Wang Y, Te H, et al. Disease association of anti-CEL autoantibodies in hidradenitis suppurativa. J Invest Dermatol. 2022. |
| 103 | Malahe SRK, Hoek RAS, Dalm V, Broers AEC, den Hoed CM, Manintveld OC, et al. Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study. Clin Infect Dis. 2022. |
| 104 | Manusama OR, van Beveren NJM, van Hagen PM, Drexhage HA, Dalm V. Psychological Symptoms in Primary Immunodeficiencies: a Common Comorbidity? J Clin Immunol. 2022;42(3):695-8. |
| 105 | Martin-Aguilar L, Lleixa C, Pascual-Goni E, Caballero-Avila M, Martinez-Martinez L, Diaz-Manera J, et al. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurol Neuroimmunol Neuroinflamm. 2022;9(1). |
| 106 | Martina MG, Giorgio C, Allodi M, Palese S, Barocelli E, Ballabeni V, et al. Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases. Eur J Med Chem. 2022;243:114703. |
| 107 | Maurits MP, Korsunsky I, Raychaudhuri S, Murphy SN, Smoller JW, Weiss ST, et al. A framework for employing longitudinally collected multicenter electronic health records to stratify heterogeneous patient populations on disease history. J Am Med Inform Assoc. 2022;29(5):761-9. |
| 108 | Melsen JE, van Ostaijen-Ten Dam MM, van den Akker EB, Welters MJP, Heezen KC, Pico-Knijnenburg I, et al. T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation. J Clin Immunol. 2022;42(6):1205-22. |
| 109 | Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageourgiou G, et al. Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients. Nat Commun. 2022;13(1):2583. |
| 110 | Molendijk E, Schiphof D, Oei EHG, de Vos RJ, Bos PK, van Meurs JBJ, et al. Accelerated menopausal changes as human disease model ‘FOCUM’ for the development of osteoarthritis and other degenerative disorders: protocol for a prospective cohort study. BMJ Open. 2022;12(11):e064779. |
| 111 | Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, et al. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nat Commun. 2022;13(1):915. |
| 112 | Mulder E, Damman J, Verver D, van der Veldt AAM, Tas S, Khemai-Mehraban T, et al. Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma. Melanoma Res. 2022;32(4):249-59. |
| 113 | Niemeyer-van der Kolk T, Buters TP, Krouwels L, Boltjes J, de Kam ML, van der Wall H, et al. Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial. J Am Acad Dermatol. 2022;86(4):854-62. |
| 114 | Nouwen AEM, Schappin R, Nguyen NT, Ragamin A, Bygum A, Bodemer C, et al. Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review. Front Immunol. 2022;13:864449. |
| 115 | Oliveira E, Costa ES, Ciudad J, Gaipa G, Sedek L, Barrena S, et al. Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome. Cancers (Basel). 2022;14(13). |
| 116 | Olofsen PA, Bosch DA, de Looper HWJ, van Strien PMH, Hoogenboezem RM, Roovers O, et al. Truncated CSF3 receptors induce pro-inflammatory responses in severe congenital neutropenia. Br J Haematol. 2022. |
| 117 | Olydam JI, de Wijs LEM, Dik WA, Ropke MA, Da Rosa JC, Hijnen DJ. EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab. J Invest Dermatol. 2022;142(12):3335-7 e1. |
| 118 | Orme ME, Voreck A, Aksouh R, Schreurs MWJ. Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. J Appl Lab Med. 2022;7(1):221-39. |
| 119 | Overweel AFP, Langerak AW, Damman J, de Haas ELM, Weerkamp F, Sandberg Y. [A patient with erythroderma and pruritus: Sezary syndrome] |
| Een man met jeuk en roodheid van de huid. Ned Tijdschr Geneeskd. 2022;166. | |
| 120 | Papri N, Doets AY, Mohammad QD, Endtz HP, Lingsma HF, Jacobs BC, et al. Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh. Ann Clin Transl Neurol. 2022;9(8):1264-75. |
| 121 | Peeters D, Pico-Knijnenburg I, Wieringa D, Rad M, Cuperus R, Ruige M, et al. AKT Hyperphosphorylation and T Cell Exhaustion in Down Syndrome. Front Immunol. 2022;13:724436. |
| 122 | Peeters D, van Scheppingen LMA, Driessen GJA, Verhagen LM. Parental and physician’s point-of-view towards antibiotic prescriptions and discharge conversations in the pediatric emergency department. BMC Pediatr. 2022;22(1):121. |
| 123 | Pennesi E, Michels N, Brivio E, van der Velden VHJ, Jiang Y, Thano A, et al. Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial. Leukemia. 2022;36(6):1516-24. |
| 124 | Petkau G, Mitchell TJ, Chakraborty K, Bell SE, V DA, Matheson L, et al. The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins. Nat Commun. 2022;13(1):2274. |
| 125 | Prens LM, Bouwman K, Troelstra LD, Prens EP, Alizadeh BZ, Horvath B. New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities. Br J Dermatol. 2022;186(5):814-22. |
| 126 | Ragamin A, Nouwen AEM, Dalm V, van Mierlo MMF, Lincke CR, Pasmans S. Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series. Dermatology. 2022:1-9. |
| 127 | Rijneveld AW, van der Holt B, de Weerdt O, Biemond BJ, van de Loosdrecht AA, van der Wagen LE, et al. Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial. Blood Adv. 2022;6(4):1115-25. |
| 128 | Rijvers L, van Langelaar J, Bogers L, Melief MJ, Koetzier SC, Blok KM, et al. Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib. JCI Insight. 2022;7(16). |
| 129 | Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Geers D, et al. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming. N Engl J Med. 2022;386(10):951-63. |
| 130 | Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Schmitz KS, et al. Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers. Clin Infect Dis. 2022. |
| 131 | Schmitz A, Brondum RF, Johnsen HE, Mellqvist UH, Waage A, Gimsing P, et al. Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial. BMC Cancer. 2022;22(1):147. |
| 132 | Schrijver B, Kolijn PM, Ten Berge J, Nagtzaam NMA, van Rijswijk A, Swagemakers SMA, et al. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. Acta Ophthalmol. 2022;100(4):403-13. |
| 133 | Schrijver B, La Distia Nora R, Nagtzaam NMA, van Laar JAM, van Hagen PM, Dik WA. Serum CCL17 distinguishes sarcoid uveitis from TB-uveitis and QFT-negative uveitis. Acta Ophthalmol. 2022;100(7):e1533-e4. |
| 134 | Sedek L, Flores-Montero J, van der Sluijs A, Kulis J, Te Marvelde J, Philippe J, et al. Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels. Cancers (Basel). 2022;14(3). |
| 135 | Smets I, Wokke B, Smolders J. Should anti-CD20 be used as an immune reconstitution therapy? Mult Scler. 2022:13524585221109386. |
| 136 | Smolders J, Hamann J. Programmed Cell Death Protein 1-Positive CD8(+) T Cells in Multiple Sclerosis: Exhausted Fighters or Peacekeepers. Neurol Neuroimmunol Neuroinflamm. 2022;9(4). |
| 137 | Smolders J, van Luijn MM, Hsiao CC, Hamann J. T-cell surveillance of the human brain in health and multiple sclerosis. Semin Immunopathol. 2022. |
| 138 | Sonneveld LJH, Emons JAM, Arends NJT, Landzaat LJ, Veenbergen S, Schreurs MWJ. ALEX versus ISAC multiplex array in analyzing food allergy in atopic children. Clin Mol Allergy. 2022;20(1):10. |
| 139 | Stavast CJ, van Zuijen I, Erkeland SJ. MicroRNA-139, an Emerging Gate-Keeper in Various Types of Cancer. Cells. 2022;11(5). |
| 140 | Stavast CJ, van Zuijen I, Karkoulia E, Ozcelik A, van Hoven-Beijen A, Leon LG, et al. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis. Leukemia. 2022;36(3):687-700. |
| 141 | Stutterheim J, de Lorenzo P, van der Sluis IM, Alten J, Ancliffe P, Attarbaschi A, et al. Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol. Eur J Cancer. 2022;160:72-9. |
| 142 | Suratannon N, Ittiwut C, Dik WA, Ittiwut R, Meesilpavikkai K, Israsena N, et al. A germline STAT6 gain-of-function variant is associated with early-onset allergies. J Allergy Clin Immunol. 2022. |
| 143 | Suratannon N, Tantithummawong P, Hurst CP, Chongpison Y, Wongpiyabovorn J, van Hagen PM, et al. Pediatric Prediction Model for Low Immunoglobulin G Level Based on Serum Globulin and Illness Status. Front Immunol. 2022;13:825867. |
| 144 | Svaton M, Skotnicova A, Reznickova L, Rennerova A, Valova T, Kotrova M, et al. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol. Blood. 2022. |
| 145 | Tamborska AA, Singh B, Leonhard SE, Hodel EM, Stowe J, Watson-Fargie T, et al. Guillain-Barre syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study. BMJ Neurol Open. 2022;4(2):e000309. |
| 146 | Tan CD, van der Walle E, Vermont CL, von Both U, Carrol ED, Eleftheriou I, et al. Guideline adherence in febrile children below 3 months visiting European Emergency Departments: an observational multicenter study. Eur J Pediatr. 2022;181(12):4199-209. |
| 147 | Terlouw S, van Boven FE, Borsboom-van Zonneveld M, de Graaf-In ‘t Veld C, van Splunter ME, van Daele PLA, et al. Homemade Food Allergen Extracts for Use in Skin Prick Tests in the Diagnosis of IgE-Mediated Food Allergy: A Good Alternative in the Absence of Commercially Available Extracts? Nutrients. 2022;14(3). |
| 148 | Tong-Minh K, van Hooijdonk S, Versnel MA, van Helden-Meeuwsen CG, van Hagen PM, van Gorp ECM, et al. Blood myxovirus resistance protein-1 measurement in the diagnostic work-up of suspected COVID-19 infection in the emergency department. Immun Inflamm Dis. 2022;10(4):e609. |
| 149 | Tzellos T, van Straalen KR, Kyrgidis A, Alavi A, Goldfarb N, Gulliver W, et al. Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2022. |
| 150 | van Beers J, Schreurs MWJ. Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun. 2022;5:100155. |
| 151 | van Binsbergen AL, de Haas V, van der Velden VHJ, de Groot-Kruseman HA, Fiocco MF, Pieters R. Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2022;69(2):e29387. |
| 152 | van Daele PLA, Hermans MAW, Oude Elberink J, van Wijk RG. [Idiopathic mast cell activation syndrome] |
| Het idiopathisch mestcelactivatiesyndroom. Ned Tijdschr Geneeskd. 2022;166. | |
| 153 | van den Bosch A, Fransen N, Mason M, Rozemuller AJ, Teunissen C, Smolders J, et al. Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage. Neurol Neuroimmunol Neuroinflamm. 2022;9(3). |
| 154 | van der Houwen TB, van Hagen PM, van Laar JAM. Immunopathogenesis of Behcet’s disease and treatment modalities. Semin Arthritis Rheum. 2022;52:151956. |
| 155 | van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, et al. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. J Allergy Clin Immunol. 2022;149(1):432-9 e4. |
| 156 | van der Sar IG, Moor CC, Oppenheimer JC, Luijendijk ML, van Daele PLA, Maitland-van der Zee AH, et al. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis. Chest. 2022;161(3):738-47. |
| 157 | van der Sijde F, Dik WA, Mustafa DAM, Vietsch EE, Besselink MG, Debets R, et al. Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients. Front Immunol. 2022;13:898498. |
| 158 | van der Steen M, Leroy PL, Driessen GJA, Bannier M. COVID-19 in children and adolescents: MIS(-C)-taken diagnoses. Eur J Pediatr. 2022;181(9):3549-54. |
| 159 | van der Straten L, Maas C, Levin MD, Visser O, Posthuma EFM, Doorduijn JK, et al. Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018. Blood Cancer J. 2022;12(4):72. |
| 160 | van der Velden VHJ, Bastian L, Bruggemann M, Hartmann AM, Darzentas N. Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq. Methods Mol Biol. 2022;2453:61-77. |
| 161 | van Kampen JJA, Dalm V, Fraaij PLA, Oude Munnink BB, Schapendonk CME, Izquierdo-Lara RW, et al. Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency. J Infect Dis. 2022;226(10):1781-9. |
| 162 | van Laar JA. Can SARS-CoV-2 vaccinations induce auto-inflammatory diseases? Rheumatology (Oxford). 2022;61(SI2):SI110-SI1. |
| 163 | van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, et al. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity. J Allergy Clin Immunol. 2022;149(6):1949-57. |
| 164 | van Romunde SHM, Vergouwen DPC, Iacovello D, Roelen DL, Verdijk RM, Ten Berge J, et al. Destructive inflammatory reaction after an autologous retinal pigment epithelium and choroid transplantation: no detection of an auto-immune response. J Ophthalmic Inflamm Infect. 2022;12(1):27. |
| 165 | van Schouwenburg PA, van der Burg M, H IJ. NGS-Based B-Cell Receptor Repertoire AnalysisRepertoire analyses in the Context of Inborn Errors of Immunity. Methods Mol Biol. 2022;2453:169-90. |
| 166 | van Straalen KR, Dudink K, Aarts P, van der Zee HH, van den Bosch TPP, Giang J, et al. Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander? Front Immunol. 2022;13:953674. |
| 167 | van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022;149(4):1150-61. |
| 168 | van Tilburg SJ, Jacobs BC, Ooijevaar-de Heer P, Fokkink WR, Huizinga R, Vidarsson G, et al. Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains. Eur J Immunol. 2022;52(4):609-17. |
| 169 | van Wijck RTA, Swagemakers SMA, van der Spek PJ, van Hagen PM, van Daele PLA. A CDC42 Stop-loss Mutation in a Patient with Relapsing Polychondritis and Autoinflammation. J Clin Immunol. 2022. |
| 170 | Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Autoantibodies in Sjogren’s syndrome and its classification criteria. J Transl Autoimmun. 2022;5:100138. |
| 171 | Verbeek MWC, Buracchi C, Laqua A, Nierkens S, Sedek L, Flores-Montero J, et al. Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies – a EuroFlow study. Br J Haematol. 2022;197(1):76-81. |
| 172 | Verbeek MWC, Erkeland SJ, van der Velden VHJ. Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies. Biomedicines. 2022;10(6). |
| 173 | Vergouwen DPC, van Laar JAM, Ten Berge JC, Ramdas WD, Rothova A. Efficacy and maintenance of rituximab treatment in non-infectious scleritis. Acta Ophthalmol. 2022;100(3):e861-e3. |
| 174 | Versteegh MM, Huygens SA, Wokke BWH, Smolders J. Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis. Value Health. 2022;25(6):984-91. |
| 175 | Volkov M, Coppola M, Huizinga R, Eftimov F, Huizinga TWJ, van der Kooi AJ, et al. Comprehensive overview of autoantibody isotype and subclass distribution. J Allergy Clin Immunol. 2022;150(5):999-1010. |
| 176 | Wahadat MJ, Schonenberg-Meinema D, van Helden-Meeuwsen CG, van Tilburg SJ, Groot N, Schatorje EJH, et al. Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study. Rheumatology (Oxford). 2022;61(11):4344-54. |
| 177 | Westers TM, Saft L, van der Velden VHJ, Te Marvelde JG, Dunlop A, Ireland R, et al. A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromes. Cytometry B Clin Cytom. 2022. |
| 178 | Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, et al. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Transl Psychiatry. 2022;12(1):457. |
| 179 | Zambito G, Mishra G, Schliehe C, Mezzanotte L. Near-Infrared Bioluminescence Imaging of Macrophage Sensors for Cancer Detection In Vivo. Front Bioeng Biotechnol. 2022;10:867164. |
| 180 | Zguro K, Baldassarri M, Fava F, Beligni G, Daga S, Leoncini R, et al. Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19. Viruses. 2022;14(6). |
| 181 | Zhou Z, Hollink I, Bouman A, Lourens MS, Brooimans RA, van Ham TJ, et al. Three patients with defects in interferon gamma receptor signaling: A challenging diagnosis. Pediatr Allergy Immunol. 2022;33(4):e13768. |
| 182 | Zhou Z, Zondag T, Hermans M, van Hagen PM, Laar JAM. Correction to: Hemophagocytic lymphohistiocytosis in activated PI3K delta syndrome, an illustrative case report. J Clin Immunol. 2022;42(4):910. |
| 183 | Zondag TCE, Torralba-Raga L, Van Laar JAM, Hermans MAW, Bouman A, Hollink I, et al. Novel RAB27A Variant Associated with Late-Onset Hemophagocytic Lymphohistiocytosis Alters Effector Protein Binding. J Clin Immunol. 2022. |
| 184 | Zoutman WH, Nell RJ, Versluis M, Pico I, Khanh Vu TH, Verdijk RM, et al. A novel digital PCR-based method to quantify (switched) B cells reveals the extent of allelic involvement in different recombination processes in the IGH locus. Mol Immunol. 2022;145:109-23. |
| 185 | Hoogstrate Y, Jenster GW, van de Werken HJG. FASTAFS: file system virtualisation of random access compressed FASTA files. BMC Bioinformatics. 2021;22(1):535. |
| 186 | D SdB, Kilpatrick AM, Marques M, Gomez-Salazar M, Ventura T, Gonzalez ZN, et al. PDGFRβ(+) cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny. Cell Rep. 2022;40(3):111114. |
| 187 | Drabarek W, van Riet J, Nguyen JQN, Smit KN, van Poppelen NM, Jansen R, et al. Identification of Early-Onset Metastasis in SF3B1 Mutated Uveal Melanoma. Cancers (Basel). 2022;14(3). |
| 188 | Erkeland SJ, Stavast CJ, Schilperoord-Vermeulen J, Dal Collo G, Van de Werken HJG, Leon LG, et al. The miR-200c/141-ZEB2-TGFbeta axis is aberrant in human T-cell prolymphocytic leukemia. Haematologica. 2022;107(1):143-53. |
| 189 | Erkeland SJ, Stavast CJ, Schilperoord-Vermeulen J, Dal Collo G, Van de Werken HJG, Leon LG, et al. The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia. Haematologica. 2022;107(1):143-53. |
| 190 | Hoogstrate Y, Ghisai SA, de Wit M, de Heer I, Draaisma K, van Riet J, et al. The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis. Neuro Oncol. 2022;24(3):429-41. |
| 191 | Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, et al. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjogren’s syndrome. Rheumatology (Oxford). 2022;61(8):3491-6. |
| 192 | Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, et al. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome. Rheumatology (Oxford). 2022;61(8):3491-6. |
| 193 | Huijser E, van Helden-Meeuwsen CG, Grashof DGB, Tarn JR, Brkic Z, Huisman JMA, et al. Trained Immunity in Primary Sjogren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype. Front Immunol. 2022;13:840751. |
| 194 | Huijser E, van Helden-Meeuwsen CG, Grashof DGB, Tarn JR, Brkic Z, Huisman JMA, et al. Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype. Front Immunol. 2022;13:840751. |
| 195 | Meijer TG, Nguyen L, Van Hoeck A, Sieuwerts AM, Verkaik NS, Ladan MM, et al. Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests. Oncogene. 2022;41(26):3498-506. |
| 196 | Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, et al. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nat Commun. 2022;13(1):915. |
| 197 | Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, et al. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nat Commun. 2022;13(1):915. |
| 198 | Nakauma-González JA, Rijnders M, van de Werken HJG, Lolkema MPJ, Boormans JL. Reply to Yuxuan Song, Caipeng Qin, and Tao Xu’s Letter to the Editor re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6. Eur Urol. 2022;82(3):e78-e9. |
| 199 | Nakauma-González JA, Rijnders M, van Riet J, van der Heijden MS, Voortman J, Cuppen E, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol. 2022;81(4):331-6. |
| 200 | Timmerman DM, Eleveld TF, Sriram S, Dorssers LCJ, Gillis AJM, Schmidtova S, et al. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. J Clin Oncol. 2022;40(26):3077-87. |
| 201 | van de Geer WS, Hoogstrate Y, Draaisma K, Robe PA, Bins S, Mathijssen RHJ, et al. Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas. Neurooncol Adv. 2022;4(1):vdab177. |
| 202 | van de Geer WS, van Riet J, van de Werken HJG. ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies. Bioinformatics. 2022;38(5):1437-9. |
| 203 | Van Hemelryk A, Tomljanovic I, de Ridder CMA, Stuurman DC, Teubel WJ, Erkens-Schulze S, et al. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling. Cells. 2022;11(22). |
PUBLICATIONS 2021
| Agathangelidis A, Chatzidimitriou A, Gemenetzi K, Giudicelli V, Karypidou M, Plevova K, et al. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood. 2021;137(10):1365-76. |
| Arteaga-Henriquez G, Burger B, Weidinger E, Grosse L, Moll N, Schuetze G, et al. Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110226. |
| Assmann J, Kolijn PM, Schrijver B, van Gammeren AJ, Loth DW, Ermens T, et al. TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients. J Leukoc Biol. 2021. |
| Bansie RD, Karim AF, van Maaren MS, Hermans MA, van Daele P, Gerth van Wijk R, et al. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review. Int J Immunopathol Pharmacol. 2021;35:20587384211015061. |
| Bastiaansen AEM, van Steenhoven RW, de Bruijn M, Crijnen YS, van Sonderen A, van Coevorden-Hameete MH, et al. Autoimmune Encephalitis Resembling Dementia Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(5). |
| Berbers RM, Drylewicz J, Ellerbroek PM, van Montfrans JM, Dalm V, van Hagen PM, et al. Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency. J Clin Immunol. 2021;41(2):362-73. |
| Berbers RM, van der Wal MM, van Montfrans JM, Ellerbroek PM, Dalm V, van Hagen PM, et al. Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency. J Clin Immunol. 2021. |
| Blom M, Berghuis D, Vermont CL, Kemper EA, Weijman G, Dekkers EHBM, et al. Voor het eerst Nederlandse SCID-patiënt geidentificeerd met de hielprikscreening. Ned Tijdschr Allergie Astma Klin Immunologie. 2021;21:24-7. |
| Blom M, Bredius RGM, Jansen ME, Weijman G, Kemper EA, Vermont CL, et al. Parents’ Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. J Clin Immunol. 2021;41(1):99-108. |
| Both T, Dalm V, Richardson SA, van Schie N, van den Broek LM, de Vries AC, et al. Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review. Autoimmun Rev. 2021;20(8):102872. |
| Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, et al. Brain-immune crosstalk in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2021;45:89-107. |
| Brand HK, Schreurs MWJ, Emons JAM, Gerth van Wijk R, de Groot H, Arends NJT. Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children. Clin Mol Allergy. 2021;19(1):14. |
| Bras AE, Osmani Z, de Haas V, Jongen-Lavrencic M, Te Marvelde JG, Zwaan CM, et al. Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia. Br J Haematol. 2021;193(5):922-7. |
| Brivio E, Locatelli F, Lopez-Yurda M, Malone A, Diaz-de-Heredia C, Bielorai B, et al. A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study). Blood. 2021;137(12):1582-90. |
| Broers MC, Bunschoten C, Drenthen J, Beck TAO, Brusse E, Lingsma HF, et al. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2021;28(6):2065-73. |
| Bus SRM, Broers MC, Lucke IM, Bunschoten C, van Lieverloo GGA, Adrichem ME, et al. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study. J Neurol. 2021. |
| Collins A, Lendrem D, Wason J, Tarn J, Howard-Tripp N, Bodewes I, et al. Revisiting the JOQUER trial: stratification of primary Sjogren’s syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatol Int. 2021;41(9):1593-600. |
| Damasceno D, Almeida J, Teodosio C, Sanoja-Flores L, Mayado A, Perez-Pons A, et al. Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Cancers (Basel). 2021;13(6). |
| Dankers W, den Braanker H, Paulissen SMJ, van Hamburg JP, Davelaar N, Colin EM, et al. The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFNgamma-independent manner. Arthritis Res Ther. 2021;23(1):157. |
| de Bruijn M, Bastiaansen AEM, Mojzisova H, van Sonderen A, Thijs RD, Majoie MJM, et al. Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score. Ann Neurol. 2021;89(4):698-710. |
| de Haas V, Pieters R, van der Sluijs-Gelling AJ, Zwaan CM, de Groot-Kruseman HA, Sonneveld E, et al. Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology. Leukemia. 2021;35(6):1773-6. |
| de Jong NW, Terlouw S, van Boven FE, van Maaren MS, Schreurs MWJ, van den Berg-Somhorst D, et al. Birch Pollen Related Pear Allergy: A Single-Blind Oral Challenge TRIAL with 2 Pear Cultivars. Nutrients. 2021;13(4). |
| de Mol CL, Looman KIM, van Luijn MM, Kreft KL, Jansen PR, van Zelm MC, et al. T cell composition and polygenic multiple sclerosis risk: A population-based study in children. Eur J Neurol. 2021. |
| de Winter DTC, Langerak AW, Te Marvelde J, Dworzak MN, De Moerloose B, Stary J, et al. The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study. Leuk Res. 2021:106652. |
| den Dunnen J, Mes L, Hoepel W, Smolders J. Multiple sclerosis: why we should focus on both sides of the (auto)antibody. Neural Regen Res. 2021;16(12):2422-4. |
| Detiger SE, Kremer TM, V ASHD, de Keizer ROB, Wubbels RJ, Metselaar JM, et al. A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves’ orbitopathy with reduced systemic steroid exposure. Acta Ophthalmol. 2021. |
| Drenthen J, Islam B, Islam Z, Mohammad QD, Maathuis EM, Visser GH, et al. Changes in motor nerve excitability in acute phase Guillain-Barre syndrome. Muscle Nerve. 2021;63(4):546-52. |
| Ekronarongchai S, Palaga T, Saonanon P, Pruksakorn V, Hirankarn N, van Hagen PM, et al. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves’ Ophthalmopathy Patients. Thyroid. 2021. |
| Erkeland SJ, Stavast CJ, Schilperoord-Vermeulen J, Dal Collo G, Van de Werken HJG, Leon LG, et al. The miR-200c/141-ZEB2-TGFbeta axis is aberrant in human T-cell prolymphocytic leukemia. Haematologica. 2021. |
| Fransen NL, de Jong BA, Hess K, Kuhlmann T, Vincenten MCJ, Hamann J, et al. Absence of B Cells in Brainstem and White Matter Lesions Associates With Less Severe Disease and Absence of Oligoclonal Bands in MS. Neurol Neuroimmunol Neuroinflamm. 2021;8(2). |
| Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, et al. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun. 2021;12(1):3189. |
| Ghebes CA, Morhayim J, Kleijer M, Koroglu M, Erkeland SJ, Hoogenboezem R, et al. Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote ex vivo Expansion of Hematopoietic Stem and Progenitor Cells. Front Bioeng Biotechnol. 2021;9:640419. |
| Goemans BF, Noort S, Blink M, Wang YD, Peters S, van Wouwe JP, et al. Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia. Leukemia. 2021;35(8):2403-6. |
| Greiner TC, Bagg A, Langerak AW. Transitioning From T-Cell Clonality Testing to High-Throughput Sequencing. J Mol Diagn. 2021;23(7):781-3. |
| Guchelaar NAD, van Laar JAM, Hermans MAW, van der Houwen TB, Atmaca S, van Maaren MS, et al. Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department. J Transl Autoimmun. 2021;4:100084. |
| Guchelaar NAD, Waling MM, Adhin AA, van Daele PLA, Schreurs MWJ, Rombach SM. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis. Autoimmun Rev. 2021;20(1):102716. |
| Haarman B, Stam E, Borkent J, Ioannou M, Drexhage HA. The aberrant immune system in bipolar disorder. In: Berk M, Leboyer M, Sommer I, editors. Immuno-psychiatry. 1: Springer; 2021. |
| Hengeveld PJ, Levin MD, Kolijn PM, Langerak AW. Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications. Exp Hematol. 2021;93:14-24. |
| Hermans MAW, van Stigt AC, van de Meerendonk S, Schrijver B, van Daele PLA, van Hagen PM, et al. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2. Front Immunol. 2021;12:625284. |
| Hsiao CC, Fransen NL, van den Bosch AMR, Brandwijk KIM, Huitinga I, Hamann J, et al. White matter lesions in multiple sclerosis are enriched for CD20(dim) CD8(+) tissue-resident memory T cells. Eur J Immunol. 2021;51(2):483-6. |
| Hsiao CC, Sankowski R, Prinz M, Smolders J, Huitinga I, Hamann J. GPCRomics of Homeostatic and Disease-Associated Human Microglia. Front Immunol. 2021;12:674189. |
| Huijser E, Versnel MA. Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjogren’s Syndrome. J Clin Med. 2021;10(3). |
| Hurkmans DP, Sassen SDT, de Joode K, Putter L, Basak EA, Wijkhuijs AJM, et al. Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors. J Immunother Cancer. 2021;9(6). |
| Islam B, Islam Z, Endtz HP, Jahan I, Jacobs BC, Mohammad QD, et al. Electrophysiology of Guillain-Barré syndrome in Bangladesh: A prospective study of 312 patients. Clinical Neurophysiology Practice. 2021;6:155-63. |
| Janssen M, Rijvers L, Koetzier SC, Wierenga-Wolf AF, Melief MJ, van Langelaar J, et al. Pregnancy-induced effects on memory B-cell development in multiple sclerosis. Sci Rep. 2021;11(1):12126. |
| Kaiser FMP, Reisli I, Pico-Knijnenburg I, Langerak AW, Kavelaars FG, Artac H, et al. Protein functionality as a potential bottleneck for somatic revertant variants. J Allergy Clin Immunol. 2021;147(1):391-3 e8. |
| Kemps PG, Hebeda KM, Pals ST, Verdijk RM, Lam KH, Bruggink AH, et al. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. J Pathol Clin Res. 2021;7(1):10-26. |
| Khan SR, van der Burgh AC, Peeters RP, van Hagen PM, Dalm V, Chaker L. Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-Analysis. Front Immunol. 2021;12:664526. |
| Koetzier SC, Neuteboom RF, Wierenga-Wolf AF, Melief MJ, de Mol CL, van Rijswijk A, et al. Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple Sclerosis. Front Immunol. 2021;12:642038. |
| Kuiper RP, Hoogeveen PG, Bladergroen R, van Dijk F, Sonneveld E, van Leeuwen FN, et al. Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all. Br J Haematol. 2021. |
| Kuitwaard K, Brusse E, Jacobs BC, Vrancken A, Eftimov F, Notermans NC, et al. Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2021;28(1):286-96. |
| Kuitwaard K, van Doorn PA, Bengrine T, van Rijs W, Baas F, Nagelkerke SQ, et al. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2021;28(5):1677-83. |
| Kusunoki S, Willison HJ, Jacobs BC. Antiglycolipid antibodies in Guillain-Barre and Fisher syndromes: discovery, current status and future perspective. J Neurol Neurosurg Psychiatry. 2021;92(3):311-8. |
| Lamers OAC, Smits BM, Leavis HL, de Bree GJ, Cunningham-Rundles C, Dalm V, et al. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review. Front Immunol. 2021;12:606099. |
| Langerak T, van Rooij I, Doornekamp L, Chandler F, Baptista M, Yang H, et al. Guillain-Barre Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections. Front Neurol. 2021;12:635753. |
| Leenders AM, Kroeze LI, Rijntjes J, Luijks J, Hebeda KM, Darzentas N, et al. Multiple Immunoglobulin kappa Gene Rearrangements within a Single Clone Unraveled by NGS-Based Clonality Assessment. J Mol Diagn. 2021. |
| Leijten EF, van Kempen TS, Olde Nordkamp MA, Pouw JN, Kleinrensink NJ, Vincken NL, et al. Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis. Arthritis Rheumatol. 2021;73(7):1220-32. |
| Leonhard SE, Halstead S, Lant SB, Militao de Albuquerque MFP, de Brito CAA, de Albuquerque LBB, et al. Guillain-Barre syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study. J Neurol Sci. 2021;420:117272. |
| Lhermitte L, Barreau S, Morf D, Fernandez P, Grigore G, Barrena S, et al. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study. Mod Pathol. 2021;34(1):59-69. |
| Lunn MP, Cornblath DR, Jacobs BC, Querol L, van Doorn PA, Hughes RA, et al. COVID-19 vaccine and Guillain-Barre syndrome: let’s not leap to associations. Brain. 2021;144(2):357-60. |
| Luque-Martin R, Mander PK, Leenen PJM, Winther MPJ. Classic and new mediators for in vitro modelling of human macrophages. J Leukoc Biol. 2021;109(3):549-60. |
| Madsen KB, Momen NC, Petersen LV, Plana-Ripoll O, Haarman BCM, Drexhage H, et al. Bidirectional associations between treatment-resistant depression and general medical conditions. Eur Neuropsychopharmacol. 2021;51:7-19. |
| Mendonca de Pontes R, Flores-Montero J, Sanoja-Flores L, Puig N, Pessoa de Magalhaes RJ, Corral-Mateos A, et al. B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients. Cancers (Basel). 2021;13(7). |
| Miedema J, Schreurs M, van der Sar-van der Brugge S, Paats M, Baart S, Bakker M, et al. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course. Front Immunol. 2021;12:684142. |
| Mimpen M, Damoiseaux J, van Doorn W, Rolf L, Muris AH, Hupperts R, et al. Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients. J Neuroimmunol. 2021;358:577664. |
| Mimpen M, Muris AH, Rolf L, Gerlach O, Kuhle J, Hupperts R, et al. Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis. Eur J Neurol. 2021;28(3):901-9. |
| Mimpen M, Rolf L, Muris AH, Gerlach O, Poelmans G, Hupperts R, et al. NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis. J Neuroimmunol. 2021;353:577499. |
| Oliva S, Bruinink DHO, Rihova L, D’Agostino M, Pantani L, Capra A, et al. Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. Blood Cancer J. 2021;11(6):106. |
| Olofsen PA, Bosch DA, Roovers O, van Strien PMH, de Looper HWJ, Hoogenboezem RM, et al. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations. Blood Adv. 2021;5(3):775-86. |
| Olsthoorn SEM, Wang X, Tillema B, Vanmierlo T, Kraan S, Leenen PJM, et al. Brown seaweed food supplementation: Effects on allergy and inflammation and its consequences. Nutrients. 2021;13(8). |
| Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain-Barre syndrome in low-income and middle-income countries: challenges and prospects. Nat Rev Neurol. 2021;17(5):285-96. |
| Perez-Galarza J, Baldeon L, Franco OH, Muka T, Drexhage HA, Voortman T, et al. Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study. J Endocrinol Invest. 2021;44(1):63-74. |
| Perez-Galarza J, Procel C, Canadas C, Aguirre D, Pibaque R, Bedon R, et al. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review. Vaccines (Basel). 2021;9(2):1-20. |
| Phan ANL, Pham TTT, Phan XT, Huynh N, Nguyen TM, Cao CTT, et al. CD40LG mutations in Vietnamese patients with X-linked hyper-IgM syndrome; catastrophic anti-phospholipid syndrome as a new complication. Mol Genet Genomic Med. 2021:e1732. |
| Ramos AP, Leonhard SE, Halstead SK, Cuba MA, Castaneda CC, Dioses JA, et al. Guillain-Barre Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection. Neurol Neuroimmunol Neuroinflamm. 2021;8(2). |
| Rao S, Lungu C, Crespo R, Steijaert TH, Gorska A, Palstra RJ, et al. Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir. Nat Commun. 2021;12(1):2475. |
| Razawy W, Alves CH, Koedam M, Asmawidjaja PS, Mus AMC, Oukka M, et al. IL-23 receptor deficiency results in lower bone mass via indirect regulation of bone formation. Sci Rep. 2021;11(1):10244. |
| Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 2021;148(9):2115-28. |
| Schrijver B, Kolijn PM, Ten Berge J, Nagtzaam NMA, van Rijswijk A, Swagemakers SMA, et al. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. Acta Ophthalmol. 2021. |
| Simon MS, Schiweck C, Arteaga-Henriquez G, Poletti S, Haarman BCM, Dik WA, et al. Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110391. |
| Smeele HTW, Schreurs MWJ, Costedoat-Chalumeau N, Cornette JMJ, Dolhain R. Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive. RMD Open. 2021;7(2). |
| Smid LM, Vermeer KA, Missotten T, van Laar JAM, van Velthoven MEJ. Parafoveal Microvascular Alterations in Ocular and Non-Ocular Behet’s Disease Evaluated With Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2021;62(3):8. |
| Smits BM, Kleine Budde I, de Vries E, Ten Berge IJM, Bredius RGM, van Deuren M, et al. Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. J Clin Immunol. 2021;41(2):382-92. |
| Smolders J, Fransen NL, Huitinga I, Hamann J. Reply: Tissue-resident CD8+ memory T cells in multiple sclerosis. Brain. 2021;144(1):e8. |
| Smolders J, Hiller A, Camu W. Editorial: Vitamin D in Neurological Diseases: From Pathophysiology to Therapy. Front Neurol. 2021;12:614900. |
| Smolders J, van den Ouweland J, Geven C, Pickkers P, Kox M. Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism. 2021;115:154434. |
| Sommer IE, Gangadin SS, de Witte LD, Koops S, van Baal C, Bahn S, et al. Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial. Schizophr Bull. 2021;47(4):1108-15. |
| Soonthornchai W, Tangtanatakul P, Meesilpavikkai K, Dalm V, Kueanjinda P, Wongpiyabovorn J. MicroRNA-378a-3p is overexpressed in psoriasis and modulates cell cycle arrest in keratinocytes via targeting BMP2 gene. Sci Rep. 2021;11(1):14186. |
| Stutterheim J, van der Sluis IM, de Lorenzo P, Alten J, Ancliffe P, Attarbaschi A, et al. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. J Clin Oncol. 2021;39(6):652-62. |
| Taft J, Markson M, Legarda D, Patel R, Chan M, Malle L, et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell. 2021. |
| Talarico R, Aguilera S, Alexander T, Amoura Z, Antunes AM, Arnaud L, et al. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021;17(3):177-84. |
| Tyler PM, Bucklin ML, Zhao M, Maher TJ, Rice AJ, Ji W, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021. |
| Van den Bossche J, Leenen PJM. Keep your macrophages fit for healthy aging. Cell Metab. 2021;33(3):468-70. |
| van den Bossche WBL, Vincent A, Teodosio C, Koets J, Taha A, Kleijn A, et al. Monocytes carrying GFAP detect glioma, brain metastasis and ischaemic stroke, and predict glioblastoma survival. Brain Commun. 2021;3(1):fcaa215. |
| van den Brand M, Rijntjes J, Mobs M, Steinhilber J, van der Klift MY, Heezen KC, et al. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS. J Mol Diagn. 2021. |
| van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, et al. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. J Allergy Clin Immunol. 2021. |
| van der Ploeg EK, Hermans MAW, van der Velden VHJ, Dik WA, van Daele PLA, Stadhouders R. Increased group 2 innate lymphoid cells in peripheral blood of adults with mastocytosis. J Allergy Clin Immunol. 2021;147(4):1490-6 e2. |
| van der Velden VHJ, Bruggemann M, Cazzaniga G, Scheijen B, Tops B, Trka J, et al. Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study. Leukemia. 2021;35(3):924-8. |
| van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA, et al. The association of Epstein-Barr virus infection with CXCR3(+) B-cell development in multiple sclerosis: impact of immunotherapies. Eur J Immunol. 2021;51(3):626-33. |
| van Stigt AC, Dalm V, Nagtzaam NMA, van Rijswijk DA, Barendregt BH, van Hagen PM, et al. Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency. J Clin Immunol. 2021;41(3):694-7. |
| van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, Schreurs MWJ, Langerak AW, Mulder CJJ, et al. Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center. Clin Transl Gastroenterol. 2021;12(8):e00387. |
| Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, et al. Intravenous immunoglobulin treatment for mild Guillain-Barre syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021. |
| Vergouwen DPC, van Laar JAM, Ten Berge JC, Ramdas WD, Rothova A. Efficacy and maintenance of rituximab treatment in non-infectious scleritis. Acta Ophthalmol. 2021. |
| Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. The Lancet Neurology. 2021;20(4):275-83. |
| Zhou Z, Zondag T, Hermans M, van Hagen PM, van Laar JAM. Hemophagocytic Lymphohistiocytosis in Activated PI3K Delta Syndrome: an Illustrative Case Report. J Clin Immunol. 2021:1-4. |
| Zouboulis CC, van Laar JAM, Schirmer M, Emmi G, Fortune F, Gul A, et al. Adamantiades-Behcet’s disease (Behcet’s disease) and COVID-19. J Eur Acad Dermatol Venereol. 2021. |
PUBLICATIONS 2020
| Allaerts, W. (immunology) (2020). How Could This Happen?: Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS). Acta Biotheoretica, 68 (4), 441-452. doi: https://doi.org/10.1007/s10441-020-09382-z |
| Baroni, M.L. (external organisation), Martinez, D.S. (external organisation), Aguera, F.G. (external organisation), Ho, H.R. (external organisation), Castella, M. (external organisation), Zanetti, S. (external organisation), Hernandez, T.V. (external organisation), Guardia, R.D. de la (external organisation), Castano, J. (external organisation), Anguita, E. (external organisation), Vives, S. (external organisation), Nomdedeu, J. (external organisation), Lapillone, H. (external organisation), Bras, A.E. (immunology), Velden, V.H.J. van der (immunology), Junca, J. (external organisation), Marin, P. (external organisation), Bataller, A. (external organisation), Esteve, J. (external organisation), Vick, B. (external organisation), Jeremias, I. (external organisation), Lopez, A. (external organisation), Sorigue, M. (external organisation), Bueno, C. (external organisation) & Menendez, P. (external organisation) (2020). 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. Journal for Immunotherapy of Cancer, 8 (1):e000845. doi: https://doi.org/10.1136/jitc-2020-000845 |
| Basak, E.A. (medical oncology), Meer, J.W.M. van der (medical oncology), Hurkmans, D.P. (medical oncology + pulmonology), Schreurs, M.W.J. (immunology), Hoop, E. de (medical oncology), Veldt, A.A.M. van der (medical oncology + radiology), Bins, S. (medical oncology), Joosse, A. (medical oncology), Koolen, S.L.W. (pharmacy + medical oncology), Debets, R. (medical oncology), Peeters, R.P. (internal medicine), Aerts, J.G.J.V. (pulmonology), Mathijssen, A.H.J. (medical oncology) & Medici, M. (internal medicine) (2020). Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients. Thyroid, 30 (7), 966-973. doi: https://doi.org/10.1089/thy.2019.0726 |
| Bastiaan-Net, S. (external organisation), Batstra, M.R. (external organisation), Aazamy, N (internal medicine), Savelkoul, H. (external organisation), Valk, J.P. van der (internal medicine), Gerth van Wijk, R. (internal medicine), Schreurs, M.W.J. (immunology), Wichers, H. (external organisation) & Jong, N.W. de (internal medicine) (2020). IgE cross-reactivity measurement of cashew nut, hazelnut and peanut using a novel IMMULITE inhibition method. Clinical Chemistry and Laboratory Medicine, 58 (11), 1875-1883. doi: https://doi.org/10.1515/cclm-2019-1083 |
| Berbers, R.M. (external organisation), Hoesein, F. (external organisation), Ellerbroek, P. (external organisation), Montfrans, J. van (external organisation), Dalm, V.A.S.H. (immunology + internal medicine), Hagen, P.M. van (immunology + internal medicine), Paganelli, F.L. (external organisation), Viveen, M.C. (external organisation), Rogers, M.R.C. (external organisation), Jong, P.A. de (external organisation), Uh, H. (external organisation), Willems, R. (external organisation) & Leavis, H. (external organisation) (2020). Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency. Frontiers in Immunology, 11:1245. doi: https://doi.org/10.3389/fimmu.2020.01245 |
| Bergh, P. Van den (external organisation), Doorn, P.A. van (neurology), Jacobs, B.C. (immunology + neurology), Querol, L. (external organisation), Bunschoten, C. (neurology + immunology) & Cornblath, D. (external organisation) (2020). Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 25, 4-8. doi: https://doi.org/10.1111/jns.12364 |
| Betjes, M.G.H. (internal medicine), Langerak, A.W. (immunology), Klepper, M. (internal medicine) & litjens, N.H.R. (internal medicine) (2020). A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation. Immunity and Ageing, 17 (1):4. doi: https://doi.org/10.1186/s12979-020-00175-z |
| Beute, J (pulmonology), Ganesh, K. (pulmonology), Nastiti, H.A. (pulmonology), Hoogenboom, R.M. (pulmonology), Bos, V. (pulmonology), Folkerts, J. (pulmonology), Schreurs, M.W.J. (immunology), Hockman, S. (external organisation), Hendriks, R.W. (pulmonology) & Kleinjan, A. (pulmonology) (2020). PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells. Frontiers in pharmacology, 11:470. doi: https://doi.org/10.3389/fphar.2020.00470 |
| Bharwani, K.D. (anesthesiology), Dirckx, M. (anesthesiology), Stronks, D.L. (anesthesiology), Dik, W.A. (immunology) & Huygen, F.J.P.M. (anesthesiology) (2020). Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting. Mediators of Inflammation, 2020:6259064. doi: https://doi.org/10.1155/2020/6259064 |
| Bodewes, I.L.A. (immunology), Gottenberg, J.E. (external organisation), Helden-Meeuwsen, C.G. van (immunology), Mariette, X. (external organisation) & Versnel, M.A. (immunology) (2020). Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren’s syndrome in the JOQUER randomized trial. Rheumatology, 59 (1), 107-111. doi: https://doi.org/10.1093/rheumatology/kez242 |
| Bons, L.R. (cardiology), Geenen, L.W. (cardiology), Hoven, A.T. van den (cardiology), Dik, W.A. (immunology), Bosch, A.E. van den (cardiology), Duijnhouwer, A.L. (external organisation), Siebelink, H. (external organisation), Budde, R.P.J. (radiology), Boersma, E. (epidemiology + cardiology), Wessels, M.W. (clinical genetics), Laar, I.M.B.H. van de (clinical genetics), DeRuiter, M.C. (external organisation), Goumans, M. (external organisation), Loeys, B. (external organisation) & Roos-Hesselink, J.W. (cardiology) (2020). Blood biomarkers in patients with bicuspid aortic valve disease. Journal of Cardiology (Tokyo), 76 (3), 287-294. doi: https://doi.org/10.1016/j.jjcc.2020.02.023 |
| Bras, A.E. (immunology) & Velden, V.H.J. van der (immunology) (2020). Robust FCS Parsing: Exploring 211,359 Public Files. Cytometry Part A, 97 (11), 1180-1186. doi: https://doi.org/10.1002/cyto.a.24187 |
| Broers, M.C. (neurology), Doorn, P.A. van (neurology), Kuitwaard, K. (external organisation), Eftimov, F. (external organisation), Wirtz, P.W. (external organisation), Goedee, S. (external organisation), Lingsma, H.F. (public health) & Jacobs, B.C. (immunology + neurology) (2020). Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: A survey among Dutch neurologists. Journal of the Peripheral Nervous System, 25 (3), 247-255. doi: https://doi.org/10.1111/jns.12399 |
| Bruijn, M.A.A.M. de (neurology), Bruijstens, A.L. (neurology), Bastiaansen, A.E.M. (neurology), Sonderen, A. van (neurology), Schreurs, M.W.J. (immunology), Sillevis Smitt, P.A.E. (neurology), Hintzen, R.Q. (neurology), Neuteboom, R.F. (neurology) & Titulaer, M.J. (neurology) (2020). Pediatric autoimmune encephalitis: Recognition and diagnosis. Neurology(R) neuroimmunology & neuroinflammation, 7. doi: https://doi.org/10.1212/NXI.0000000000000682 |
| Casabonne, D. (external organisation), Benavente, Y. (external organisation), Seifert, J. (external organisation), Costas, L. (external organisation), Armesto, M. (external organisation), Arestin, M. (external organisation), Besson, C. (external organisation), Saberi Hosnijeh, F. (immunology), Duell, E. (external organisation), Weiderpass, E. (external organisation), Masala, G. (external organisation), Kaaks, R. (external organisation), Canzian, F. (external organisation), Chirlaque, M. (external organisation), Perduca, V. (external organisation), Mancini, F.R. (external organisation), Pala, V. (external organisation), Trichopoulou, A. (external organisation), Karakatsani, A. (external organisation), Vecchia, C. La (external organisation), Sánchez, M.J. (external organisation), Tumino, R. (external organisation), Gunter, M. (external organisation), Amiano, P. (external organisation), Panico, S. (external organisation), Sacerdote, C. (external organisation), Schmidt, J.A. (external organisation), Boeing, H. (external organisation), Schulze, M. (external organisation), Barricarte, A. (external organisation), Riboli, E. (external organisation), Olsen, A. (external organisation), Tjønneland, A. (external organisation), Vermeulen, R. (external organisation), Nieters, A. (external organisation), Lawrie, C.H. (external organisation) & Sanjosé, S. de (external organisation) (2020). Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. International Journal of Cancer, 147 (5), 1315-1324. doi: https://doi.org/10.1002/ijc.32894 |
| Çakici, N. (internal medicine), Sutterland, A. (external organisation), Penninx, B. (external organisation), Dalm, V.A.S.H. (immunology + internal medicine), Haan, L. de (external organisation) & Beveren, N.J.M. van (Psychiatry + neurosciences) (2020). Altered peripheral blood compounds in drug-naive first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Brain Behavior & Immunity, 88, 547-558. doi: https://doi.org/10.1016/j.bbi.2020.04.039 |
| Cools N, Depterter B, van der Velden VHJ (immunology). Joint Bsac-Nvc Congress 2019: A Colourful World. |
| Belg J Hematol. 2020;11(4):185-9. |
| Dammeijer, F.H.W.P. (pulmonology), Gulijk, M.L. van (pulmonology), Mulder, E.E.A.P. (surgery), Lukkes, M. (pulmonology), Klaase, L. (pulmonology), Bosch, T.P.P. van den (pathology), Nimwegen, M. van (pulmonology), Lau, S.P. (surgery + pulmonology), Latupeirissa, K. (pulmonology), Schetters, S. (external organisation), Kooyk, Y. van (external organisation), Boon, L. (external organisation), Moyaart, A. (pathology), Mueller, Y.M. (immunology), Katsikis, P.D. (immunology), Eggermont, A.M.M. (surgery), Vroman, H. (pulmonology), Stadhouders, R. (pulmonology + cell biology), Hendriks, R.W. (pulmonology), Thüsen, J.H. von der (pathology), Grünhagen, D.J. (surgery), Verhoef, C. (surgery), Hall, T. van (external organisation) & Aerts, J.G.J.V. (pulmonology) (2020). The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. Cancer Cell, 38 (5), 685-700.e8. doi: https://doi.org/10.1016/j.ccell.2020.09.001 |
| Davi, F. (external organisation), Langerak, A.W. (immunology), Septenville, A.L. de (external organisation), Kolijn, P.M. (immunology), Hengeveld, P.J. (immunology), Chatzidimitriou, A. (external organisation), Bonfiglio, S. (external organisation), Sutton, L. (external organisation), Rosenquist, R. (external organisation), Ghia, P. (external organisation) & Stamatopoulos, K. (external organisation) (2020). Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing. Leukemia, 34 (10), 2545-2551. doi: https://doi.org/10.1038/s41375-020-0923-9 |
| Detiger, S.E. (external organisation), Karim, A.F. (immunology), Monserez, D. (otorhinolaryngology), Verdijk, R. (pathology), Hagen, P.M. van (immunology), Paridaens, A.D.A. (ophthalmology) & Laar, J.A.M. van (immunology) (2020). IgG4-Related Disease of Skull Base: Case Series of 3 Patients with Headache. WORLD NEUROSURGERY, 134, 536-539. doi: https://doi.org/10.1016/j.wneu.2019.10.111 |
| Dijkstra-de Neijs L, Leenen PJM (immunology), Hays JP, van der Valk ES, Kraaij R, van Rossum EFC, Ester WA. |
| Biological Consequences of Psychological Distress in Caregivers of Children with Autism Spectrum Disorder and Its Potential Relevance to Other Chronic Diseases Including Cancer. |
| Current Epidemiology Reports. 2020;7:139-48. |
| Dik, W.A. (immunology) & Heron, M. (external organisation) (2020). Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Netherlands Journal of Medicine, 78 (5), 220-231. |
| Distia Nora, R. la (immunology), Putera, I. (external organisation), Khalisha, D.F. (external organisation), Septiana, I. (external organisation), Ridwan, A.S. (external organisation) & Sitompul, R. (external organisation) (2020). Are eyes the windows to COVID-19? Systematic review and meta-analysis. Bmj Open Ophthalmology, 5 (1):e000563. doi: https://doi.org/10.1136/bmjophth-2020-000563 |
| Ferreira, M.L.B. (external organisation), Albuquerque, M.D.F.P. Militão de (external organisation), Brito, C.A.A. de (external organisation), França, R.F. de Oliveira (external organisation), Moreira, Á.J. Porto (external organisation), Machado, M.Í. de Morais (external organisation), Melo, R. da Paz (external organisation), Medialdea-Carrera, R. (external organisation), Mesquita, S. Dornelas (external organisation), Santos, M. (external organisation), Mehta, R. (external organisation), Silva, R. de (external organisation), Leonhard, S.E. (neurology), Ellul, M. (external organisation), Rosala-Hallas, A. (external organisation), Burnside, G. (external organisation), Turtle, L. (external organisation), Griffiths, M.J. (external organisation), Jacobs, B.C. (immunology + neurology), Bhojak, M. (external organisation), Willison, H.J. (external organisation), Pena, L.J. (external organisation), Pardo, C.A. (external organisation), Ximenes, R.A.D. (external organisation), Martelli, C.M.T. (external organisation), Brown, D. (external organisation), Cordeiro, M.T. (external organisation), Lant, S. (external organisation) & Solomon, T. (external organisation) (2020). Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study. The Lancet Neurology, 19 (10), 826-839. doi: https://doi.org/10.1016/S1474-4422(20)30232-5 |
| Fransen, N.L. (external organisation), Hsiao, C.C. (external organisation), Poel, M. (external organisation), Engelenburg, H.J. (external organisation), Verdaasdonk, K. (external organisation), Vincenten, M.C.J. (external organisation), Remmerswaal, E.B.M. (external organisation), Kuhlmann, T. (external organisation), Mason, M.R.J. (external organisation), Hamann, J. (external organisation), Smolders, J.J.M. (immunology + neurology) & Huitinga, I. (external organisation) (2020). Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain, 143, 1714-1730. doi: https://doi.org/10.1093/brain/awaa117 |
| Frel, D.L. de (external organisation), Atsma, D.E. (external organisation), Pijl, H. (external organisation), Seidell, J.C. (external organisation), Leenen, P.J.M. (immunology), Dik, W.A. (immunology) & Rossum, E.F.C. van (internal medicine) (2020). The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19. Frontiers in Nutrition, 7:597600. doi: https://doi.org/10.3389/fnut.2020.597600 |
| Fritz, D. (external organisation), Timmermans, W.M.C. (internal medicine + immunology), Laar, J.A.M. van (immunology + internal medicine), Hagen, P.M. van (immunology + internal medicine), Siepman, T.A.M. (neurology), Beek, D.. van de (external organisation) & Brouwer, M. (external organisation) (2020). Infliximab treatment in pathology-confirmed neurosarcoidosis. Neurology(R) neuroimmunology & neuroinflammation, 7 (5). doi: https://doi.org/10.1212/NXI.0000000000000847 |
| Groen-Hakan, F. (ophthalmology), Laar, J.A.M. van (immunology + internal medicine), Bakker, M. (pulmonology), Hagen, P.M. van (immunology + internal medicine), Hardjosantoso, H.C. (ophthalmology) & Rothova, A. (ophthalmology) (2020). Prevalence of Positive QuantiFERON-TB Gold In-Tube Test in Uveitis and its Clinical Implications in a Country Nonendemic for Tuberculosis. American Journal of Ophthalmology, 211, 151-158. doi: https://doi.org/10.1016/j.ajo.2019.11.009 |
| Groenen, P.J.F. (external organisation), Langerak, A.W. (immunology), Fend, F. (external organisation) & Krieken, J. Van (external organisation) (2020). Memento for interprofessional learning. Virchows Archiv, 477 (5), 755-756. doi: https://doi.org/10.1007/s00428-020-02803-x |
| Grosserichter – Wagener, C. (immunology), Franco-Gallego, A. (external organisation), Ahmadi, F. (immunology), Moncada-Velez, M. (external organisation), Dalm, V.A.S.H. (immunology + internal medicine), Rojas, J.L. (external organisation), Orrego, J.C. (external organisation), Vargas, N.C. (external organisation), Hammarstrom, L. (external organisation), Schreurs, M.W.J. (immunology), Dik, W.A. (immunology), Hagen, P.M. van (immunology + internal medicine), Boon, L. (external organisation), Dongen, J.J.M. van (immunology), Burg, M. van der (immunology), Pan-Hammarstrom, Q. (external organisation), Franco, J.L. (external organisation) & Zelm, M.C. van (immunology) (2020). Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency. Clinical & Translational Immunology, 9 (5):e1130. doi: https://doi.org/10.1002/cti2.1130 |
| Hamann D, Damoiseaux JGMC, Langerak AW (immunology), Van Lochem EG, Otten HG. |
| Gas Geven of Remmen? Immuunmonitoring Als Basis Voor Immuuntherapie. |
| Ned Tijdschr Allergie Astma Klin Immunologie. 2020;20:24-8. |
| Hanekamp, D. (external organisation), Snel, A. (external organisation), Kelder, A. (external organisation), Scholten, W. (external organisation), Khan, N. (external organisation), Metzner, M. (external organisation), Irno-Consalvo, M. (external organisation), Sugita, M. (external organisation), Jong, A. (external organisation), Oude Alink, S.M. (immunology), Eidhof, H. (external organisation), Wilhelm, M. (external organisation), Feuring-Buske, M. (external organisation), Slomp, J. (external organisation), Velden, V.H.J. van der (immunology), Sonneveld, E.D.J.A. (external organisation), Guzman, M.G. (external organisation), Roboz, G. (external organisation), Buccisano, F. (external organisation), Vyas, P. (external organisation), Freeman, S. (external organisation), Bachas, C. (external organisation), Ossenkoppele, G. (external organisation), Schuurhuis, G.J. (external organisation) & Cloos, J. (external organisation) (2020). Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting. British Journal of Haematology, 190 (6), 891-900. doi: https://doi.org/10.1111/bjh.16594 |
| Heeringa, J.J. (immunology), McKenzie, C. (external organisation), Varese, N. (external organisation), Hew, M. (external organisation), Bakx, A.T.C.M. (external organisation), Aui, P.M. (external organisation), Rolland, J.M. (external organisation), O’hehir, R.E. (external organisation) & Zelm, M. van (external organisation) (2020). Induction of IgG2 and IgG4 B-cell memory following sublingual immunotherapy for ryegrass pollen allergy. Allergy: European Journal of Allergy and Clinical Immunology, 75 (5), 1121-1132. doi: https://doi.org/10.1111/all.14073 |
| Helfricht, A. (Molecular Genetics), Thijssen, P. (external organisation), Rother, M.B. (external organisation), Shah, R.V. (external organisation), Du, L. (external organisation), Takada, S. (external organisation), Rogier, M. (external organisation), Moritz, J. (external organisation), Ijspeert, H. (immunology), Stoepker, C. (external organisation), Ostaijen-Ten Dam, M.M. van (external organisation), Heyer, V. (external organisation), Luijsterburg, M. (external organisation), Groot, A. (external organisation), Jak, R. (external organisation), Grootaers, G. (external organisation), Wang, J. (external organisation), Rao, P.C. (external organisation), Vertegaal, A.C.O. (external organisation), Tol, M.J.D. van (external organisation), Pan-Hammarström, Q. (external organisation), Reina-San-Martin, B. (external organisation), Shah, G.M. (external organisation), Burg, M.P. (external organisation), Maarel, S. van der (external organisation) & Attikum, H. van (external organisation) (2020). Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome. The Journal of experimental medicine, 217 (11). doi: https://doi.org/10.1084/jem.20191688 |
| Hengeveld, P.J. (immunology), Khader, A.O. (external organisation), Bruin, L.H.A. de (external organisation), Geelen, I.G.P. (external organisation), Baalen, E.A. van (external organisation), Jansen, E. (external organisation), Bouwer, N.I. (external organisation), Balak, O. (external organisation), Riedl, J.A. (external organisation), Langerak, A.W. (immunology), Westerweel, P. (external organisation) & Levin, M.D. (external organisation) (2020). Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study. British Journal of Haematology, 190 (4), E201-E204. doi: https://doi.org/10.1111/bjh.16983 |
| Hofste op Bruinink, D. (hematology), Oliva, S. (external organisation), Rihova, L. (external organisation), Schmitz, A. (external organisation), Gilestro, M. (external organisation), Marvelde, J.G. te (immunology), Kralova, R. (external organisation), Høholt, H. (external organisation), Broijl, A. (hematology), Johnsen, H.E. (external organisation), Hajek, R. (external organisation), Boccadoro, M. (external organisation), Sonneveld, P. (hematology), Omedè, P. (external organisation) & Velden, V.H.J. van der (immunology) (2020). Standardization of flow cytometric minimal residual disease assessment in international clinical trials – a feasibility study from the European Myeloma Network. Haematologica, Online ahe. doi: https://doi.org/10.3324/haematol.2020.267831 |
| Hope, J.L. (immunology), Spantidea, P. (immunology), Kiernan, C.H. (immunology), Stairiker, C.J. (immunology), Rijsbergen, L.C. (immunology), Meurs, M. van (immunology), Haspels, A.A. (immunology), Müller, Y.M. (immunology), Nelson, D.J. (external organisation), Bradley, L.M. (external organisation), Aerts, J.G.J.V. (pulmonology) & Katsikis, P.D. (immunology) (2020). Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model. Frontiers in Immunology, 10:3074. doi: https://doi.org/10.3389/fimmu.2019.03074 |
| Saberi Hosnijeh, F. (immunology), Kolijn, P.M. (immunology), Casabonne, D. (external organisation), Nieters, A. (external organisation), Solans, M. (external organisation), Naudin, S. (external organisation), Ferrari, P. (external organisation), Mckay, J. (external organisation), Weiderpass, E. (external organisation), Perduca, V. (external organisation), Besson, C. (external organisation), Mancini, F.R. (external organisation), Masala, G. (external organisation), Krogh, V. (external organisation), Ricceri, F. (external organisation), Huerta, J. (external organisation), Petrova, D. (external organisation), Sala, N. (external organisation), Trichopoulou, A. (external organisation), Karakatsani, A. (external organisation), Vecchia, C. La (external organisation), Kaaks, R. (external organisation), Canzian, F. (external organisation), Aune, D. (external organisation), Boeing, H. (external organisation), Schulze, M. (external organisation), Perez-Cornago, A. (external organisation), Langerak, A.W. (immunology), Velden, V.H.J. van der (immunology) & Vermeulen, R. (external organisation) (2020). Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development. Scientific Reports, 10 (1):13814. doi: https://doi.org/10.1038/s41598-020-70790-9 |
| Saberi Hosnijeh, F. (immunology), Straten, L. van der (immunology), Kater, A. (external organisation), Oers, M. van (external organisation), Posthuma, W.F.M. (external organisation), Chamuleau, M. (external organisation), Bellido, M. (external organisation), Doorduijn, J.K. (hematology), Gelder, M. (external organisation), Hoogendoorn, M. (external organisation), Boer, F. (external organisation), Raa, G.D. te (external organisation), Kerst, J. (external organisation), Marijt, E. (external organisation), Raymakers, R. (external organisation), Koene, H.R. (external organisation), Schaafsma, M.R. (external organisation), Dobber, J.A. (external organisation), Tonino, S.H. (external organisation), Kersting, S.S. (external organisation), Langerak, A.W. (immunology) & Levin, M.D. (external organisation) (2020). Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. Experimental Hematology, 89, 55-60.e6. doi: https://doi.org/10.1016/j.exphem.2020.08.002 |
| Houwen, T.B. van der (internal medicine + immunology) & Laar, J.A.M. van (immunology + internal medicine) (2020). Behcet’s Disease, and the Role of TNF-alpha and TNF-alpha Blockers. International journal of molecular sciences, 21 (9):3072. doi: https://doi.org/10.3390/ijms21093072 |
| Houwen, T.B. van der (internal medicine + immunology), Dik, W.A. (immunology), Goeijenbier, M. (virology), Hayat, M. (internal medicine), Nagtzaam, N.M.A. (immunology), Hagen, P.M. van (immunology + internal medicine) & Laar, J.A.M. van (immunology + internal medicine) (2020). Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients. Rheumatology (Oxford, England), 59 (12), 3971-3979. doi: https://doi.org/10.1093/rheumatology/keaa251 |
| van der Houwen TB, van Laar JAM, Kappen JH, van Hagen PM, de Zoete MR, van Muijlwijk GH, Berbers RM, Fluit AC, Rogers M, Groot J, Hazelbag CM, Consolandi C, Severgnini M, Peano C, D’Elios MM, Emmi G, Leavis HL. |
| Behcet’s Disease under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behcet’s Disease Patients. |
| Front Immunol. 2020;11:1192. |
| Janssen M (immunology), Bruijstens AL, van Langelaar J (immunology), Wong Y, Wierenga-Wolf AF (immunology), Melief MJ (immunology), Rijvers L (immunology), van Pelt ED, Smolders J (immunology + neurology), Wokke BH, van Luijn MM (immunology). |
| Naive B Cells in Neuromyelitis Optica Spectrum Disorders: Impact of Steroid Use and Relapses. |
| Brain Commun. 2020;2(2):fcaa197. |
| Jong, G.M. de (clinical microbiology), McCall, M.B.B. (clinical microbiology), Dik, W.A. (immunology), Urbanus, R. (external organisation), Wammes, L.J. (clinical microbiology), Koelewijn, R. (clinical microbiology), Sauerwein, R.W. (external organisation), Verbon, A. (clinical microbiology), Hellemond, J.J. van (clinical microbiology) & Genderen, P.J.J. van (clinical microbiology) (2020). Transforming growth factor-beta profiles correlate with clinical symptoms and parameters of haemostasis and inflammation in a controlled human malaria infection. Cytokine, 125:154838. doi: https://doi.org/10.1016/j.cyto.2019.154838 |
| Kalina, T. (external organisation), Bakardjieva, M. (external organisation), Blom, M. (external organisation), Perez-Andres, M. (external organisation), Barendregt, B.H. (immunology), Kanderova, V. (external organisation), Bonroy, C. (external organisation), Philippe, J. (external organisation), Blanco, E. (external organisation), Knijnenburg, I. (immunology), Paping, J. (external organisation), Wolska-Kusnierz, B. (external organisation), Pac, M. (external organisation), Tkazcyk, J. (external organisation), Haerynck, F. (external organisation), Akar, H. (external organisation), Formankova, R. (external organisation), Freiberger, T. (external organisation), Svatori, M. (external organisation), Sediva, A. (external organisation), Arriba-Mendez, S. (external organisation), Orfao, A. (external organisation), Dongen, J.J.M. (external organisation) & Burg, M. van der (immunology) (2020). EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children. Frontiers in Immunology, 11:371. doi: https://doi.org/10.3389/fimmu.2020.00371 |
| Takam Kamga, P.(external organisation), Dal Collo, G. (immunology + external organisation), Cassaro, A. (external organisation), Bazzoni, R. (external organisation), Delfino, P. (external organisation), Adamo, A. (external organisation), Bonato, A. (external organisation), Carbone, C. (external organisation), Tanasi, I. (external organisation), Bonifacio, M. (external organisation) & Krampera, M. (external organisation) (2020). Small Molecule Inhibitors of Microenvironmental Wnt/beta-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia. Cancers, 12 (9):2696. doi: https://doi.org/10.3390/cancers12092696 |
| Kemps, P.G. (external organisation), Zondag, T.C. (immunology), Steenwijk, E.C. (external organisation), Andriessen, Q. (external organisation), Borst, J.G.G. (external organisation), Vloemans, S. (external organisation), Roelen, D. (external organisation), Voortman, L.M. (external organisation), Verdijk, R.M. (pathology), Noesel, C.J.M. van (external organisation), Cleven, A.H.G. (external organisation), Hawkins, C. (external organisation), Lang, V. (external organisation), Ru, A. de (external organisation), Janssen, G. (external organisation), Haasnoot, G. (external organisation), Franken, K. (external organisation), Eijk, R. (external organisation), Solleveld-Westerink, N. (external organisation), Wezel, T. van (external organisation), Egeler, R.M. (external organisation), Beishuizen, A. (pediatrics-hematology), Laar, J.A.M. van (immunology), Abla, O. (external organisation), Bos, C. van den (external organisation), Veelen, P. van (external organisation) & Halteren, A.G.S. van (external organisation) (2020). Apparent Lack of BRAF(V600E) Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8(+) T Cells in Langerhans Cell Histiocytosis. Frontiers in Immunology, 10:3045. doi: https://doi.org/10.3389/fimmu.2019.03045 |
| Kemps, P.G. (internal medicine + immunology), Buijs, J. (gastroenterology & hepatology), Verdijk, R.M. (pathology), Ledeboer, Q.C.P. (external organisation), Baatenburg de Jong, R.J. (otorhinolaryngology) & Laar, J.A.M. van (immunology + internal medicine) (2020). Persistent Laryngeal Swelling Caused by Primary Intralymphatic Histiocytosis. Jama Otolaryngology-Head & Neck Surgery, 146 (7), 675-677. doi: https://doi.org/10.1001/jamaoto.2020.0849 |
| Kiernan CH (immunology), Asmawidjaja PS, Fahy N, Witte-Bouma J, Wolvius EB, Brama PAJ, Lubberts E, Farrell E. |
| Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in Cd4+ Memory T Cells. |
| Tissue Eng Part A. 2020;26(9-10):490-502. |
| Kilinc, D. (external organisation), Pasch, S. van de (external organisation), Doets, A.Y. (neurology), Jacobs, B.C. (immunology + neurology), Vliet, J. (external organisation) & Garssen, M.P.J. (external organisation) (2020). Guillain-Barre syndrome after SARS-CoV-2 infection. European Journal of Neurology, 27 (9), 1757-1758. doi: https://doi.org/10.1111/ene.14398 |
| Koetzier, S.C. (immunology), Langelaar, J. van (immunology), Blok, K.M. (neurology), Bosch, T.P.P. van den (pathology), Wierenga-Wolf, A.F. (immunology), Melief, J.A.M. (immunology), Pol, K. (immunology), Siepman, T.A.M. (neurology), Verjans, G.M.G.M. (virology), Smolders, J.J.M. (immunology + neurology), lubberts, E. (rheumatology), Vries, H.J. (external organisation) & Luijn, M.M. van (immunology) (2020). Brain-homing CD4+ T cells display glucocorticoid-resistant features in MS. Neurology(R) neuroimmunology & neuroinflammation, 7 (6). doi: https://doi.org/10.1212/nxi.0000000000000894 |
| Korinthenberg, R. (external organisation), Trollmann, R. (external organisation), Felderhoff-Muser, U. (external organisation), Bernert, G. (external organisation), Hackenberg, A. (external organisation), Hufnagel, M. (external organisation), Pohl, M.O. (external organisation), Hahn, G. (external organisation), Mentzel, H.J. (external organisation), Sommer, C. (external organisation), Lambeck, J. (external organisation), Mecher, F. (external organisation), Hessenauer, M. (external organisation), Winterholler, C. (external organisation), Kempf, U. (external organisation), Jacobs, B.C. (immunology + neurology), Rostasy, K. (external organisation) & Muller-Felber, W. (external organisation) (2020). Diagnosis and treatment of Guillain-Barre Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. European Journal of Paediatric Neurology, 25, 5-16. doi: https://doi.org/10.1016/j.ejpn.2020.01.003 |
| Langelaar, J. van (immunology), Rijvers, L. (immunology), Smolders, J.J.M. (immunology + neurology) & Luijn, M.M. van (immunology) (2020). B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers. Frontiers in Immunology, 11:760. doi: https://doi.org/10.3389/fimmu.2020.00760 |
| Langerak AW, Davi F, Stamatopoulos K. |
| Immunoglobulin Heavy Variable Somatic Hyper Mutation Status in Chronic Lymphocytic Leukaemia: On the Threshold of a New Era? |
| Br J Haematol. 2020;189(5):809-10. |
| Leonhard, S.E. (neurology), Bresani-Salvi, C.C. (external organisation), Batista, J.D.L. (external organisation), Cunha, S. (external organisation), Jacobs, B.C. (immunology + neurology), Ferreira, M.L.B. (external organisation) & Albuquerque, M. de (external organisation) (2020). Guillain-Barre syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype. PLoS Neglected Tropical Diseases (print), 14 (4):e0008264. doi: https://doi.org/10.1371/journal.pntd.0008264 |
| Leonhard SE, Cornblath DR, Endtz HP, Sejvar JJ, Jacobs BC (neurology + immunology). |
| Guillain-Barre Syndrome in Times of Pandemics. |
| J Neurol Neurosurg Psychiatry. 2020;91(10):1027-9. |
| Li, T. (external organisation), Wolfert, M.A. (external organisation), Wei, N. (external organisation), Huizinga, R. (immunology), Jacobs, B.C. (immunology + neurology) & Boons, G.J. (external organisation) (2020). Chemoenzymatic Synthesis of Campylobacter jejuni Lipo-oligosaccharide Core Domains to Examine Guillain-Barré Syndrome Serum Antibody Specificities. Journal of the American Chemical Society, 142 (46), 19611-19621. doi: https://doi.org/10.1021/jacs.0c08583 |
| Lipka, A.F. (external organisation), Boldingh, M.I. (external organisation), Zwet, E. van (external organisation), Schreurs, M.W.J. (immunology), Kuks, J. (external organisation), Tallaksen, C.M. (external organisation), Titulaer, M.J. (neurology) & Verschuuren, J.J.G.M. (external organisation) (2020). Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome. Neurology, 94, e511-e520. doi: https://doi.org/10.1212/WNL.0000000000008747 |
| litjens, N.H.R. (internal medicine), Langerak, A.W. (immunology), List, A.C.J. van der (internal medicine), Klepper, M. (internal medicine), Bie, M. de (immunology), Azmani, Z. (cell biology), Dekker, A.T. den (cell biology), Brouwer, R.W.W. (cell biology), Betjes, M.G.H. (internal medicine) & IJcken, W.F.J. van (cell biology) (2020). Validation of a Combined Transcriptome and T Cell Receptor Alpha/Beta (TRA/TRB) Repertoire Assay at the Single Cell Level for Paucicellular Samples. Frontiers in Immunology, 11:1999. doi: https://doi.org/10.3389/fimmu.2020.01999 |
| Looman, K.I.M. (external organisation), Meel, E.R. van (epidemiology), Grosserichter – Wagener, C. (immunology), Vissers, F.J.M. (external organisation), Klingenberg, J.H. (Generation R), Jong, N.W. de (internal medicine), Jongste, J.C. de (pediatrics-pulmonology), Pasmans, S.G.M.A. (dermatology), Duijts, L. (pediatrics-pulmonology + pediatrics-IC/N), Zelm, M. van (external organisation) & Moll, H.A. (pediatrics-generalnde) (2020). Associations of Th2, Th17, Treg cells, and IgA+ memory B cells with atopic disease in children: The Generation R Study. Allergy: European Journal of Allergy and Clinical Immunology, 75, 178-187. doi: https://doi.org/10.1111/all.14010 |
| Meel, E.R. van (pediatrics-pulmonology + Generation R), Jaddoe, V.W.V.K. (pediatrics-other + Generation R), Reiss, I.K.M. (pediatrics-IC/N), Zelm, M.C. van (immunology), Jongste, J.C. de (pediatrics-pulmonology), Moll, H.A. (pediatrics-generalnde) & Duijts, L. (pediatrics-pulmonology + pediatrics-IC/N + Generation R) (2020). The influence of Epstein-Barr virus and cytomegalovirus on childhood respiratory health: A population-based prospective cohort study. Clinical & Experimental Allergy, 50 (4), 499-507. doi: https://doi.org/10.1111/cea.13579 |
| Meessen, J.M.T.A. (external organisation), Saberi Hosnijeh, F. (immunology), Bomer, N. (external organisation), Hollander, W. den (external organisation), Bom, J.G. (EMC overig), Hilten, J.A. van (external organisation), Spil, W. van (external organisation), So-Osman, C. (external organisation), Uitterlinden, A.G. (internal medicine), Kloppenburg, M. (external organisation), Nelissen, R. (external organisation), Duijn, C.M. van (epidemiology), Slagboom, P. (external organisation), Meurs, J. van (internal medicine) & Meulenbelt, I. (external organisation) (2020). Serum fatty acid chain length associates with prevalent symptomatic end-stage osteoarthritis, independent of BMI. Scientific Reports, 10 (1):15459. doi: https://doi.org/10.1038/s41598-020-71811-3 |
| Meijers, R.W.J. (immunology), Muggen, A.F. (immunology), Gonzalez Leon, L. (immunology), Bie, M. de (immunology), Dongen, J.J.M. van (immunology), Hendriks, R.W. (pulmonology) & Langerak, A.W. (immunology) (2020). Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-kappa B pathway. Haematologica, 105 (1), 182-192. doi: https://doi.org/10.3324/haematol.2018.215566 |
| Muñoz-Lopetegi, A. (external organisation), Bruijn, M.A.A.M. de (neurology), Boukhrissi, S. (immunology), Bastiaansen, A.E.M. (neurology), Nagtzaam, M.M.P. (neurology), Hulsenboom, E.S.P. (neurology), Boon, A.J.W. (neurology), Neuteboom, R.F. (neurology), Vries, J.M. de (neurology), Sillevis Smitt, P.A.E. (neurology), Schreurs, M.W.J. (immunology) & Titulaer, M.J. (neurology) (2020). Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment. Neurology(R) neuroimmunology & neuroinflammation, 7. doi: https://doi.org/10.1212/NXI.0000000000000696 |
| Morhayim J, Ghebes CA, Erkeland SJ (immunology), Ter Borg MND, Hoogenboezem RM, Bindels EMJ, van Alphen FPJ, Kassem M, van Wijnen AJ, Cornelissen JJ, van Leeuwen JP, van der Eerden BCJ, Voermans C, van de Peppel J, Braakman E. |
| Identification of Osteolineage Cell-Derived Extracellular Vesicle Cargo Implicated in Hematopoietic Support. |
| FASEB J. 2020;34(4):5435-52. |
| Osborne, L.M. (external organisation), Gilden, J. (Psychiatry), Kamperman, A.M. (Psychiatry), Hoogendijk, W.J.G. (Psychiatry), Spicer, J. (external organisation), Drexhage, H.A. (immunology) & Bergink, V. (Psychiatry) (2020). T-cell defects and postpartum depression. Brain Behavior & Immunity, 87, 397-403. doi: https://doi.org/10.1016/j.bbi.2020.01.007 |
| Pal Singh, S. (pulmonology + immunology), Bruijn, J.W. de (pulmonology), Graca, C.V.G. da (pulmonology), Corneth, O.B.J. (pulmonology), Rip, J. (pulmonology), Stadhouders, R. (pulmonology + cell biology), Meijers, R.W.J. (immunology), Schurmans, S. (external organisation), Kerr, W. (external organisation), Burg, J. (external organisation), Eldering, E. (external organisation), Langerak, A.W. (immunology), Yuvaraj, S.Y. (pulmonology) & Hendriks, R.W. (pulmonology) (2020). Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival. Journal of Immunology, 204 (2), 360-374. doi: https://doi.org/10.4049/jimmunol.1900153 |
| Pawlowski, P. (external organisation), Poplawska, I. (external organisation), Mysliwiec, J. (external organisation), Dik, W.A. (immunology), Eckstein, A. (external organisation), Berchner-Pfannschmidt, U. (external organisation), Milewski, R. (external organisation), Lawicki, S. (external organisation), Dzieciol-Anikiej, Z. (external organisation), Rejdak, R. (external organisation) & Reszec, J. (external organisation) (2020). Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves’ orbitopathy. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 58 (1), 37-45. doi: https://doi.org/10.5603/FHC.a2020.0003 |
| Razawy, W. (immunology + rheumatology), Asmawidjaja, P.S. (immunology + rheumatology), Mus, A.M.C. (immunology + rheumatology), Salioska, N. (rheumatology + immunology), Davelaar, N. (rheumatology + immunology), Kops, N. (orthopaedics), Oukka, M. (external organisation), Alves, C.H.F. (immunology + rheumatology) & lubberts, E. (rheumatology + immunology) (2020). CD4+CCR6+ T cells, but not γδ T cells, are important for the IL-23R-dependent progression of antigen-induced inflammatory arthritis in mice. European Journal of Immunology, 50, 245-255. doi: https://doi.org/10.1002/eji.201948112 |
| Rijvers, L. (immunology), Melief, J.A.M. (immunology), Langelaar, J. van (immunology), Vuurst de Vries, R.M. van der (neurology), Wierenga-Wolf, A.F. (immunology), Koetzier, S.C. (immunology), Priatel, J. (external organisation), Jorritsma, T. (external organisation), Ham, S.M. van (external organisation), Hintzen, R.Q. (immunology + neurology) & Luijn, M.M. van (immunology) (2020). The Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor-Mediated HLA Class II Pathway. Journal of Immunology, 205 (4), 945-956. doi: https://doi.org/10.4049/jimmunol.1901409 |
| Rösken GHJ, van Beek AA, Bakker-Jonges LE, Schreurs MWJ (immunology). |
| Antinuclear Antibodies in Systemic Autoimmune Disease. |
| Ned Tijdschr Geneeskd. 2020;164(18): D4066. |
| Schiweck, C. (external organisation), Claes, S. (external organisation), Oudenhove, L. Van (external organisation), Lafit, G. (external organisation), Vaessen, T. (external organisation), Beeck, G. Op de (external organisation), Berghmans, R. (external organisation), Wijkhuijs, A. (immunology), Muller, N. (external organisation), Arolt, V. (external organisation), Drexhage, H. (immunology) & Vrieze, E. de (external organisation) (2020). Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression. Translational Psychiatry, 10 (1):296. doi: https://doi.org/10.1038/s41398-020-00979-z |
| Schiweck, C. (external organisation), Valles-Colomer, M. (external organisation), Arolt, V. (external organisation), Muller, N. (external organisation), Raes, J. (external organisation), Wijkhuijs, J.M. (immunology), Claes, S. (external organisation), Drexhage, H. (immunology) & Vrieze, E. de (external organisation) (2020). Depression and suicidality: A link to premature T helper cell aging and increased Th17 cells. Brain Behavior & Immunity, 87, 603-609. doi: https://doi.org/10.1016/j.bbi.2020.02.005 |
| Schrijver, B. (immunology), Dijkstra, D.J. (external organisation), Borggreven, N.V. (external organisation), Nora, R.L. (external organisation), Huijser, E. (immunology), Versnel, M.A. (immunology), Hagen, P.M. van (immunology + internal medicine), Joosten, S.A. (external organisation), Trouw, L. (external organisation) & Dik, W.A. (immunology + internal medicine) (2020). Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis. Clinical & Translational Immunology, 9 (10):e1196. doi: https://doi.org/10.1002/cti2.1196 |
| Schrijver B (immunology), Assmann J (immunology), van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW (immunology), Dik WA (immunology), van der Velden VHJ (immunology), Ermens T. |
| Extensive Longitudinal Immune Profiling Reveals Sustained Innate Immune Activation in Covid-19 Patients with Unfavorable Outcome. |
| Eur Cytokine Netw. 2020;31(4):154-67. |
| Sciarrillo, R. (external organisation), Wojtuszkiewicz, A. (external organisation), Kooi, I. (external organisation), Leon, L.G. (immunology), Sonneveld, E. (external organisation), Kuiper, R.P. (external organisation), Jansen, G. (external organisation), Giovannetti, E. (external organisation), Kaspers, G.J. (external organisation) & Cloos, J. (external organisation) (2020). Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation. Cancers, 12 (3):723. doi: https://doi.org/10.3390/cancers12030723 |
| Sharapova, S.O. (external organisation), Skomska-Pawliszak, M. (external organisation), Rodina, Y.A. (external organisation), Wolska-Kusnierz, B. (external organisation), Dabrowska-Leonik, N. (external organisation), Mikoluc, B. (external organisation), Pashchenko, O.E. (external organisation), Pasic, S. (external organisation), Freiberger, T. (external organisation), Milota, T. (external organisation), Formankova, R. (external organisation), Szaflarska, A. (external organisation), Siedlar, M. (external organisation), Avcin, T. (external organisation), Markelj, G. (external organisation), Ciznar, P. (external organisation), Kalwak, K. (external organisation), Kottan, S. (external organisation), Jackowska, T. (external organisation), Drabko, K. (external organisation), Gagro, A. (external organisation), Pac, M. (external organisation), Naumova, E. (external organisation), Kandilarova, S. (external organisation), Babol-Pokora, K. (external organisation), Varabyou, D.S. (external organisation), Barendregt, B.H. (immunology), Raykina, E.V. (external organisation), Varlamova, T.V. (external organisation), Pavlova, A.V. (external organisation), Grombirikova, H. (external organisation), Debeljak, M. (external organisation), Mersiyanova, I.V. (external organisation), Bondarenko, A.V. (external organisation), Chernyshova, L.I. (external organisation), Kostyuchenko, L.V. (external organisation), Guseva, M.N. (external organisation), Rascon, J. (external organisation), Muleviciene, A. (external organisation), Preiksaitiene, E. (external organisation), Geier, C.B. (external organisation), Leiss-Piller, A. (external organisation), Yamazaki, Y. (external organisation), Kawai, T. (external organisation), Walter, J. (external organisation), Kondratenko, I.V. (external organisation), Sediva, A. (external organisation), Burg, M. van der (immunology), Kuzmenko, N.B. (external organisation), Notarangelo, L. (external organisation), Bernatowska, E. (external organisation) & Aleinikova, O.V. (external organisation) (2020). The Clinical and Genetic Spectrum of 82 Patients WithRAGDeficiency Including a c.256_257delAA Founder Variant in Slavic Countries. Frontiers in Immunology, 11:900. doi: https://doi.org/10.3389/fimmu.2020.00900 |
| Smolders, J.J.M. (immunology + neurology), Fransen, N.L. (external organisation), Hsiao, C.C. (external organisation), Hamann, J. (external organisation) & Huitinga, I. (external organisation) (2020). Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis. Expert Review of Neurotherapeutics, 20 (8), 835-848. doi: https://doi.org/10.1080/14737175.2020.1776609 |
| Solans, M. (external organisation), Benavente, Y. (external organisation), Saez, M. (external organisation), Agudo, A. (external organisation), Jakszyn, P. (external organisation), Naudin, S. (external organisation), Hosnijeh, F.S. (immunology), Nieters, A. (external organisation) & Casabonne, D. (external organisation) (2020). Inflammatory potential of diet and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition. European Journal of Nutrition, 59 (2), 813-823. doi: https://doi.org/10.1007/s00394-019-01947-0 |
| Sparreboom, C.L. (surgery), Komen, N.A.P. (external organisation), Rizopoulos, D. (Biostatistics), Verhaar, A.P. (gastroenterology & hepatology), Dik, W.A. (immunology), Wu, Z. (surgery), Westreenen, H.L. van (external organisation), Doornebosch, P.G. (external organisation), Dekker, J.W. (external organisation), Menon, A.G. (external organisation), Daams, F. (external organisation), Lips, D. (external organisation), Grevenstein, W. van (external organisation), Karsten, T.M. (external organisation), Bayon, Y. (external organisation), Peppelenbosch, M.P. (gastroenterology & hepatology), Wolthuis, A.M. (external organisation), D’Hoore, A. (external organisation) & Lange, J.F. (surgery) (2020). A multicentre cohort study of serum and peritoneal biomarkers to predict anastomotic leakage after rectal cancer resection. Colorectal Disease, 22, 36-45. doi: https://doi.org/10.1111/codi.14789 |
| Stairiker, C.J. (immunology), Meurs, M. van (immunology), Leon, L.G. (immunology), Brouwers-Haspels, A.A. (immunology), Rijsbergen, L.C. (virology), Mueller, Y.M. (immunology) & Katsikis, P.D. (immunology) (2020). Heatr9is an infection responsive gene that affects cytokine production in alveolar epithelial cells. PLoS One (print), 15 (7):e0236195. doi: https://doi.org/10.1371/journal.pone.0236195 |
| Stigt, A.C. van (immunology + internal medicine), Dik, W.A. (immunology), Kamphuis, L.S.J. (immunology + pulmonology), Smits, B.M. (external organisation), Montfrans, J. van (external organisation), Hagen, P.M. van (immunology + internal medicine), Dalm, V.A.S.H. (immunology + internal medicine) & Ijspeert, H. (immunology) (2020). What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review. Frontiers in Immunology, 11:606389. doi: https://doi.org/10.3389/fimmu.2020.606389 |
| Stoszko, M.L. (biochemistry), Al-Hatmi, A. (external organisation), Skriba, A. (external organisation), Roling, M.D. (biochemistry), Ne, E. (biochemistry), Crespo Galván, R. (biochemistry), Mueller, Y.M. (immunology), Najafzadeh, M. (external organisation), Kang, J. (external organisation), Ptackova, R. (external organisation), LeMasters, E. (biochemistry), Biswas, P. (biochemistry), Bertoldi, A. (biochemistry), Kan, T.W. (biochemistry), Crignis, E. de (biochemistry), Sulc, M. (external organisation), Lebbink, J.H.G. (Molecular Genetics), Rokx, C. (internal medicine), Verbon, A. (internal medicine), IJcken, W.F.J. van (clinical genetics), Katsikis, P.D. (immunology), Palstra, R.J.T.S. (biochemistry), Havlicek, V. (external organisation), Hoog, S. de (external organisation) & Mahmoudi, T. (biochemistry) (2020). Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency. Science Advances, 6 (33):eaha6617. doi: https://doi.org/10.1126/sciadv.aba6617 |
| Stuvel, K. (dermatology), Heeringa, J.J. (immunology), Dalm, V.A.S.H. (immunology + internal medicine), Meijers, R.W.J. (immunology), Hoffen, E. (external organisation), Gerritsen, S.A.M. (external organisation), Zelm, M. van (external organisation) & Pasmans, S.G.M.A. (dermatology) (2020). Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency. Allergy: European Journal of Allergy and Clinical Immunology, 75 (7), 1710-1720. doi: https://doi.org/10.1111/all.14197 |
| Suratannon, N. (immunology), Dik, W.A. (immunology + internal medicine), Chatchatee, P. (external organisation) & Hagen, P.M. van (immunology + internal medicine) (2020). COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis. Asian Pacific Journal of Allergy and Immunology, 38 (3), 170-177. doi: https://doi.org/10.12932/AP-170720-0920 |
| Suratannon, N. (immunology), Wijck, R.T.A. van (internal medicine), Broer, L. (internal medicine), Xue, L.X. (internal medicine), Meurs, J. van (internal medicine), Barendregt, B.H. (immunology), Burg, M. (external organisation), Dik, W.A. (immunology), Chatchatee, P. (external organisation), Langerak, A.W. (immunology), Swagemakers, S.M.A. (pathology + bioinformatics), Goos, J.A.C. (plastic and reconstructive surgery), Mathijssen, I.M.J. (plastic and reconstructive surgery), Dalm, V.A.S.H. (immunology + internal medicine), Suphapeetiporn, K. (external organisation), Heezen, K.C. (immunology), Drabwell, J. (external organisation), Uitterlinden, A.G. (internal medicine), Spek, P.J. van der (bioinformatics) & Hagen, P.M. van (immunology + internal medicine) (2020). Rapid Low-Cost Microarray-Based Genotyping for Genetic Screening in Primary Immunodeficiency. Frontiers in Immunology, 11:614. doi: https://doi.org/10.3389/fimmu.2020.00614 |
| Themeli, M. (external organisation), Chhatta, A. (external organisation), Boersma, E. (external organisation), Prins, H. (external organisation), Cordes, M. (external organisation), Wilt, E. de (external organisation), Farahani, A.S. (external organisation), Vandekerckhove, B. (external organisation), Burg, M. van der (immunology), Hoeben, R.C. (external organisation), Staal, F.J.T. (external organisation) & Mikkers, H.M.M. (external organisation) (2020). iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests. Stem Cell Reports, 14 (2), 300-311. doi: https://doi.org/10.1016/j.stemcr.2019.12.010 |
| Uncini, A. (external organisation), Vallat, J.M. (external organisation) & Jacobs, B.C. (immunology + neurology) (2020). Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. Journal of neurology, neurosurgery, and psychiatry, 91 (10), 1105-1110. doi: https://doi.org/10.1136/jnnp-2020-324491 |
| Veenbergen S (immunology), Dik WA (immunology), Schreurs MWJ (immunology). |
| Een Traag Werkende Schildklier – Hashimoto Thyreoïditis. |
| VAPvisie 02/Analyse 03 2020:46-9. |
| Van der Velden VHJ (immunology). |
| Flowcytometrische Analyse Bij Acute Leukemie Patiënten Behandeld Met Immuuntherapie. |
| Analyse. 2020;3:40-4. |
| Verboon, J.C. (neurology), Berg, B. van den (neurology), Cornblath, D. (external organisation), Venema, E. (public health + neurology), Gorson, K. (external organisation), Lunn, M.P. (external organisation), Lingsma, H.F. (public health), Bergh, P. Van den (external organisation), Harbo, T. (external organisation), Bateman, K. (external organisation), Pereon, Y. (external organisation), Sindrup, S.H. (external organisation), Kusunoki, S. (external organisation), Miller, J. (external organisation), Islam, Z. (external organisation), Hartung, H.P. (external organisation), Chavada, G. (external organisation), Jacobs, B.C. (immunology + neurology), Hughes, R.A.C. (external organisation) & Doorn, P.A. van (neurology) (2020). Original research: Second IVIg course in Guillain-Barre syndrome with poor prognosis: the non-randomised ISID study. Journal of Neurology Neurosurgery and Psychiatry, 91 (2), 113-121. doi: https://doi.org/10.1136/jnnp-2019-321496 |
| Vergouwen, D.P.C. (ophthalmology + immunology), Rothova, A. (ophthalmology), Berge, J.C.E.M. ten (ophthalmology), Verdijk, R.M. (pathology), Laar, J.A.M. van (immunology + internal medicine), Vingerling, J.R. (ophthalmology) & Schreurs, M.W.J. (immunology) (2020). Current insights in the pathogenesis of scleritis. Experimental Eye Research, 197:108078. doi: https://doi.org/10.1016/j.exer.2020.108078 |
| Vermeiren, M.R. (internal medicine), Kranenburg, L.W. (Psychiatry), Daele, P.L.A. van (immunology + internal medicine), Gerth van Wijk, R. (internal medicine) & Hermans, M.A.W. (internal medicine) (2020). Psychological functioning and quality of life in patients with mastocytosis A cross-sectional study. Annals of Allergy Asthma & Immunology, 124 (4), 373-+. doi: https://doi.org/10.1016/j.anai.2019.12.020 |
| Xue, L.X. (internal medicine), Bilsen, C.E.F. van (internal medicine), Schreurs, M.W.J. (immunology), Velthoven, M. van (external organisation), Missotten, T.O.A.R. (internal medicine), Thiadens, A.A.H.J. (ophthalmology), Kuijpers, R.W.A.M. (ophthalmology), Biezen, P. van (internal medicine), Dalm, V.A.S.H. (immunology + internal medicine), Laar, J.A.M. van (immunology + internal medicine), Hermans, M.A.W. (internal medicine), Dik, W.A. (immunology), Daele, P.L.A. van (internal medicine + immunology) & Hagen, P.M. van (internal medicine + immunology) (2020). Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade(R)to Remsima(R)? An Observational Study. Frontiers in Medicine, 7:418. doi: https://doi.org/10.3389/fmed.2020.00418 |
| Zalm, I.J.B. van der (internal medicine), Valk, E.S. van der (internal medicine), Wester, V.L. (internal medicine), Nagtzaam, N.M.A. (immunology), Rossum, E.F.C. van (internal medicine), Leenen, P.J.M. (immunology) & Dik, W.A. (immunology) (2020). Obesity-associated T-cell and macrophage activation improve partly after a lifestyle intervention. International Journal of Obesity, 44 (9), 1838-1850. doi: https://doi.org/10.1038/s41366-020-0615-6 |
| Zhao, M. (immunology), Kiernan, C.H. (immunology), Stairiker, C.J. (immunology), Hope, J. (external organisation), Gonzalez Leon, L. (immunology), Meurs, M. van (immunology), Haspels, A.A. (immunology), Boers, R.G. (Developmental Biology), Boers, J. (Developmental Biology), Gribnau, J.H. (Developmental Biology), IJcken, W.F.J. van (cell biology), Bindels, E.M.J. (hematology), Hoogenboezem, R.M. (hematology), Erkeland, S.J. (immunology), Müller, Y.M. (immunology) & Katsikis, P.D. (immunology) (2020). Rapid in vitro generation of bona fide exhausted CD8+T cells is accompanied byTcf7 promotor methylation. PLoS Pathogens (print), 16 (6):e1008555. doi: https://doi.org/10.1371/journal.ppat.1008555 |
| Zughaier, S.M. (external organisation), lubberts, E. (immunology) & Bener, A. (external organisation) (2020). Editorial: Immune-Modulatory Effects of Vitamin D. Frontiers in Immunology, 11:596611. doi: https://doi.org/10.3389/fimmu.2020.596611 |
| van der Zwan M, Hesselink DA, Brusse E, van Doorn PA, van den Hoogen MWF, de Weerd AE, Jacobs BC (neurology + immunology). Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy after Alemtuzumab Therapy in Kidney Transplant Recipients. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e721. |
TOME – ABSTRACT
Dik, W.A. (immunology) & Meurs, J.C. van (ophthalmology) (2020). Retinal Pigment Epithelium in Proliferative Disorders. In Klettner A. & Dithmar S (Eds.), Retinal Pigment Epithelium in Health and Disease (pp. 139-160). [S.l.]: Springer
Langerak AW (immunology). Moleculaire Klonaliteitsdiagnostiek Van Lymfoproliferaties. In: Goswami PR, Schreurs MWJ, Souverijn JHM, Tax M, Wielders JPM, eds. Handboek Medische Laboratoriumdiagnostiek. Houten: Prelum Uitgevers 2020:533-6.
Dik WA (immunology), Langerak AW (immunology). Diagnostiek Van Primaire Immunodeficiënties. In: Goswami PR, Schreurs MWJ, Souverijn JHM, Tax M, Wielders JPM, eds. Handboek Medische Laboratoriumdiagnostiek. Houten: Prelum Uitgevers 2020:611-6.
BOOK
Goswami PR, Schreurs MWJ (immunology), Souverijn JHM, Tax M, Wielders JPM. Handboek Medische Laboratoriumdiagnostiek: Prelum Uitgevers 2020.
DISSERTATION
Muggen, A.F. (immunology) (2020, januari 7). Chronic Lymphocytic Leukemia: The B cell receptor and beyond. EUR Prom./coprom.: Dr. J.M. van Dongen, Prof. Dr. R.W. Hendriks & Dr. A.W. Langerak.
– http://hdl.handle.net/1765/122602 (IR)
– Dissertatie 1 (Dissertatie)
Estrella Cahueñas B (immunology) (2020, january 24). Effects of Air Pollution on the Respiratory Health and the Respiratory Immune System: Studies in Ecuadorian Children [Ph.D. thesis]: Erasmus University Rotterdam; 2020.
Prom: Prof.dr. P.D. Katsikis. Other member: Prof.dr. E.N. Naumova, Prof dr Hemmo A Drexhage (immunology), Dr J. Nouwen, Dr P.L.A. van Daele (immunology)
PUBLICATIONS 2019
| Verboom DM, van der Houwen TB, Kappen JH, van Daele PLA, Dik WA, Schreurs MWJ, van Hagen PM, van Laar JAM. Adalimumab Provides Long-Lasting Clinical Improvement in Refractory Mucocutaneous Behcet’s Disease without Formation of Antidrug Antibodies. Clin Exp Rheumatol. 2019;37 Suppl 121(6):43-7. | |
| Ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA, Rothova A. Intraocular Cytokine Profile and Autoimmune Reactions in Retinitis Pigmentosa, Age-Related Macular Degeneration, Glaucoma and Cataract. Acta Ophthalmol. 2019;97(2):185-92. | |
| Schrijver B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, Virakul S, Paridaens D, Peeters RP, van Hagen PM, Dalm V, Dik WA. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves’ Orbitopathy. Thyroid. 2019;29(3):395-404. | |
| Meesilpavikkai K, Dik WA, Schrijver B, van Helden-Meeuwsen CG, Versnel MA, van Hagen PM, Bijlsma EK, Ruivenkamp CAL, Oele MJ, Dalm V. Efficacy of Baricitinib in the Treatment of Chilblains Associated with Aicardi-Goutieres Syndrome, a Type I Interferonopathy. Arthritis Rheumatol. 2019;71(5):829-31. | |
| Huizer K, Sacchetti A, Dik WA, Mustafa DA, Kros JM. Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration. J Oncol. 2019;2019:3560830. | |
| Fazil Z, Ten Berge JC, Langerak AW, Rothova A, Dik WA. An Intraocular Inflammatory Profile of Rubella Associated Uveitis. Ocul Immunol Inflamm. 2019;27(3):418-23. | |
| Eurelings LEM, Miedema JR, Dalm V, van Daele PLA, van Hagen PM, van Laar JAM, Dik WA. Sensitivity and Specificity of Serum Soluble Interleukin-2 Receptor for Diagnosing Sarcoidosis in a Population of Patients Suspected of Sarcoidosis. PLoS One. 2019;14(10):e0223897. | |
| de Hoog J, Dik WA, Lu L, Heezen KC, Ten Berge JC, Swagemakers SMA, van der Spek PJ, van Dongen JJM, van der Velden VHJ, Rothova A, Langerak AW. Combined Cellular and Soluble Mediator Analysis for Improved Diagnosis of Vitreoretinal Lymphoma. Acta Ophthalmol. 2019;97(6):626-32. | |
| Bharwani KD, Dik WA, Dirckx M, Huygen F. Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome. Mol Diagn Ther. 2019;23(5):615-26. | |
| Sparreboom CL, Komen N, Rizopoulos D, Verhaar AP, Dik WA, Wu Z, van Westreenen HL, Doornebosch PG, Dekker JWT, Menon AG, Daams F, Lips D, van Grevenstein WMU, Karsten TM, Bayon Y, Peppelenbosch MP, Wolthuis AM, D’Hoore A, Lange JF. A Multicentre Cohort Study of Serum and Peritoneal Biomarkers to Predict Anastomotic Leakage after Rectal Cancer Resection. Colorectal Dis. 2020;22(1):36-45. | |
| de Jong GM, McCall MBB, Dik WA, Urbanus RT, Wammes LJ, Koelewijn R, Sauerwein RW, Verbon A, van Hellemond JJ, van Genderen PJJ. Transforming Growth Factor-Beta Profiles Correlate with Clinical Symptoms and Parameters of Haemostasis and Inflammation in a Controlled Human Malaria Infection. Cytokine. 2020;125:154838. | |
| Olsson P, Bodewes ILA, Nilsson AM, Turesson C, Jacobsson LTH, Theander E, Versnel MA, Mandl T. Associations of Cigarette Smoking with Disease Phenotype and Type I Interferon Expression in Primary Sjogren’s Syndrome. Rheumatol Int. 2019;39(9):1575-84. | |
| Meesilpavikkai K, Dik WA, Schrijver B, van Helden-Meeuwsen CG, Versnel MA, van Hagen PM, Bijlsma EK, Ruivenkamp CAL, Oele MJ, Dalm V. Efficacy of Baricitinib in the Treatment of Chilblains Associated with Aicardi-Goutieres Syndrome, a Type I Interferonopathy. Arthritis Rheumatol. 2019;71(5):829-31. | |
| Huijser E, van Helden-Meeuwsen CG, Groot N, Bodewes ILA, Wahadat MJ, Schreurs MWJ, van Daele PLA, Dalm V, van Laar JAM, van Hagen PM, Waris M, Kamphuis S, Versnel MA. Mxa Is a Clinically Applicable Biomarker for Type I Interferon Activation in Systemic Lupus Erythematosus and Systemic Sclerosis. Rheumatology (Oxford). 2019;58(7):1302-3. | |
| Bodewes ILA, van der Spek PJ, Leon LG, Wijkhuijs AJM, van Helden-Meeuwsen CG, Tas L, Schreurs MWJ, van Daele PLA, Katsikis PD, Versnel MA. Fatigue in Sjogren’s Syndrome: A Search for Biomarkers and Treatment Targets. Front Immunol. 2019;10(FEB):312. | |
| Bodewes ILA, Bjork A, Versnel MA, Wahren-Herlenius M. Innate Immunity and Interferons in the Pathogenesis of Sjogren’s Syndrome. Rheumatology (Oxford). 2019. | |
| Zeijlemaker W, Grob T, Meijer R, Hanekamp D, Kelder A, Carbaat-Ham JC, Oussoren-Brockhoff YJM, Snel AN, Veldhuizen D, Scholten WJ, Maertens J, Breems DA, Pabst T, Manz MG, van der Velden VHJ, Slomp J, Preijers F, Cloos J, van de Loosdrecht AA, Lowenberg B, Valk PJM, Jongen-Lavrencic M, Ossenkoppele GJ, Schuurhuis GJ. Cd34(+)Cd38(-) Leukemic Stem Cell Frequency to Predict Outcome in Acute Myeloid Leukemia. Leukemia. 2019;33(5):1102-12. | |
| van der Velden VHJ, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, Kalina T, Philippe J, Bonroy C, de Bie M, Te Marvelde J, Teodosio C, Corral Mateos A, Kanderova V, van der Burg M, Van Hoof D, van Dongen JJM, Orfao A. Optimization and Testing of Dried Antibody Tube: The Euroflow Lst and Pidot Tubes as Examples. J Immunol Methods. 2019;475:112287. | |
| Theunissen PMJ, de Bie M, van Zessen D, de Haas V, Stubbs AP, van der Velden VHJ. Next-Generation Antigen Receptor Sequencing of Paired Diagnosis and Relapse Samples of B-Cell Acute Lymphoblastic Leukemia: Clonal Evolution and Implications for Minimal Residual Disease Target Selection. Leuk Res. 2019;76:98-104. | |
| Sedek L, Theunissen P, Sobral da Costa E, van der Sluijs-Gelling A, Mejstrikova E, Gaipa G, Sonsala A, Twardoch M, Oliveira E, Novakova M, Buracchi C, van Dongen JJM, Orfao A, van der Velden VHJ, Szczepanski T, EuroFlow C. Differential Expression of Cd73, Cd86 and Cd304 in Normal Vs. Leukemic B-Cell Precursors and Their Utility as Stable Minimal Residual Disease Markers in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. J Immunol Methods. 2019;475:112429. | |
| Pott C, Bruggemann M, Ritgen M, van der Velden VHJ, van Dongen JJM, Kneba M. Mrd Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative Pcr. Methods Mol Biol. 2019;1956:199-228. | |
| Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuela JM, Schafer B, Spinelli O, Akiki S, Avigad S, Bendit I, Borg K, Cave H, Elia L, Reshmi SC, Gerrard G, Hayette S, Hermanson M, Juh A, Jurcek T, Chillon MC, Homburg C, Martinelli G, Kairisto V, Lange T, Lion T, Mueller MC, Pane F, Rai L, Damm-Welk C, Sacha T, Schnittger S, Touloumenidou T, Valerhaugen H, Vandenberghe P, Zuna J, Serve H, Herrmann E, Markovic S, Van Dongen JJM, Ottmann OG. Standardisation and Consensus Guidelines for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + All) by Real-Time Quantitative Reverse Transcriptase Pcr of E1a2 Bcr-Abl1. Leukemia. 2019;33(8):1910-22. | |
| Novakova M, Glier H, Brdickova N, Vlkova M, Santos AH, Lima M, Roussel M, Flores-Montero J, Szczepanski T, Bottcher S, van der Velden VHJ, Fernandez P, Mejstrikova E, Burgos L, Paiva B, van Dongen JJM, Orfao A, Kalina T. How to Make Usage of the Standardized Euroflow 8-Color Protocols Possible for Instruments of Different Manufacturers. J Immunol Methods. 2019;475:112388. | |
| Grille S, Iastrebner M, Lorand-Metze I, van der Velden VHJ, Ikoma MRV, Vidal-Senmache G, Colado E, Rabelo-Carrasco LJ, Blanco A, Huaman-Garaicoa F, O’Connor JE, Cao Pochintesta C, Jensen E, Bacal NS, Diaz L, Lens D. Flow Cytometry Diagnosis in Myelodysplastic Syndrome: Current Practice in Latin America and Comparison with Other Regions of the World. Leuk Res. 2019;79:69-74. | |
| Glier H, Novakova M, Te Marvelde J, Bijkerk A, Morf D, Thurner D, Rejlova K, Lange S, Finke J, van der Sluijs-Gelling A, Sedek L, Flores-Montero J, Bottcher S, Fernandez P, Ritgen M, van Dongen JJM, Orfao A, van der Velden VHJ, Kalina T. Comments on Euroflow Standard Operating Procedures for Instrument Setup and Compensation for Bd Facs Canto Ii, Navios and Bd Facs Lyric Instruments. J Immunol Methods. 2019;475:112680. | |
| Flores-Montero J, Kalina T, Corral-Mateos A, Sanoja-Flores L, Perez-Andres M, Martin-Ayuso M, Sedek L, Rejlova K, Mayado A, Fernandez P, van der Velden V, Bottcher S, van Dongen JJM, Orfao A. Fluorochrome Choices for Multi-Color Flow Cytometry. J Immunol Methods. 2019;475:112618. | |
| Flores-Montero J, Grigore G, Fluxa R, Hernandez J, Fernandez P, Almeida J, Munoz N, Bottcher S, Sedek L, van der Velden V, Barrena S, Hernandez A, Paiva B, Lecrevisse Q, Lima M, Santos AH, van Dongen JJM, Orfao A. Euroflow Lymphoid Screening Tube (Lst) Data Base for Automated Identification of Blood Lymphocyte Subsets. J Immunol Methods. 2019;475:112662. | |
| de Hoog J, Dik WA, Lu L, Heezen KC, Ten Berge JC, Swagemakers SMA, van der Spek PJ, van Dongen JJM, van der Velden VHJ, Rothova A, Langerak AW. Combined Cellular and Soluble Mediator Analysis for Improved Diagnosis of Vitreoretinal Lymphoma. Acta Ophthalmol. 2019;97(6):626-32. | |
| Brooimans RA, van der Velden VHJ, Boeckx N, Slomp J, Preijers F, Te Marvelde JG, Van NM, Heijs A, Huys E, van der Holt B, de Greef GE, Kelder A, Schuurhuis GJ. Immunophenotypic Measurable Residual Disease (Mrd) in Acute Myeloid Leukemia: Is Multicentric Mrd Assessment Feasible? Leuk Res. 2019;76:39-47. | |
| Bras AE, van der Velden VHJ. Lossless Compression of Cytometric Data. Cytometry A. 2019;95(10):1108-12. | |
| Bras AE, de Haas V, van Stigt A, Jongen-Lavrencic M, Beverloo HB, Te Marvelde JG, Zwaan CM, van Dongen JJM, Leusen JHW, van der Velden VHJ. Cd123 Expression Levels in 846 Acute Leukemia Patients Based on Standardized Immunophenotyping. Cytometry B Clin Cytom. 2019;96(2):134-42. | |
| Bottcher S, van der Velden VHJ, Villamor N, Ritgen M, Flores-Montero J, Escobar HM, Kalina T, Bruggemann M, Grigore G, Martin-Ayuso M, Lecrevisse Q, Pedreira CE, van Dongen JJM, Orfao A. Lot-to-Lot Stability of Antibody Reagents for Flow Cytometry. J Immunol Methods. 2019;475:112294. | |
| Bader P, Salzmann-Manrique E, Balduzzi A, Dalle JH, Woolfrey AE, Bar M, Verneris MR, Borowitz MJ, Shah NN, Gossai N, Shaw PJ, Chen AR, Schultz KR, Kreyenberg H, Di Maio L, Cazzaniga G, Eckert C, van der Velden VHJ, Sutton R, Lankester A, Peters C, Klingebiel TE, Willasch AM, Grupp SA, Pulsipher MA. More Precisely Defining Risk Peri-Hct in Pediatric All: Pre- Vs Post-Mrd Measures, Serial Positivity, and Risk Modeling. Blood Adv. 2019;3(21):3393-405. | |
| Verboom DM, van der Houwen TB, Kappen JH, van Daele PLA, Dik WA, Schreurs MWJ, van Hagen PM, van Laar JAM. Adalimumab Provides Long-Lasting Clinical Improvement in Refractory Mucocutaneous Behcet’s Disease without Formation of Antidrug Antibodies. Clin Exp Rheumatol. 2019;37 Suppl 121(6):43-7. | |
| van Coevorden-Hameete MH, de Bruijn M, de Graaff E, Bastiaansen D, Schreurs MWJ, Demmers JAA, Ramberger M, Hulsenboom ESP, Nagtzaam MMP, Boukhrissi S, Veldink JH, Verschuuren J, Hoogenraad CC, Sillevis Smitt PAE, Titulaer MJ. The Expanded Clinical Spectrum of Anti-Gababr Encephalitis and Added Value of Kctd16 Autoantibodies. Brain. 2019;142(6):1631-43. | |
| Hurkmans DP, Basak EA, van Dijk T, Mercieca D, Schreurs MWJ, Wijkhuijs AJM, Bins S, Hoop EO, Debets R, Joerger M, Odink A, van der Veldt AAM, van der Leest CH, Aerts J, Mathijssen RHJ, Koolen SLW. A Prospective Cohort Study on the Pharmacokinetics of Nivolumab in Metastatic Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Cancer Patients. J Immunother Cancer. 2019;7(1):192. | |
| Huijser E, van Helden-Meeuwsen CG, Groot N, Bodewes ILA, Wahadat MJ, Schreurs MWJ, van Daele PLA, Dalm V, van Laar JAM, van Hagen PM, Waris M, Kamphuis S, Versnel MA. Mxa Is a Clinically Applicable Biomarker for Type I Interferon Activation in Systemic Lupus Erythematosus and Systemic Sclerosis. Rheumatology (Oxford). 2019;58(7):1302-3. | |
| Hermans MAW, Schreurs MWJ, van Daele PLA. Systemic Mastocytosis with Normal Serum Tryptase: Rule or Exception? J Eur Acad Dermatol Venereol. 2019;33(12):e472-e4. | |
| de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, Schreurs MWJ, Rouhl RPW, van Donselaar CA, Majoie MHJM, Neuteboom RF, Sillevis Smitt PAE, Thijs RD, Titulaer MJ. Evaluation of Seizure Treatment in Anti-Lgi1, Anti-Nmdar, and Anti-Gababr Encephalitis. Neurology. 2019;92(19):e2185-e96. | |
| Crijnen YS, de Vries JM, Schreurs MWJ, Titulaer MJ. [Clinical Symptoms of Patients with Autoimmune Encephalitis: A Guide to Timely Recognition and Treatment] Symptomen Van Een Auto-Immuunencefalitis: Leidraad Tot Tijdige Herkenning En Behandeling. Ned Tijdschr Geneeskd. 2019;163. | |
| Bodewes ILA, van der Spek PJ, Leon LG, Wijkhuijs AJM, van Helden-Meeuwsen CG, Tas L, Schreurs MWJ, van Daele PLA, Katsikis PD, Versnel MA. Fatigue in Sjogren’s Syndrome: A Search for Biomarkers and Treatment Targets. Front Immunol. 2019;10(FEB):312. | |
| Basak EA, Koolen SLW, Hurkmans DP, Schreurs MWJ, Bins S, Oomen-de Hoop E, Wijkhuijs AJM, Besten ID, Sleijfer S, Debets R, van der Veldt AAM, Aerts JGJV, Mathijssen RHJ. Correlation between Nivolumab Exposure and Treatment Outcomes in Non-Small-Cell Lung Cancer. Eur J Cancer. 2019;109:12-20. | |
| Hope JL, Spantidea PI, Kiernan CH, Stairiker CJ, Rijsbergen LC, van Meurs M, Brouwers-Haspels I, Mueller YM, Nelson DJ, Bradley LM, Aerts J, Katsikis PD. Microenvironment-Dependent Gradient of Ctl Exhaustion in the Ae17sova Murine Mesothelioma Tumor Model. Front Immunol. 2019;10:3074. | |
| van Beek AA, Van den Bossche J, Mastroberardino PG, de Winther MPJ, Leenen PJM. Metabolic Alterations in Aging Macrophages: Ingredients for Inflammaging? Trends Immunol. 2019;40(2):113-27. | |
| Mourik BC, de Steenwinkel JEM, de Knegt GJ, Huizinga R, Verbon A, Ottenhoff THM, van Soolingen D, Leenen PJM. Mycobacterium Tuberculosis Clinical Isolates of the Beijing and East-African Indian Lineage Induce Fundamentally Different Host Responses in Mice Compared to H37rv. Sci Rep. 2019;9(1):19922. | |
| de Oliveira PG, Gomes CM, Avila LR, Ribeiro-Dias F, Leenen PJM, de Oliveira MAP. Dendritic Cell Line Ap284 Supports Th17 Amplification. Cell Immunol. 2019;337:54-61. | |
| Scheijen B, Meijers RWJ, Rijntjes J, van der Klift MY, Mobs M, Steinhilber J, Reigl T, van den Brand M, Kotrova M, Ritter JM, Catherwood MA, Stamatopoulos K, Bruggemann M, Davi F, Darzentas N, Pott C, Fend F, Hummel M, Langerak AW, Groenen P, EuroClonality NGSWG. Next-Generation Sequencing of Immunoglobulin Gene Rearrangements for Clonality Assessment: A Technical Feasibility Study by Euroclonality-Ngs. Leukemia. 2019;33(9):2227-40. | |
| Muggen AF, de Jong M, Wolvers-Tettero ILM, Kallemeijn MJ, Teodosio C, Darzentas N, Stadhouders R, H IJ, van der Burg M, van IWF, Verhaar JAN, Abdulahad WH, Brouwer E, Boots AMH, Hendriks RW, van Dongen JJM, Langerak AW. The Presence of Cll-Associated Stereotypic B Cell Receptors in the Normal Bcr Repertoire from Healthy Individuals Increases with Age. Immun Ageing. 2019;16(1):22. | |
| Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Duhrsen U, Huttmann A, Casasnovas O, Westin JR, Ritgen M, Bottcher S, Langerak AW, Roschewski M, Wilson WH, Gaidano G, Rossi D, Bahlo J, Hallek M, Tibshirani R, Diehn M, Alizadeh AA. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. 2019;178(3):699-713 e19. | |
| Knecht H, Reigl T, Kotrova M, Appelt F, Stewart P, Bystry V, Krejci A, Grioni A, Pal K, Stranska K, Plevova K, Rijntjes J, Songia S, Svaton M, Fronkova E, Bartram J, Scheijen B, Herrmann D, Garcia-Sanz R, Hancock J, Moppett J, van Dongen JJM, Cazzaniga G, Davi F, Groenen P, Hummel M, Macintyre EA, Stamatopoulos K, Trka J, Langerak AW, Gonzalez D, Pott C, Bruggemann M, Darzentas N, EuroClonality NGSWG. Quality Control and Quantification in Ig/Tr Next-Generation Sequencing Marker Identification: Protocols and Bioinformatic Functionalities by Euroclonality-Ngs. Leukemia. 2019;33(9):2254-65. | |
| Fischer K, Ritgen M, Al-Sawaf O, Robrecht S, Tandon M, Fink AM, Schilhabel A, Stubig T, Bruggemann M, Jiang Y, Schary W, Eichhorst BF, Wendtner CM, Tausch E, Kreuzer KA, Langerak AW, Goede V, Bottcher S, Stilgenbauer S, Kneba M, Hallek M. Quantitative Analysis of Minimal Residual Disease (Mrd) Shows High Rates of Undetectable Mrd after Fixed-Duration Chemotherapy-Free Treatment and Serves as Surrogate Marker for Progression-Free Survival: A Prospective Analysis of the Randomized Cll14 Trial. Blood. 2019;134(Supplement_1):36. | |
| Fischer K, Al-Sawaf O, Bahlo J, Fink AM, Tandon M, Dixon M, Robrecht S, Warburton S, Humphrey K, Samoylova O, Liberati AM, Pinilla-Ibarz J, Opat S, Sivcheva L, Le Du K, Fogliatto LM, Niemann CU, Weinkove R, Robinson S, Kipps TJ, Boettcher S, Tausch E, Humerickhouse R, Eichhorst B, Wendtner CM, Langerak AW, Kreuzer KA, Ritgen M, Goede V, Stilgenbauer S, Mobasher M, Hallek M. Venetoclax and Obinutuzumab in Patients with Cll and Coexisting Conditions. N Engl J Med. 2019;380(23):2225-36. | |
| Fazil Z, Ten Berge JC, Langerak AW, Rothova A, Dik WA. An Intraocular Inflammatory Profile of Rubella Associated Uveitis. Ocul Immunol Inflamm. 2019;27(3):418-23. | |
| de Hoog J, Dik WA, Lu L, Heezen KC, Ten Berge JC, Swagemakers SMA, van der Spek PJ, van Dongen JJM, van der Velden VHJ, Rothova A, Langerak AW. Combined Cellular and Soluble Mediator Analysis for Improved Diagnosis of Vitreoretinal Lymphoma. Acta Ophthalmol. 2019;97(6):626-32. | |
| Bruggemann M, Kotrova M, Knecht H, Bartram J, Boudjogrha M, Bystry V, Fazio G, Fronkova E, Giraud M, Grioni A, Hancock J, Herrmann D, Jimenez C, Krejci A, Moppett J, Reigl T, Salson M, Scheijen B, Schwarz M, Songia S, Svaton M, van Dongen JJM, Villarese P, Wakeman S, Wright G, Cazzaniga G, Davi F, Garcia-Sanz R, Gonzalez D, Groenen P, Hummel M, Macintyre EA, Stamatopoulos K, Pott C, Trka J, Darzentas N, Langerak AW, EuroClonality NGSwg. Standardized Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for Mrd Marker Identification in Acute Lymphoblastic Leukaemia; a Euroclonality-Ngs Validation Study. Leukemia. 2019;33(9):2241-53. | |
| Boone E, Heezen KC, Groenen P, Langerak AW, EuroClonality C. Pcr Genescan and Heteroduplex Analysis of Rearranged Immunoglobulin or T-Cell Receptor Genes for Clonality Diagnostics in Suspect Lymphoproliferations. Methods Mol Biol. 2019;1956:77-103. | |
| Armand M, Derrieux C, Beldjord K, Wabeke T, Lenze D, Boone E, Bruggemann M, Evans PAS, Gameiro P, Hummel M, Villarese P, Groenen P, Langerak AW, Macintyre EA, Davi F. A New and Simple Trg Multiplex Pcr Assay for Assessment of T-Cell Clonality: A Comparative Study from the Euroclonality Consortium. Hemasphere. 2019;3(3):e255. | |
| Stavast CJ, Erkeland SJ. The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells. 2019 Nov 19;8(11). PMID: 31752361 | |
| Ghanbari M, Munshi ST, Ma B, Lendemeijer B, Bansal S, Erkeland SJ, et al. A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease. Hum Mutat. 2019 Nov;40(11):2131-2145. PMID: 31322790 | |
| Zhao M, De Crignis E, Rokx C, Verbon A, van Gelder T, Mahmoudi T, et al. T cell toxicity of HIV latency reversing agents. Pharmacol Res. 2019;139:524-34. | |
| Tirosh I, Yamazaki Y, Frugoni F, Ververs FA, Allenspach EJ, Zhang Y, et al. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype. J Allergy Clin Immunol. 2019;143(2):726-35. | |
| Ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA, et al. Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract. Acta Ophthalmol. 2019;97(2):185-92. | |
| Smolders J, Jacobs BC, Tio-Gillen AP, Nijhuis F, Verrips A. Mycoplasma Pneumoniae and Antibodies against Galactocerebroside in a 9-Year-Old Boy with Encephalitis. Neuropediatrics. 2019;50(1):54-6. | |
| Schutz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, et al. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group. J Clin Immunol. 2019;39(1):45-54. | |
| Meyer Sauteur PM, de Bruijn A, Graca C, Tio-Gillen AP, Estevao SC, Hoogenboezem T, et al. Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae. Infect Immun. 2019;87(2). | |
| Meshaal SS, El Hawary RE, Abd Elaziz DS, Eldash A, Alkady R, Lotfy S, et al. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population. Clin Exp Immunol. 2019;195(2):202-12. | |
| Langerak AW, Ritgen M, Goede V, Robrecht S, Bahlo J, Fischer K, et al. Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood. 2019;133(5):494-7. | |
| Kater AP, Seymour JF, Hillmen P, Eichhorst B, Langerak AW, Owen C, et al. Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study. J Clin Oncol. 2019;37(4):269-77. | |
| Groen-Hakan F, Eurelings L, van Laar J, Rothova A. Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):175-80. | |
| Detiger SE, Karim AF, van Laar JAM, Paridaens D, Verdijk RM. The histological absence of IgG4 positive plasma cells in juvenile xanthogranuloma; comments on ‘Systemic juvenile xanthogranuloma: a case report and brief review’. Clin Exp Dermatol. 2019;44(1):91-2. | |
| Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, et al. IVIg-induced plasmablasts in patients with Guillain-Barre syndrome. Ann Clin Transl Neurol. 2019;6(1):129-43. | |
| Al-Hakem H, Sindrup SH, Andersen H, de la Cour CD, Lassen LL, van den Berg B, et al. Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol. 2019;266(2):440-9. | |
| Zhu C, Mustafa DAM, Krebber MM, Chrifi I, Leenen PJM, Duncker DJ, et al. Comparative proteomic analysis of cat eye syndrome critical region protein 1- function in tumor-associated macrophages and immune response regulation of glial tumors. Oncotarget. 2018;9(71):33500-14. |
BOEK HOOFDSTUKKEN
Retinal pigment epithelium in proliferative disorders
Dik WA, Bastiaans J, van Meurs JC.
The Retinal Pigment Epithelium in Health and Disease
(Eds:Alexa K Klettner, Stefan Dithmar; Springer; 2019 ISBN 978-3-030-28383-4)
Systemic Lupus Erythematosus
van Hagen PM, Dik WA, van Bilsen CEF.
Encyclopedia of Gastroenterology, 2nd Edition
(Ed: Ernst J Kuipers; Elsevier Science Publishing Co Inc; 2019 ISBN: 9780128124604)
PUBLICATIONS 2018
| Zeijlemaker W, Grob T, Meijer R, Hanekamp D, Kelder A, Carbaat-Ham JC, et al. CD34(+)CD38(-) leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia. 2018. | |
| Yeh EA, Hintzen RQ. Specific myelopathy diagnoses using advancing diagnostics: Idiopathic no more. Neurology. 2018;90(2):51-2. | |
| Wong YYM, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Melief MJ, Wierenga AF, et al. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes. Mult Scler. 2018;24(13):1715-24. | |
| Wijntjes J, Bechakra M, Schreurs MWJ, Jongen JLM, Koppenaal A, Titulaer MJ. Pruritus in anti-DPPX encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e455. | |
| Wijdeven RH, van Luijn MM, Wierenga-Wolf AF, Akkermans JJ, van den Elsen PJ, Hintzen RQ, et al. Chemical and genetic control of IFNgamma-induced MHCII expression. EMBO Rep. 2018;19(9). | |
| Wentink MWJ, van Zelm MC, van Dongen JJM, Warnatz K, van der Burg M. Deficiencies in the CD19 complex. Clin Immunol. 2018;195:82-7. | |
| Wentink MWJ, Mueller YM, Dalm V, Driessen GJ, van Hagen PM, van Montfrans JM, et al. Exhaustion of the CD8(+) T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta. Front Immunol. 2018;9(MAR):446. | |
| Wentink M. Connecting B cell differentiation pathways and antibody deficiencies [Ph.D. thesis]: Erasmus University Rotterdam; 2018. | |
| Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA, et al. Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial. J Peripher Nerv Syst. 2018;23(4):210-5. | |
| Wahadat MJ, Bodewes ILA, Maria NI, van Helden-Meeuwsen CG, van Dijk-Hummelman A, Steenwijk EC, et al. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? Arthritis Res Ther. 2018;20(1):4. | |
| Villarese P, Lours C, Trinquand A, Le Noir S, Belhocine M, Lhermitte L, et al. TCRalpha rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome. Leukemia. 2018;32(1):61-71. | |
| Vermeulen R, Saberi Hosnijeh F, Bodinier B, Portengen L, Liquet B, Garrido-Manriquez J, et al. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses. Int J Cancer. 2018;143(6):1335-47. | |
| Verhoekx JSN, Karim AF, van Laar JAM, Verdijk RM, Paridaens D. The tarsal plate manifestation of IgG4-related disease. Int Ophthalmol. 2018. | |
| Vergaelen E, Schiweck C, Van Steeland K, Counotte J, Veling W, Swillen A, et al. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? Brain Behav Immun. 2018;70:88-95. | |
| van Schouwenburg PA, H IJ, Pico-Knijnenburg I, Dalm V, van Hagen PM, van Zessen D, et al. Identification of CVID Patients With Defects in Immune Repertoire Formation or Specification. Front Immunol. 2018;9(NOV):2545. | |
| van Rees GF, Lago SG, Cox DA, Tomasik J, Rustogi N, Weigelt K, et al. Evidence of microglial activation following exposure to serum from first-onset drug-naive schizophrenia patients. Brain Behav Immun. 2018;67:364-73. | |
| Van Nieuwenhove E, Garcia-Perez JE, Helsen C, Rodriguez PD, van Schouwenburg PA, Dooley J, et al. A kindred with mutant IKAROS and autoimmunity. J Allergy Clin Immunol. 2018;142(2):699-702 e12. | |
| van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA, et al. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain. 2018;141(5):1334-49. | |
| van Laar JAM. Can epidemiological studies uncover the origin of Behcet’s disease? Rheumatology (Oxford). 2018;57(1):3-4. | |
| van Gammeren AJ, van Rijckevorsel M, Bras AE, Brandt-Hagens C, Te Marvelde JG, de Visser C, et al. Usability of femoral head bone marrow to verify reference ranges for the assessment of myelodysplasia by flow cytometry. Int J Lab Hematol. 2018;40(6):726-33. | |
| van Eijk JJJ, Cintas P, Jacobs BC, Kamar N, Dalton HR. Reply to: “Association of hepatitis E virus infection and myasthenia gravis: A pilot study”. J Hepatol. 2018;68(6):1321-2. | |
| van der Vuurst de Vries RM, Wong YYM, Mescheriakova JY, van Pelt ED, Runia TF, Jafari N, et al. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. Mult Scler. 2018:1352458518775303. | |
| van der Straten L, Dinmohamed AG, Westerweel PE, Langerak AW, Riedl J, Doorduijn JK, et al. Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy. Leuk Lymphoma. 2018:1-5. | |
| van der Spek AH, Surovtseva OV, Jim KK, van Oudenaren A, Brouwer MC, Vandenbroucke-Grauls C, et al. Regulation of Intracellular Triiodothyronine Is Essential for Optimal Macrophage Function. Endocrinology. 2018;159(5):2241-52. | |
| van der Pol P, Bakker-Jonges LE, Kuijpers J, Schreurs MWJ. Analytical and clinical comparison of two fully automated immunoassay systems for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta. 2018;476:154-9. | |
| van der Meulen M, Bromberg JEC, Lam KH, Dammers R, Langerak AW, Doorduijn JK, et al. Flow cytometry shows added value in diagnosing lymphoma in brain biopsies. Cytometry B Clin Cytom. 2018;94(6):928-34. | |
| van der Heiden M, de Rond LGH, van Zelm MC, Berbers GAM, Boots AMH, Buisman AM. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults. Front Immunol. 2018;9:46. | |
| van den Bossche WBL, Rykov K, Teodosio C, Ten Have B, Knobben BAS, Sietsma MS, et al. Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage. Clin Immunol. 2018;197:224-30. | |
| van den Bossche WBL, Kleijn A, Teunissen CE, Voerman JSA, Teodosio C, Noske DP, et al. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment. Neuro Oncol. 2018;20(11):1494-504. | |
| van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC. Clinical outcome of Guillain-Barre syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry. 2018;89(9):949-54. | |
| van de Bovenkamp FS, Derksen NIL, Ooijevaar-de Heer P, van Schie KA, Kruithof S, Berkowska MA, et al. Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region. Proc Natl Acad Sci U S A. 2018;115(8):1901-6. | |
| van Beek AA, Fransen F, Meijer B, de Vos P, Knol EF, Savelkoul HFJ. Aged mice display altered numbers and phenotype of basophils, and bone marrow-derived basophil activation, with a limited role for aging-associated microbiota. Immun Ageing. 2018;15:32. | |
| Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol. 2018;141(2):730-40. | |
| Timmermans M. Immunopathogenesis of Granulomas in Chronic Inflammatory Diseases : Relevance to diagnostics, biomarkers and treatment [Ph.D. thesis]: Erasmus University Rotterdam; 2018. | |
| Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, et al. No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Front Immunol. 2018;9:1506. | |
| Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A. Autoimmunity in uveitis. Acta Ophthalmol. 2018;96(5):481-5. | |
| Ten Berge JC, Schreurs MW, van Rosmalen J, Rothova A. Autoantibody profiling in intraocular fluid of patients with uveitis. Exp Eye Res. 2018;176:141-6. | |
| Ten Berge JC, Groen-Hakan F, Rothova A, Schreurs MWJ. Antinuclear antibody profiling in uveitis. Acta Ophthalmol. 2018;96(5):e660-e1. | |
| Ten Berge J, van Dijk EHC, Schreurs MWJ, Vermeer J, Boon CJF, Rothova A. Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications. Acta Ophthalmol. 2018;96(1):56-62. | |
| Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, et al. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst. 2018;23(4):227-34. | |
| Stelekati E, Chen Z, Manne S, Kurachi M, Ali MA, Lewy K, et al. Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. Cell Rep. 2018;23(7):2142-56. | |
| Stavast CJ, Leenen PJM, Erkeland SJ. The interplay between critical transcription factors and microRNAs in the control of normal and malignant myelopoiesis. Cancer Lett. 2018;427:28-37. | |
| Sonderen AV, Arends S, Tavy DLJ, Bastiaansen AEM, Bruijn M, Schreurs MWJ, et al. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2018;89(10):1101-6. | |
| Snijders G, Titulaer MJ, Bergink V, Bastiaansen AE, Schreurs MWJ, Ophoff RA, et al. No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder. Psychiatry Res. 2018;259:460-2. | |
| Smith V, Scire CA, Talarico R, Airo P, Alexander T, Allanore Y, et al. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000782. | |
| Shariatzadeh M, Brandt MM, Cheng C, Ten Berge JC, Rothova A, Leenen PJM, et al. Three-dimensional tubule formation assay as therapeutic screening model for ocular microvascular disorders. Eye (Lond). 2018;32(8):1380-6. | |
| Sedek L, Theunissen P, Sobral da Costa E, van der Sluijs-Gelling A, Mejstrikova E, Gaipa G, et al. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. J Immunol Methods. 2018. | |
| Schreurs MWJ, De Vries A. Immunoassays voor het meten van serumconcentraties biologics ean anti-biologic antilichamen bij patiënten. . Bijblijven. 2018;34:179-86. | |
| Schoenaker MHD, Henriet SS, Zonderland J, van Deuren M, Pan-Hammarstrom Q, Posthumus-van Sluijs SJ, et al. Immunodeficiency in Bloom’s Syndrome. J Clin Immunol. 2018;38(1):35-44. | |
| Saberi Hosnijeh F, Kavousi M, Boer CG, Uitterlinden AG, Hofman A, Reijman M, et al. Development of a prediction model for future risk of radiographic hip osteoarthritis. Osteoarthritis Cartilage. 2018;26(4):540-6. | |
| Romao VC, Talarico R, Scire CA, Vieira A, Alexander T, Baldini C, et al. Sjogren’s syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000789. | |
| Rijvers L, Melief MJ, van der Vuurst de Vries RM, Stephant M, van Langelaar J, Wierenga-Wolf AF, et al. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis. Eur J Immunol. 2018;48(11):1861-71. | |
| Razawy W, van Driel M, Lubberts E. The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling. Eur J Immunol. 2018;48(2):220-9. | |
| Ponsford MJ, Klocperk A, Pulvirenti F, Dalm V, Milota T, Cinetto F, et al. Hyper-IgE in the allergy clinic–when is it primary immunodeficiency? Allergy. 2018;73(11):2122-36. | |
| Pfajfer L, Mair NK, Jimenez-Heredia R, Genel F, Gulez N, Ardeniz O, et al. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity. J Allergy Clin Immunol. 2018;142(5):1589-604 e11. | |
| Palstra RJ, de Crignis E, Roling MD, van Staveren T, Kan TW, van Ijcken W, et al. Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1. Sci Adv. 2018;4(2):e1701729. | |
| Pal Singh S, de Bruijn MJW, de Almeida MP, Meijers RWJ, Nitschke L, Langerak AW, et al. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency. Front Immunol. 2018;9(SEP):1996. | |
| Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17(1):57. | |
| Nechvatalova J, Bartol SJW, Chovancova Z, Boon L, Vlkova M, van Zelm MC. Absence of Surface IgD Does Not Impair Naive B Cell Homeostasis or Memory B Cell Formation in IGHD Haploinsufficient Humans. J Immunol. 2018;201(7):1928-35. | |
| Mulders-Manders CM, Kanters TA, van Daele PLA, Hoppenreijs E, Legger GE, van Laar JAM, et al. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study. Orphanet J Rare Dis. 2018;13(1):59. | |
| Mulder VC, Bastiaans J, van Leuven CJM, van Meurs JC, Kluft C. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment. Ophthalmologica. 2018;240(1):23-8. | |
| Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gur-Demirel Y, et al. Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners. Lung. 2018;196(5):569-75. | |
| Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Drenthen J, Unger WWJ, Jacobs E, et al. Intrathecal antibody responses to GalC in Guillain-Barre syndrome triggered by Mycoplasma pneumoniae. J Neuroimmunol. 2018;314:13-6. | |
| Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, et al. Antibody responses to GalC in severe and complicated childhood Guillain-Barre syndrome. J Peripher Nerv Syst. 2018;23(1):67-9. | |
| Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273-84. | |
| Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NMA, Posthumus-van Sluijs SJ, van Hagen PM, et al. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1). J Allergy Clin Immunol. 2018;142(1):328-30 e2. | |
| Matarraz S, Leoz P, Fernandez C, Colado E, Chillon MC, Vidriales MB, et al. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy. Mod Pathol. 2018;31(8):1318-31. | |
| Liu C, Dalm V, van Hagen PM, Croon-de Boer F, Paridaens D. Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma. Orbit. 2018;37(4):299-302. | |
| Lhermitte L, Mejstrikova E, van der Sluijs-Gelling AJ, Grigore GE, Sedek L, Bras AE, et al. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia. Leukemia. 2018;32(4):874-81. | |
| Leonhard SE, Munts AG, van der Eijk AA, Jacobs BC. Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika virus infection. J Neurol Neurosurg Psychiatry. 2018;89(10):1118-9. | |
| Leonhard SE, Lant S, Jacobs BC, Wilder-Smith A, Ferreira MLB, Solomon T, et al. Zika virus infection in the returning traveller: what every neurologist should know. Pract Neurol. 2018;18(4):271-7. | |
| Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, et al. IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation. J Clin Immunol. 2018;38(2):185-92. | |
| Langerak AW, Assmann J. Large granular lymphocyte cells and immune dysregulation diseases – the chicken or the egg? Haematologica. 2018;103(2):193-4. | |
| Laksono BM, Grosserichter-Wagener C, de Vries RD, Langeveld SAG, Brem MD, van Dongen JJM, et al. In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells. J Virol. 2018;92(8). | |
| Laksono BM, de Vries RD, Verburgh RJ, Visser EG, de Jong A, Fraaij PLA, et al. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat Commun. 2018;9(1):4944. | |
| La Distia Nora R, Walburg KV, van Hagen PM, Swagemakers SMA, van der Spek PJ, Quinten E, et al. Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon Signaling. Invest Ophthalmol Vis Sci. 2018;59(3):1384-95. | |
| La Distia Nora R, Ten Berge JC, Rothova A, Schreurs MW. Antinuclear and antiretinal antibodies in uveitis associated with active and latent tuberculosis. Acta Ophthalmol. 2018;96(5):e659-e60. | |
| La Distia Nora R, Sitompul R, Bakker M, Versnel MA, Swagemakers SMA, van der Spek PJ, et al. Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis? PLoS One. 2018;13(10):e0206073. | |
| La Distia Nora R. Mycobacterium Tuberculosis-Associated Uveitis: Infection and Autoimmunity [Ph.D. thesis]: Erasmus University Rotterdam; 2018. | |
| Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study). J Peripher Nerv Syst. 2018;23(1):5-10. | |
| Kriek N, Schreurs MWJ, Groeneweg JG, Dik WA, Tjiang GCH, Gultuna I, et al. Spinal Cord Stimulation in Patients With Complex Regional Pain Syndrome: A Possible Target for Immunomodulation? Neuromodulation. 2018;21(1):77-86. | |
| Karim AF, Hermans MA, Verdijk RM, Van Hagen PM, Van Laar JA. IgG4-gerelateerde ziekte: huidige stand van zaken. . Nederlands Tijdschrift voor Allergie, Astma en Klinische Immunologie. 2018(18):3-9. | |
| Karim AF, Heeringa JJ, van Laar JAM, Verdijk RM, Dik WA, Paridaens AD, et al. Reply. J Allergy Clin Immunol. 2018;141(5):1958-60 e4. | |
| Karim AF, Eurelings LEM, van Hagen PM, van Laar JAM. Implications of elevated C-reactive protein and serum amyloid A levels in IgG4-related disease: comment on the article by Perugino et al. Arthritis Rheumatol. 2018;70(2):317-8. | |
| Karim AF, Eurelings LEM, Bansie RD, van Hagen PM, van Laar JAM, Dik WA. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease. Mediators Inflamm. 2018;2018:6103064. | |
| Kallemeijn MJ, Kavelaars FG, van der Klift MY, Wolvers-Tettero ILM, Valk PJM, van Dongen JJM, et al. Next-Generation Sequencing Analysis of the Human TCRgammadelta+ T-Cell Repertoire Reveals Shifts in Vgamma- and Vdelta-Usage in Memory Populations upon Aging. Front Immunol. 2018;9(MAR):448. | |
| Kallemeijn M. Normal and Aberrant TCRγδ+ T Cells and T Cell Large Granular Lymphocyte Leukemia [Ph.D. thesis]: Erasmus University Rotterdam; 2018. | |
| Jansen M, van Zelm M, Groeneweg M, Jaddoe V, Dik W, Schreurs M, et al. The identification of celiac disease in asymptomatic children: the Generation R Study. J Gastroenterol. 2018;53(3):377-86. | |
| Islam B, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, et al. Small volume plasma exchange for Guillain-Barre syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open. 2018;8(8):e022862. | |
| Islam B, Islam Z, GeurtsvanKessel CH, Jahan I, Endtz HP, Mohammad QD, et al. Guillain-Barre syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. 2018;37(3):511-8. | |
| Indhirajanti S, van Daele PLA, Bos S, Mulder MT, Bot I, Roeters van Lennep JE. Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels. Atherosclerosis. 2018;268:152-6. | |
| Hoogeveen PG, de Bie M, Noordijk R, Sonneveld E, Koning-Goedheer A, Beverloo HB, et al. Pitfalls in short-tandem repeat analysis as quality control for sample mix-up of pediatric acute lymphoblastic leukemia patients. Leuk Lymphoma. 2018;59(6):1508-10. | |
| Hermans MAW, Schrijver B, van Holten-Neelen C, Gerth van Wijk R, van Hagen PM, van Daele PLA, et al. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. Clin Exp Allergy. 2018;48(11):1412-20. | |
| Heeringa JJ, Rijvers L, Arends NJ, Driessen GJ, Pasmans SG, van Dongen JJM, et al. IgE-expressing memory B cells and plasmablasts are increased in blood of children with asthma, food allergy, and atopic dermatitis. Allergy. 2018;73(6):1331-6. | |
| Heeringa JJ, Karim AF, van Laar JAM, Verdijk RM, Paridaens D, van Hagen PM, et al. Expansion of blood IgG4(+) B, TH2, and regulatory T cells in patients with IgG4-related disease. J Allergy Clin Immunol. 2018;141(5):1831-43 e10. | |
| Heeringa JJ, Fieten KB, Bruins FM, van Hoffen E, Knol EF, Pasmans S, et al. Treatment for moderate to severe atopic dermatitis in alpine and moderate maritime climates differentially affects helper T cells and memory B cells in children. Clin Exp Allergy. 2018;48(6):679-90. | |
| Heeringa J. The B-cell side of Allergy and Chronic Inflammatory Disease: Studies on the source of IgE and IgG4 [Ph.D. thesis]: Erasmus University Rotterdam; 2018. | |
| Hanekamp D, Denys B, Kaspers GJL, Te Marvelde JG, Schuurhuis GJ, De Haas V, et al. Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients. Br J Haematol. 2018;183(3):512-6. | |
| Hancock AS, Stairiker CJ, Boesteanu AC, Monzon-Casanova E, Lukasiak S, Mueller YM, et al. Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation. J Virol. 2018;92(21). | |
| Haarman BCM, Burger H, Drexhage HA, Nolen WA, Riemersma-Van der Lek RF. [The dysregulated brain – Consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis] | |
| Het ontregelde brein; consequenties van ruimtelijke en temporele complexiteit van het brein voor pathofysiologie en diagnostiek van de bipolaire stoornis. Tijdschr Psychiatr. 2018;60(2):105-13. | |
| Groen-Hakan F, Eurelings L, Rothova A, van Laar J. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis. Br J Ophthalmol. 2018. | |
| Ghanbari M, Peters MJ, de Vries PS, Boer CG, van Rooij JGJ, Lee YC, et al. A systematic analysis highlights multiple long non-coding RNAs associated with cardiometabolic disorders. J Hum Genet. 2018;63(4):431-46. | |
| GeurtsvanKessel CH, Islam Z, Jacobs BC, Endtz HP. Reply to: Comment on: Zika virus and Guillain-Barre syndrome in Bangladesh. Ann Clin Transl Neurol. 2018;5(9):1140-1. | |
| GeurtsvanKessel CH, Islam Z, Islam MB, Kamga S, Papri N, van de Vijver D, et al. Zika virus and Guillain-Barre syndrome in Bangladesh. Ann Clin Transl Neurol. 2018;5(5):606-15. | |
| Flasinski M, Scheibke K, Zimmermann M, Creutzig U, Reinhardt K, Verwer F, et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study. Blood Adv. 2018;2(13):1532-40. | |
| Fazil Z, Ten Berge JC, Langerak AW, Rothova A, Dik WA. An Intraocular Inflammatory Profile of Rubella Associated Uveitis. Ocul Immunol Inflamm. 2018:1-6. | |
| Falkenburg WJJ, von Richthofen HJ, Koers J, Weykamp C, Schreurs MWJ, Bakker-Jonges LE, et al. Clinically relevant discrepancies between different rheumatoid factor assays. Clin Chem Lab Med. 2018;56(10):1749-58. | |
| Esenboga S, Cagdas D, Ozgur TT, Gur Cetinkaya P, Turkdemir LM, Sanal O, et al. Clinical and genetic features of the patients with X-Linked agammaglobulinemia from Turkey: Single-centre experience. Scand J Immunol. 2018;87(3). | |
| Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barre syndrome. Brain. 2018;141(10):2866-77. | |
| Doets AY, Jacobs BC, van Doorn PA. Advances in management of Guillain-Barre syndrome. Curr Opin Neurol. 2018;31(5):541-50. | |
| Dimier N, Delmar P, Ward C, Morariu-Zamfir R, Fingerle-Rowson G, Bahlo J, et al. A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. Blood. 2018;131(9):955-62. | |
| de Wit J, Brada RJK, van Veldhuizen J, Dalm V, Pasmans S. Skin disorders are prominent features in primary immunodeficiency diseases: A systematic overview of current data. Allergy. 2018. | |
| de Goeje PL, Klaver Y, Kaijen-Lambers MEH, Langerak AW, Vroman H, Kunert A, et al. Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS. Front Immunol. 2018;9(SEP):2034. | |
| de Bruijn M, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, et al. Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis. Neurology. 2018;90(22):e1997-e2005. | |
| Dankers W, Gonzalez-Leal C, Davelaar N, Asmawidjaja PS, Mus AMC, Hazes JMW, et al. 1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6(+) T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade. Arthritis Res Ther. 2018;20(1):212. | |
| Damoiseaux J, Schreurs MWJ, al. e. International Consensus on ANA Patterns (ICAP): inbedding in het Nederlandse taalgebied. . Laboratoriumgeneeskunde. 2018;3:17-26. | |
| Counotte J, Drexhage HA, Wijkhuijs JM, Pot-Kolder R, Bergink V, Hoek HW, et al. Th17/T regulator cell balance and NK cell numbers in relation to psychosis liability and social stress reactivity. Brain Behav Immun. 2018;69:408-17. | |
| Cazzaniga G, De Lorenzo P, Alten J, Rottgers S, Hancock J, Saha V, et al. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. Haematologica. 2018;103(1):107-15. | |
| Bunschoten C, Eftimov F, van der Pol WL, Jacobs BC, Consortium I. International chronic inflammatory demyelinating polyneuropathy outcome study (ICOS): Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome. J Peripher Nerv Syst. 2018. | |
| Buizert A, Verboon JC, Wirtz PW, Koopman JP, van Roosmalen RM, Jacobs BC, et al. [Bell’s palsy: different doctor, different care?] | |
| Bellse parese: andere dokter, andere zorg? Ned Tijdschr Geneeskd. 2018;162(35). | |
| Bras AE, de Haas V, van Stigt A, Jongen-Lavrencic M, Beverloo HB, Te Marvelde JG, et al. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping. Cytometry B Clin Cytom. 2018. | |
| Bras AE, Beishuizen A, Langerak AW, Jongen-Lavrencic M, Te Marvelde JG, van den Heuvel-Eibrink MM, et al. CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy. Br J Haematol. 2018;180(2):292-6. | |
| Bouwens van der Vlis TAM, Kros JM, Mustafa DAM, van Wijck RTA, Ackermans L, van Hagen PM, et al. The complement system in glioblastoma multiforme. Acta Neuropathol Commun. 2018;6(1):91. | |
| Boeddha NP, Kerklaan D, Dunbar A, van Puffelen E, Nagtzaam NMA, Vanhorebeek I, et al. HLA-DR Expression on Monocyte Subsets in Critically Ill Children. Pediatr Infect Dis J. 2018;37(10):1034-40. | |
| Bodewes ILA, Versnel MA. Interferon activation in primary Sjogren’s syndrome: recent insights and future perspective as novel treatment target. Expert Rev Clin Immunol. 2018;14(10):817-29. | |
| Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm V, et al. TBK1: A key regulator and potential treatment target for interferon positive Sjogren’s syndrome, systemic lupus erythematosus and systemic sclerosis. J Autoimmun. 2018;91:97-102. | |
| Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, et al. Systemic interferon type I and type II signatures in primary Sjogren’s syndrome reveal differences in biological disease activity. Rheumatology (Oxford). 2018;57(5):921-30. | |
| Blanco E, Perez-Andres M, Arriba-Mendez S, Contreras-Sanfeliciano T, Criado I, Pelak O, et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J Allergy Clin Immunol. 2018;141(6):2208-19 e16. | |
| Bjorkman A, Du L, van der Burg M, Cormier-Daire V, Borck G, Pie J, et al. Reduced immunoglobulin gene diversity in patients with Cornelia de Lange syndrome. J Allergy Clin Immunol. 2018;141(1):408-11 e8. | |
| Berger E, Delpierre C, Hosnijeh FS, Kelly-Irving M, Portengen L, Bergdahl IA, et al. Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts. Sci Rep. 2018;8(1):10805. | |
| Becking K, Haarman BCM, Grosse L, Nolen WA, Claes S, Arolt V, et al. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J Neuroimmunol. 2018;319:28-36. | |
| Bastiaans J, Mulder VC, van Meurs JC, Smits-Te Nijenhuis M, van Holten-Neelen C, van Hagen PM, et al. Dabigatran inhibits intravitreal thrombin activity. Acta Ophthalmol. 2018;96(5):452-8. | |
| Basak EA, Wijkhuijs AJM, Mathijssen RHJ, Koolen SLW, Schreurs MWJ. Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum Concentrations. Ther Drug Monit. 2018;40(5):596-601. | |
| Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, et al. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica. 2018;103(4):e158-e61. | |
| Agathangelidis A, Sutton LA, Hadzidimitriou A, Tresoldi C, Langerak AW, Belessi C, et al. Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation. J Vis Exp. 2018;2018(141). |
PUBLICATIONS 2017
| Zoutman WH, Nell RJ, Versluis M, van Steenderen D, Lalai RN, Out-Luiting JJ, et al. Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays. J Mol Diagn. 2017;19(2):236-43. | |
| Zhu C, Mustafa D, Zheng PP, van der Weiden M, Sacchetti A, Brandt M, et al. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression. Neuro Oncol. 2017;19(5):648-59. | |
| Zhu C, Chrifi I, Mustafa D, van der Weiden M, Leenen PJM, Duncker DJ, et al. CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma. Oncogene. 2017;36(38):5356-68. | |
| Zhou X, Huang F, Xu L, Lin Z, de Vrij FMS, Ayo-Martin AC, et al. Hepatitis E Virus Infects Neurons and Brains. J Infect Dis. 2017;215(8):1197-206. | |
| Young E, Noerenberg D, Mansouri L, Ljungstrom V, Frick M, Sutton LA, et al. EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. Leukemia. 2017;31(7):1547-54. | |
| Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, et al. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes. Clin Cancer Res. 2017;23(17):5292-301. | |
| Wren D, Walker BA, Bruggemann M, Catherwood MA, Pott C, Stamatopoulos K, et al. Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing. Haematologica. 2017;102(2):e57-e60. | |
| Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: surveillance and cost of treatment strategies – Authors’ reply. Lancet. 2017;389(10066):253-4. | |
| Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, et al. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. Haematologica. 2017;102(2):308-19. | |
| Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Scholvinck L, Kalina T, et al. Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86. | |
| Walgaard C, Lingsma HF, van Doorn PA, van der Jagt M, Steyerberg EW, Jacobs BC. Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barre Syndrome. Neurocrit Care. 2017;26(1):6-13. | |
| Waanders E, Scheijen B, Jongmans MC, Venselaar H, van Reijmersdal SV, van Dijk AH, et al. Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences. Leukemia. 2017;31(4):821-8. | |
| Vogels RJ, Koenders MA, van Rossum EF, Spijker AT, Drexhage HA. T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome. Front Psychiatry. 2017;8(MAR):34. | |
| Verboon C, van Doorn PA, Jacobs BC. Treatment dilemmas in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2017;88(4):346-52. | |
| Verboon C, van Berghem H, van Doorn PA, Ruts L, Jacobs BC. Prediction of disease progression in Miller Fisher and overlap syndromes. J Peripher Nerv Syst. 2017;22(4):446-50. | |
| van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, et al. Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol. 2017;81(2):193-8. | |
| van Nierop GP, van Luijn MM, Michels SS, Melief MJ, Janssen M, Langerak AW, et al. Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol. 2017;134(3):383-401. | |
| Van Dongen JJM, Van der Velden VHJ, Brüggemann M, Orfao A. Minimal residual disease (MRD) diagnostics: Methodology and prognostic significance. In: Vora J, editor. Childhood acute lymphoblastic leukemia: Springer; 2017. p. 139-62. | |
| van der Velden VH, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017. | |
| van der Houwen TB, van Hagen PM, Timmermans WM, Bartol SJ, Lam KH, Kappen JH, et al. Chronic signs of memory B cell activation in patients with Behcet’s disease are partially restored by anti-tumour necrosis factor treatment. Rheumatology (Oxford). 2017;56(1):134-44. | |
| van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM. An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults. Front Immunol. 2017;8:1962. | |
| van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM. An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults. Front Immunol. 2017;8(JAN):1962. | |
| van den Heuvel D, Jansen MAE, Nasserinejad K, Dik WA, van Lochem EG, Bakker-Jonges LE, et al. Effects of nongenetic factors on immune cell dynamics in early childhood: The Generation R Study. J Allergy Clin Immunol. 2017;139(6):1923-34 e17. | |
| van den Heuvel D, Jansen MA, Bell AI, Rickinson AB, Jaddoe VW, van Dongen JJ, et al. Transient reduction in IgA(+) and IgG(+) memory B cell numbers in young EBV-seropositive children: the Generation R Study. J Leukoc Biol. 2017;101(4):949-56. | |
| van den Bosch TP, Caliskan K, Kraaij MD, Constantinescu AA, Manintveld OC, Leenen PJ, et al. CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection. Front Immunol. 2017;8(MAR):346. | |
| van den Boogaard ML, Thijssen PE, Aytekin C, Licciardi F, Kiykim AA, Spossito L, et al. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2. Clin Genet. 2017;92(4):380-7. | |
| van Bezooijen JS, van Doorn MBA, Schreurs MWJ, Koch BCP, Te Velthuis H, Prens EP, et al. Prolongation of Biologic Dosing Intervals in Patients With Stable Psoriasis: A Feasibility Study. Ther Drug Monit. 2017;39(4):379-86. | |
| van Bezooijen JS, Schreurs MWJ, Koch BCP, Velthuis HT, van Doorn MBA, Prens EP, et al. Intrapatient Variability in the Pharmacokinetics of Etanercept Maintenance Treatment. Ther Drug Monit. 2017;39(4):333-8. | |
| van Beek AA, Hugenholtz F, Meijer B, Sovran B, Perdijk O, Vermeij WP, et al. Frontline Science: Tryptophan restriction arrests B cell development and enhances microbial diversity in WT and prematurely aging Ercc1(-/Delta7) mice. J Leukoc Biol. 2017;101(4):811-21. | |
| Theunissen PMJ, van Zessen D, Stubbs AP, Faham M, Zwaan CM, van Dongen JJM, et al. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones. Haematologica. 2017;102(11):1869-77. | |
| Theunissen PMJ, van den Branden A, Van Der Sluijs-Gelling A, De Haas V, Beishuizen A, van Dongen JJM, et al. Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 2017;178(2):267-78. | |
| Theunissen PMJ, Sedek L, De Haas V, Szczepanski T, Van Der Sluijs A, Mejstrikova E, et al. Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. Br J Haematol. 2017;178(2):257-66. | |
| Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347-57. | |
| Tan ACS, Yzer S, Atebara N, Marr BP, Verdijk RM, Dalm V, et al. Three Cases of Erdheim-Chester Disease With Intraocular Manifestations: Imaging and Histopathology Findings of a Rare Entity. Am J Ophthalmol. 2017;176:141-7. | |
| Sutton LA, Hadzidimitriou A, Baliakas P, Agathangelidis A, Langerak AW, Stilgenbauer S, et al. Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification. Haematologica. 2017;102(6):968-71. | |
| Suez D, Krivan G, Jolles SR, Hussain I, Stein MR, Gupta S, et al. A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America. J Allergy Clin Immunol. 2017;139(2):AB216. | |
| Stoop MP, Runia TF, Stingl C, van der Vuurst de Vries RM, Luider TM, Hintzen RQ. Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis. Proteomics Clin Appl. 2017;11(11-12). | |
| Snijders G, Mesman E, de Wit H, Wijkhuijs A, Nolen WA, Drexhage HA, et al. Immune dysregulation in offspring of a bipolar parent. Altered serum levels of immune growth factors at adolescent age. Brain Behav Immun. 2017;64:116-23. | |
| Snijders G, de Witte L, Mesman E, Kemner S, Vonk R, Brouwer R, et al. The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies. Int J Bipolar Disord. 2017;5(1):1. | |
| Singh SP, Rip J, Hendriks RW. Targeting Bruton’s tyrosine kinase expression levels through microRNAs in chronic lymphocytic leukemia treatment. Translational Cancer Research. 2017:S502-S7. | |
| Singh SP, Pillai SY, de Bruijn MJW, Stadhouders R, Corneth OBJ, van den Ham HJ, et al. Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling. Oncotarget. 2017;8(42):71981-95. | |
| Schauwvlieghe A, Vonk AG, Buddingh EP, Hoek RAS, Dalm VA, Klaassen CHW, et al. Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis. J Antimicrob Chemother. 2017;72(11):3047-50. | |
| Rovito R, Korndewal MJ, van Zelm MC, Ziagkos D, Wessels E, van der Burg M, et al. T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes. J Immunol. 2017;198(1):102-9. | |
| Rosenquist R, Ghia P, Hadzidimitriou A, Sutton LA, Agathangelidis A, Baliakas P, et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations. Leukemia. 2017;31(7):1477-81. | |
| Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, et al. Diagnosis of Guillain-Barre syndrome in children and validation of the Brighton criteria. J Neurol. 2017;264(5):856-61. | |
| Razawy W, Alves CH, Molendijk M, Asmawidjaja PS, Mus AMC, Lubberts E. Experimental Arthritis Mouse Models Driven by Adaptive and/or Innate Inflammation. Methods Mol Biol. 2017;1559:391-410. | |
| Rao VK, Webster S, Dalm V, Sediva A, van Hagen PM, Holland S, et al. Effective “activated PI3Kdelta syndrome”-targeted therapy with the PI3Kdelta inhibitor leniolisib. Blood. 2017;130(21):2307-16. | |
| Poletti S, de Wit H, Mazza E, Wijkhuijs AJM, Locatelli C, Aggio V, et al. Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls. Brain Behav Immun. 2017;61:317-25. | |
| Poletti S, Aggio V, Hoogenboezem TA, Ambree O, de Wit H, Wijkhuijs AJ, et al. Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder. Eur Psychiatry. 2017;40:33-7. | |
| Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2017;66(5):1082-95. | |
| Paiva B, Puig N, Cedena MT, de Jong BG, Ruiz Y, Rapado I, et al. Differentiation stage of myeloma plasma cells: biological and clinical significance. Leukemia. 2017;31(2):382-92. | |
| Paerewijck O, Maertens B, Dreesen L, Van Meulder F, Peelaers I, Ratman D, et al. Interleukin-17 receptor A (IL-17RA) as a central regulator of the protective immune response against Giardia. Sci Rep. 2017;7(1):8520. | |
| Ozcan B, Leenen PJM, Delhanty PJD, Baldeon-Rojas LY, Neggers SJ, van der Lely AJ. Unacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states. Diabetol Metab Syndr. 2017;9(1):43. | |
| Novakova M, Glier H, Brdickova N, Vlkova M, Santos AH, Lima M, et al. How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers. J Immunol Methods. 2017. | |
| Nelde A, Walz JS, Kowalewski DJ, Schuster H, Wolz OO, Peper JK, et al. HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. Oncoimmunology. 2017;6(3):e1219825. | |
| Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM. Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Front Immunol. 2017;8(APR):294. | |
| Mourik BC, Leenen PJ, de Knegt GJ, Huizinga R, van der Eerden BC, Wang J, et al. Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis. Am J Respir Cell Mol Biol. 2017;56(2):233-41. | |
| Moser SC, Voerman JSA, Buckley DL, Winter GE, Schliehe C. Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules. Front Immunol. 2017;8:1920. | |
| Moser SC, Voerman JSA, Buckley DL, Winter GE, Schliehe C. Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules. Front Immunol. 2017;8:1920. | |
| Meijers RW, Dzierzanowska-Fangrat K, Zborowska M, Solarska I, Tielemans D, van Turnhout BA, et al. Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence. J Clin Immunol. 2017;37(2):133-42. | |
| Meesilpavikkai K, Dik WA, Schrijver B, Nagtzaam NM, van Rijswijk A, Driessen GJ, et al. A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation. Front Immunol. 2017;8(MAR):274. | |
| Matarraz S, Almeida J, Flores-Montero J, Lecrevisse Q, Guerri V, Lopez A, et al. Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry. Cytometry B Clin Cytom. 2017;92(3):218-27. | |
| Martin-Martin L, Langerak AW, Quijano S, Almeida J, Flores-Montero J, Penalver J, et al. Occult CNS involvement by flow cytometry in aggressive lymphoma. . In: Van Dongen JJM, editor. 6th ESLHO symposium book. Leiden2017. p. 107-11. | |
| Maria NI, Steenwijk EC, AS IJ, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, et al. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2017;76(4):721-30. | |
| Lukas D, Yogev N, Kel JM, Regen T, Mufazalov IA, Tang Y, et al. TGF-beta inhibitor Smad7 regulates dendritic cell-induced autoimmunity. Proc Natl Acad Sci U S A. 2017;114(8):E1480-E9. | |
| Looman KIM, Jansen MAE, Voortman T, van den Heuvel D, Jaddoe VWV, Franco OH, et al. The role of vitamin D on circulating memory T cells in children: The Generation R study. Pediatr Allergy Immunol. 2017;28(6):579-87. | |
| Langerak AW, van der Velden VHJ. Molecular diagnostics of lymphoid malignancies. Molecular Diagnostics: Part 2: Clinical, Veterinary, Agrobotanical and Food Safety Applications2017. p. 103-29. | |
| Langerak AW, Van der Velden VHJ. Molecular diagnostics of lymphoid malignancies. . In: Van Pelt-Verkuil E, van Leeuwen WB, Te Witt R, editors. Molecular diagnostics. Singapore: Springer; 2017. p. 103-29. | |
| Langerak AW, Bruggemann M, Davi F, Darzentas N, van Dongen JJM, Gonzalez D, et al. High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges. J Immunol. 2017;198(10):3765-74. | |
| Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2017;22(4):425-32. | |
| Kuitwaard K, Fokkink WR, Brusse E, Vrancken A, Eftimov F, Notermans NC, et al. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2017;22(4):425-32. | |
| Kotrova M, van der Velden VHJ, van Dongen JJM, Formankova R, Sedlacek P, Bruggemann M, et al. Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transplant. 2017;52(7):962-8. | |
| Kosack L, Gawish R, Lercher A, Vilagos B, Hladik A, Lakovits K, et al. The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis. Sci Rep. 2017;7(1):11289. | |
| Kleijn A, van den Bossche W, Haefner ES, Belcaid Z, Burghoorn-Maas C, Kloezeman JJ, et al. The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8(+)T Cell Anti-tumor Activity. Mol Ther Oncolytics. 2017;5:11-9. | |
| Karim F, de Hoog J, Paridaens D, Verdijk R, Schreurs M, Rothova A, et al. IgG4-related disease as an emerging cause of scleritis. Acta Ophthalmol. 2017;95(8):e795-e6. | |
| Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600. | |
| Kannegieter NM, Hesselink DA, Dieterich M, Kraaijeveld R, Rowshani AT, Leenen PJ, et al. The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function. PLoS One. 2017;12(1):e0170806. | |
| Kannegieter NM, Hesselink DA, Dieterich M, de Graav GN, Kraaijeveld R, Rowshani AT, et al. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. Ther Drug Monit. 2017;39(5):463-71. | |
| Kalteren WS, Schreurs MWJ, Jorritsma-Smit A, Touw DJ, de Jong JW, Zweers P, et al. Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report. Br J Clin Pharmacol. 2017;83(10):2330-2. | |
| Kallemeijn MJ, de Ridder D, Schilperoord-Vermeulen J, van der Klift MY, Sandberg Y, van Dongen JJ, et al. Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia. PLoS One. 2017;12(4):e0175670. | |
| Kallemeijn MJ, Boots AMH, van der Klift MY, Brouwer E, Abdulahad WH, Verhaar JAN, et al. Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells. Sci Rep. 2017;7(1):5509. | |
| Kahlmann V, Roodbol J, van Leeuwen N, Ramakers CRB, van Pelt D, Neuteboom RF, et al. Validated age-specific reference values for CSF total protein levels in children. Eur J Paediatr Neurol. 2017;21(4):654-60. | |
| Jansen MAE, van den Heuvel D, Jaddoe VWV, van Zelm MC, Moll HA. Abnormalities in CD57+ cytotoxic T cells and Vdelta1+ gammadeltaT cells in subclinical celiac disease in childhood are affected by cytomegalovirus. The Generation R Study. Clin Immunol. 2017;183:233-9. | |
| Jansen MAE, van den Heuvel D, Jaddoe VWV, Moll HA, van Zelm MC. No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study. J Infect Dis. 2017;215(6):883-8. | |
| Jansen MAE, Beth SA, van den Heuvel D, Kiefte-de Jong JC, Raat H, Jaddoe VWV, et al. Ethnic differences in coeliac disease autoimmunity in childhood: the Generation R Study. Arch Dis Child. 2017;102(6):529-34. | |
| Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, et al. International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome. J Peripher Nerv Syst. 2017;22(2):68-76. | |
| Islam MB, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, et al. Small volume plasma exchange for Guillain-Barre syndrome in resource poor settings: a safety and feasibility study. Pilot Feasibility Stud. 2017;3:40. | |
| Ishaque T, Islam MB, Ara G, Endtz HP, Mohammad QD, Jacobs BC, et al. High mortality from Guillain-Barre syndrome in Bangladesh. J Peripher Nerv Syst. 2017;22(2):121-6. | |
| IJspeert H, van Schouwenburg PA, van Zessen D, Pico-Knijnenburg I, Stubbs AP, van der Burg M. Antigen Receptor Galaxy: A User-Friendly, Web-Based Tool for Analysis and Visualization of T and B Cell Receptor Repertoire Data. J Immunol. 2017;198(10):4156-65. | |
| Huang L, Betjes MGH, Klepper M, Langerak AW, Baan CC, Litjens NHR. End-Stage Renal Disease Causes Skewing in the TCR Vbeta-Repertoire Primarily within CD8(+) T Cell Subsets. Front Immunol. 2017;8(DEC):1826. | |
| Hope JL, Stairiker CJ, Spantidea PI, Gracias DT, Carey AJ, Fike AJ, et al. The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8(+) T Cells via SHIP-1. Front Immunol. 2017;8(DEC):1696. | |
| Hofste op Bruinik D, Van der Velden VHJ. Minimale restziekte. In: Van de Donk NWCJ, Kramer PA, editors. Multipel myeloom: Academic Pharmaceutical Productions; 2017. | |
| Hara M, Arino H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, et al. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. 2017;88(14):1340-8. | |
| Hanalioglu D, Ayvaz DC, Ozgur TT, van der Burg M, Sanal O, Tezcan I. A novel mutation in TAP1 gene leading to MHC class I deficiency: Report of two cases and review of the literature. Clin Immunol. 2017;178:74-8. | |
| Haarman BCM, Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JC, et al. Corrigendum to “Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study” [Brain Behav. Immun. (2015)]. Brain Behav Immun. 2017;61:387-8. | |
| Gudmundsdottir J, Lundqvist C, Ijspeert H, van der Slik E, Oskarsdottir S, Lindgren S, et al. T-cell receptor sequencing reveals decreased diversity 18 years after early thymectomy. J Allergy Clin Immunol. 2017;140(6):1743-6 e7. | |
| Groen-Hakan F, Eurelings L, ten Berge JC, van Laar J, Ramakers CRB, Dik WA, et al. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis. JAMA Ophthalmol. 2017;135(12):1352-8. | |
| Groen F, van Laar JAM, Rothova A. Chest Radiographic Screening for Sarcoidosis in the Diagnosis of Patients with Active Uveitis. Ann Am Thorac Soc. 2017;14(6):912-8. | |
| Ghanbari M, Iglesias AI, Springelkamp H, van Duijn CM, Ikram MA, Dehghan A, et al. A Genome-Wide Scan for MicroRNA-Related Genetic Variants Associated With Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2017;58(12):5368-77. | |
| Ghanbari M, Erkeland SJ, Xu L, Colijn JM, Franco OH, Dehghan A, et al. Genetic variants in microRNAs and their binding sites within gene 3’UTRs associate with susceptibility to age-related macular degeneration. Hum Mutat. 2017;38(7):827-38. | |
| Fokkink WR, Walgaard C, Kuitwaard K, Tio-Gillen AP, van Doorn PA, Jacobs BC. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barre Syndrome. JAMA Neurol. 2017;74(2):189-96. | |
| Fokkink WR, Jacobs BC. Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barre Syndrome?-Reply. JAMA Neurol. 2017;74(7):872. | |
| Fokkink W, Koch B, Ramakers C, van Doorn PA, van Gelder T, Jacobs BC. Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated Neuropathies. Clin Pharmacol Ther. 2017;102(4):709-16. | |
| Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, Garcia-Sanchez O, Bottcher S, et al. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094-103. | |
| Fischer K, Al-Sawaf O, Fink AM, Dixon M, Bahlo J, Warburton S, et al. Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood. 2017;129(19):2702-5. | |
| Eppinga H, Thio HB, Schreurs MWJ, Blakaj B, Tahitu RI, Konstantinov SR, et al. Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF). PLoS One. 2017;12(5):e0176955. | |
| Eindhoven S, Levels J, Huisman M, de Winter KR, Dalm V, Alwani R. MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination. Allergy Asthma Clin Immunol. 2017;13(1):49. | |
| Drenthen J, Roodbol J, Maathuis EM, Catsman-Berrevoets CE, Blok JH, de Wit MY, et al. Motor nerve excitability after childhood Guillain-Barre syndrome. J Peripher Nerv Syst. 2017;22(2):100-5. | |
| Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, et al. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984-1008. | |
| Dedeoglu B, de Weerd AE, Huang L, Langerak AW, Dor FJ, Klepper M, et al. Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation. Clin Exp Immunol. 2017;188(2):299-310. | |
| de Jong BG, H IJ, Marques L, van der Burg M, van Dongen JJ, Loos BG, et al. Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age. Immunol Cell Biol. 2017;95(9):744-52. | |
| de Bruijn MJ, Rip J, van der Ploeg EK, van Greuningen LW, Ta VT, Kil LP, et al. Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling. J Immunol. 2017;198(8):3058-68. | |
| Dalton HR, van Eijk JJJ, Cintas P, Madden RG, Jones C, Webb GW, et al. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017;67(5):925-32. | |
| Cremers EM, Westers TM, Alhan C, Cali C, Visser-Wisselaar HA, Chitu DA, et al. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica. 2017;102(2):320-6. | |
| Corneth OBJ, Verstappen GMP, Paulissen SMJ, de Bruijn MJW, Rip J, Lukkes M, et al. Enhanced Bruton’s Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease. Arthritis Rheumatol. 2017;69(6):1313-24. | |
| Carey AJ, Hope JL, Mueller YM, Fike AJ, Kumova OK, van Zessen DBH, et al. Public Clonotypes and Convergent Recombination Characterize the Naive CD8(+) T-Cell Receptor Repertoire of Extremely Preterm Neonates. Front Immunol. 2017;8:1859. | |
| Cante-Barrett K, Mendes RD, Li Y, Vroegindeweij E, Pike-Overzet K, Wabeke T, et al. Loss of CD44(dim) Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8(JAN):32. | |
| Cagdas D, Aytac S, Kuskonmaz B, Ariga T, van der Burg M, Cetinkaya DU, et al. Low T Cell Numbers Resembling T-B+ SCID in a Patient with Wiskott-Aldrich Syndrome and the Outcome of Two Hematopoietic Stem Cell Transplantations. J Clin Immunol. 2017;37(1):18-21. | |
| Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, et al. ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data. Bioinformatics. 2017;33(3):435-7. | |
| Bruinsma IB, van Dijk M, Bridel C, van de Lisdonk T, Haverkort SQ, Runia TF, et al. Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS. J Neuroinflammation. 2017;14(1):235. | |
| Bottcher S, van der Velden VHJ, Villamor N, Ritgen M, Flores-Montero J, Murua Escobar H, et al. Lot-to-lot stability of antibody reagents for flow cytometry. J Immunol Methods. 2017. | |
| Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjogren’s syndrome: beyond the dryness – From pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14(3):191-200. | |
| Both T. Beyond the dryness of Sjögren’s syndrome : renal complications and bone metabolism [Ph.D. thesis]. Rotterdam: Erasmus University Rotterdam; 2017. | |
| Boer JM, Steeghs EM, Marchante JR, Boeree A, Beaudoin JJ, Beverloo HB, et al. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia. Oncotarget. 2017;8(3):4618-28. | |
| Blom M, Pico-Knijnenburg I, Sijne-van Veen M, Boelen A, Bredius RGM, van der Burg M, et al. An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program. Clin Immunol. 2017;180:106-10. | |
| Blanco E, Perez-Andres M, Sanoja-Flores L, Wentink M, Pelak O, Martin-Ayuso M, et al. Selection and validation of antibody clones against IgG and IgA subclasses in switched memory B-cells and plasma cells. J Immunol Methods. 2017. | |
| Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ, Huygen F. Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes? Mediators Inflamm. 2017;2017:2764261. | |
| Berciano J, Sedano MJ, Pelayo-Negro AL, Garcia A, Orizaola P, Gallardo E, et al. Proximal nerve lesions in early Guillain-Barre syndrome: implications for pathogenesis and disease classification. J Neurol. 2017;264(2):221-36. | |
| Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, et al. Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder. J Clin Psychiatry. 2017;78(8):e986-e93. | |
| Bain CC, Montgomery J, Scott CL, Kel JM, Girard-Madoux MJH, Martens L, et al. TGFbetaR signalling controls CD103(+)CD11b(+) dendritic cell development in the intestine. Nat Commun. 2017;8(1):620. | |
| Artlett CM, Sassi-Gaha S, Hope JL, Feghali-Bostwick CA, Katsikis PD. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther. 2017;19(1):144. | |
| Alvarez-Twose I, Matito A, Morgado JM, Sanchez-Munoz L, Jara-Acevedo M, Garcia-Montero A, et al. Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature. Oncotarget. 2017;8(40):68950-63. | |
| Allaerts W, Chang TW. Skewed Exposure to Environmental Antigens Complements Hygiene Hypothesis in Explaining the Rise of Allergy. Acta Biotheor. 2017;65(2):117-34. |
PUBLICATIONS 2016
| Zondag TC, Rokx C, van Lom K, van den Berg AR, Sonneveld P, Dik WA, et al. Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis. Int J Hematol. 2016;103(4):469-72. | |
| Wojtowicz EE, Lechman ER, Hermans KG, Schoof EM, Wienholds E, Isserlin R, et al. Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors. Cell Stem Cell. 2016;19(3):383-96. | |
| Wohn C, Brand A, van Ettinger K, Brouwers-Haspels I, Waisman A, Laman JD, et al. Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A. Cell Immunol. 2016;308:57-65. | |
| Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388(10045):717-27. | |
| Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, et al. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol. 2016;137(2):517-26 e3. | |
| Virakul S, Phetsuksiri T, van Holten-Neelen C, Schrijver B, van Steensel L, Dalm VA, et al. Histamine induces NF-kappaB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1. Exp Eye Res. 2016;147:85-93. | |
| Virakul S, Heutz JW, Dalm VA, Peeters RP, Paridaens D, van den Bosch WA, et al. Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts. Mol Cell Endocrinol. 2016;433:94-104. | |
| Virakul S. New insights in the pathogenesis of Graves’ ophthalmopathy: potentials for targeted therapy [Ph.D. thesis]. Erasmus University Rotterdam: Erasmus University Rotterdam; 2016. | |
| Veltman M, Stolarczyk M, Radzioch D, Wojewodka G, De Sanctis JB, Dik WA, et al. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L1000-L14. | |
| Veen C, Myint AM, Burgerhout KM, Schwarz MJ, Schutze G, Kushner SA, et al. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression. J Affect Disord. 2016;189:298-305. | |
| van Veen M, Nijman RG, Zijlstra M, Dik WA, de Rijke YB, Moll HA, et al. Neutrophil CD64 expression is not a useful biomarker for detecting serious bacterial infections in febrile children at the emergency department. Infect Dis (Lond). 2016;48(5):331-7. | |
| van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449-56. | |
| van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time. Autoimmun Rev. 2016;15(10):970-4. | |
| van Sonderen A, Schreurs MW, de Bruijn MA, Sillevis Smitt PA, Titulaer MJ. Antistofgeassocieerde encephalitis: handvatten voor diagnostiek en behandeling. Ned Tijdschr Neurol Neurochir. 2016;117(2):78-88. | |
| van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology. 2016;86(18):1692-9. | |
| van Sonderen A, Arino H, Petit-Pedrol M, Leypoldt F, Kortvelyessy P, Wandinger KP, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016;87(5):521-8. | |
| van Onkelen RS, Gosselink MP, van Meurs M, Melief MJ, Schouten WR, Laman JD. Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 2016;20(9):619-25. | |
| van Nierop GP, Janssen M, Mitterreiter JG, van de Vijver DA, de Swart RL, Haagmans BL, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46(2):347-53. | |
| van Luijn MM, van Meurs M, Stoop MP, Verbraak E, Wierenga-Wolf AF, Melief MJ, et al. Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions. J Neuropathol Exp Neurol. 2016;75(1):86-98. | |
| van Leeuwen N, Lingsma HF, Vanrolleghem AM, Sturkenboom MC, van Doorn PA, Steyerberg EW, et al. Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome. PLoS One. 2016;11(2):e0143837. | |
| van Gent DC, IJspeert H, van der Burg M. Nonhomologous end-joining. DNA Replication, Recombination, and Repair: Molecular Mechanisms and Pathology: Springer Japan; 2016. p. 341-62. | |
| Van Dongen JJM, Teodosio C, Van den Bossche WBL, Berkowska M, Perez M, Almeida J, et al. Nieuwe ontwikkelingen in immuunmonitoring: flowcytometrische analyse van differentiatie-, maturatie-, en activatieprocessen. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 177-83. | |
| van Dongen JJM, Langerak AW, Kroese FGM. Vorming en expressie van antigeenreceptoren op T- en B-lymfocyten. In: Rijkers GT, Kroese FGM, Kallenberg CGM, Derksen RHWM, editors. Leerboek immunologie. Houten: Bohn, Stafleu, van Loghum; 2016. p. 103-26. | |
| van der Zee HH, Horvath B, Jemec GBE, Prens EP. The Association between Hidradenitis Suppurativa and Crohn’s Disease: in Search of the Missing Pathogenic Link. J Invest Dermatol. 2016;136(9):1747-8. | |
| Van der Velden VHJ, Theunissen PMJ, Van Der Sluijs-Gelling A, De Haas V, Van Dongen JJM, Consortium nhE. Detectie van minimale restziekte in acute lymfatische leukemie. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 99-116. | |
| van der Velden VH, de Launaij D, de Vries JF, de Haas V, Sonneveld E, Voerman JS, et al. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia. Br J Haematol. 2016;172(5):769-81. | |
| van der Valk JP, Schreurs MW, El Bouch R, Arends NJ, de Jong NW. Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review. Eur J Pediatr. 2016;175(9):1227-34. | |
| van der Heiden M, van Zelm MC, Bartol SJ, de Rond LG, Berbers GA, Boots AM, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892. | |
| van der Eerden BC, Koek WN, Roschger P, Zillikens MC, Waarsing JH, van der Kemp A, et al. Lifelong challenge of calcium homeostasis in male mice lacking TRPV5 leads to changes in bone and calcium metabolism. Oncotarget. 2016;7(18):24928-41. | |
| Van der Burg M, IJspeert H, Driessen GJA. T-cel deficiënties. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 87-94. | |
| van den Hoogen LL, Fritsch-Stork RD, Versnel MA, Derksen RH, van Roon JA, Radstake TR. Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use. Ann Rheum Dis. 2016;75(12):e81. | |
| van den Heuvel D, Jansen MA, Dik WA, Bouallouch-Charif H, Zhao D, van Kester KA, et al. Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study. J Infect Dis. 2016;213(2):233-42. | |
| van den Berg R, Laman JD, van Meurs M, Hintzen RQ, Hoogenraad CC. Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis. J Neurosci Methods. 2016;262:66-76. | |
| Van Den Berg B, Van Den Beukel JC, Alsma J, Van DenEijk AA, Ruts L, Van Doorn PA, et al. Guillain-Barré syndrome following infection with the Zika virus Background. Ned Tijdschr Geneeskd. 2016;160(21):D155. | |
| Van Daele PLA. Immunosuppressive medication and infections. Nederlands Tijdschrift voor Dermatologie en Venereologie. 2016;26(9):525-7. | |
| van Daele PL. Pamidronate in complex regional pain syndrome: effective therapy in CRPS. Neth J Med. 2016;74(1):3-4. | |
| van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA, Hoogenraad CC. Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System. Front Mol Neurosci. 2016;9:37. | |
| van Bezooijen JS, Koch BC, van Doorn MB, Prens EP, van Gelder T, Schreurs MW. Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations. Ther Drug Monit. 2016;38(4):432-8. | |
| van Bezooijen JS, Balak DM, van Doorn MB, Looman CW, Schreurs MW, Koch BC, et al. Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study. Dermatology. 2016;232(4):407-14. | |
| van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, et al. Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1-/Delta7 Mice. Front Immunol. 2016;7:408. | |
| Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, et al. Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response. Benef Microbes. 2016;7(2):275-87. | |
| Timmermans WM, van Laar JA, van Hagen PM, van Zelm MC. Immunopathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunology. 2016;5(12):e118. | |
| Timmermans WM, van Laar JA, van der Houwen TB, Kamphuis LS, Bartol SJ, Lam KH, et al. B-Cell Dysregulation in Crohn’s Disease Is Partially Restored with Infliximab Therapy. PLoS One. 2016;11(7):e0160103. | |
| Theunissen P, Mejstrikova E, Sedek L, Van der Sluijs A, Gaipa G, Bartels M, et al. Standardized next-generation flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. In: Van Dongen JJM, editor. 5th ESLHO Symposium New Developments in the ESLHO Networks. Leiden2016. p. 37-43. | |
| Theunissen P. Normale en maligne B-cellen in acute lymfoblatische leukemie [Ph.D. thesis]: Erasmus University Rotterdam; 2016. | |
| Ten Berge JC, van Rosmalen J, Vermeer J, Hellstrom C, Lindskog C, Nilsson P, et al. Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy. PLoS One. 2016;11(12):e0167909. | |
| ten Berge JC, van Daele PL, Rothova A. Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report. Ocul Immunol Inflamm. 2016;24(1):113-4. | |
| Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A. Prevalence and clinical impact of antiretinal antibodies in uveitis. Acta Ophthalmol. 2016;94(3):282-8. | |
| Te Velde AA, Bezema T, van Kampen AH, Kraneveld AD, t Hart BA, van Middendorp H, et al. Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders. Front Immunol. 2016;7:587. | |
| Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, et al. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica. 2016;101(8):959-67. | |
| Suratannon N, Yeetong P, Srichomthong C, Amarinthnukrowh P, Chatchatee P, Sosothikul D, et al. Adaptive immune defects in a patient with leukocyte adhesion deficiency type III with a novel mutation in FERMT3. Pediatr Allergy Immunol. 2016;27(2):214-7. | |
| Stetler-Stevenson M, Paiva B, Stoolman L, Lin P, Jorgensen JL, Orfao A, et al. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition. Cytometry B Clin Cytom. 2016;90(1):26-30. | |
| Snijders G, Schiweck C, Mesman E, Grosse L, De Wit H, Nolen WA, et al. A dynamic course of T cell defects in individuals at risk for mood disorders. Brain Behav Immun. 2016;58:11-7. | |
| Schreurs MWJ, Titulaer MJ. Diagnostiek van neuronale antistoffen bij auto-immuun encefalitis. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 39-53. | |
| Sandberg Y, Langerak AW, Lam KH, Rijneveld AW, van Lom K. [Leukocytosis and skin lesions: consider malignancy; adult T-cell leukaemia/lymphoma] | |
| Leukocytose en huidafwijkingen: denk aan maligniteit; adulte T-celleukemie/-lymfoom. Ned Tijdschr Geneeskd. 2016;160:A9866. | |
| Sandberg Y, Dijkshoorn ML, Schoots IG. [A woman with subcutaneous nodules after buttock augmentation] | |
| Een vrouw met subcutane noduli na bilvergroting. Ned Tijdschr Geneeskd. 2016;160(0):D443. | |
| Rother MB, Schreurs MW, Kroek R, Bartol SJ, van Dongen JJ, van Zelm MC. The Human Thymus Is Enriched for Autoreactive B Cells. J Immunol. 2016;197(2):441-8. | |
| Rother MB, Palstra RJ, Jhunjhunwala S, van Kester KA, van IJcken WF, Hendriks RW, et al. Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci. Nucleic Acids Res. 2016;44(1):175-86. | |
| Rother MB, Jensen K, van der Burg M, van de Bovenkamp FS, Kroek R, van IWF, et al. Decreased IL7Ralpha and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin. Sci Rep. 2016;6:33924. | |
| Rokx C, van Laar JA, Rijnders BJ. Suggested Relationship Between Hemophagocytic Lymphohistiocytosis and Bartonella henselae. Clin Infect Dis. 2016;63(3):427-8. | |
| Rietveld MJ, Schreurs MW, Gerth van Wijk R, van Daele PL, Hermans MA. The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis. Int Arch Allergy Immunol. 2016;169(2):125-9. | |
| Preijers FW, van der Velden VH, Preijers T, Brooimans RA, Marijt E, Homburg C, et al. Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward. Cytometry B Clin Cytom. 2016;90(3):267-78. | |
| Pojero F, Flores-Montero J, Sanoja L, Perez JJ, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90(1):91-100. | |
| Pieters R, de Groot-Kruseman H, Van der Velden V, Fiocco M, van den Berg H, de Bont E, et al. Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. J Clin Oncol. 2016;34(22):2591-601. | |
| Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, et al. Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients. Blood. 2016;127(25):3165-74. | |
| Novakova M, Zaliova M, Sukova M, Wlodarski M, Janda A, Fronkova E, et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica. 2016;101(6):707-16. | |
| Nazary M, Prens EP, Boer J. Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients. Br J Dermatol. 2016;174(3):639-41. | |
| Navrkalova V, Young E, Baliakas P, Radova L, Sutton LA, Plevova K, et al. ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. Haematologica. 2016;101(9):e369-73. | |
| Muggen AF, Singh SP, Hendriks RW, Langerak AW. Targeting Signaling Pathways in Chronic Lymphocytic Leukemia. Curr Cancer Drug Targets. 2016;16(8):669-88. | |
| Miller IM, Ring HC, Prens EP, Rytgaard H, Mogensen UB, Ellervik C, et al. Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases. Dermatology. 2016;232(4):511-9. | |
| Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: A case-control study. Ann Neurol. 2016;80(4):566-80. | |
| McGuiness B, Gibney SM, Beumer W, Versnel MA, Sillaber I, Harkin A, et al. Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice. Neuroimmunomodulation. 2016;23(3):137-50. | |
| Mayado A, Teodosio C, Garcia-Montero AC, Matito A, Rodriguez-Caballero A, Morgado JM, et al. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression. Leukemia. 2016;30(1):124-30. | |
| Massolt ET, Effraimidis G, Korevaar TI, Wiersinga WM, Visser WE, Peeters RP, et al. Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease. PLoS One. 2016;11(4):e0153892. | |
| Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, et al. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjogren’s Syndrome. Arthritis Rheumatol. 2016;68(7):1688-99. | |
| Lubberts E, Kolls JK. Utility of Adenoviral Vectors in Animal Models of Human Disease III: Acquired Diseases. Adenoviral Vectors for Gene Therapy: Second Edition2016. p. 675-96. | |
| Ljungstrom V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2016;127(8):1007-16. | |
| Lilleker JB, Jones MS, Mohanraj R, Yeo T, Chai JY, Tan K, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology. 2016;87(17):1848-9. | |
| Langerak T, Yang H, Baptista M, Doornekamp L, Kerkman T, Codrington J, et al. Zika Virus Infection and Guillain-Barre Syndrome in Three Patients from Suriname. Front Neurol. 2016;7(DEC):233. | |
| Langerak AW, Dik WA, Lu L, Heezen KC, Swagemakers SMA, Van der Velden VHJ, et al. Diagnostiek van intra-oculair lymfoom: gecombineerde rol voor flowcytometrie en proteomics. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 117-30. | |
| Langerak AW. Toward Standardization of Clonality Testing in Veterinary Medicine. Vet Pathol. 2016;53(4):705-6. | |
| Lagresle-Peyrou C, Luce S, Ouchani F, Soheili TS, Sadek H, Chouteau M, et al. X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene. J Allergy Clin Immunol. 2016;138(6):1681-9 e8. | |
| Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14(1):18. | |
| Karim AF, Verdijk RM, Guenoun J, van Hagen PM, van Laar JA. An inflammatory condition with different faces: immunoglobulin G4-related disease. Neth J Med. 2016;74(3):110-5. | |
| Kamphuis LSJ. The Many Faces of Sarcoidosis. Novel insights into pathogenesis, diagnostics and therapy [Ph.D. thesis]: Erasmus University Rotterdam; 2016. | |
| Kallenberg CGM, Drexhage HA. Auto-immuniteit. In: Rijkers GT, Kroese FGM, Kallenberg CGM, Derksen RHWM, editors. Leerboek immunologie. Houten: Bohn, Stafleu, van Loghum; 2016. p. 343-80. | |
| Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, et al. Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study. J Pediatr Gastroenterol Nutr. 2016;63(4):423-30. | |
| Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, et al. Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood. J Pediatr. 2016;170:126-34 e1-6. | |
| Janda A, Schwarz K, van der Burg M, Vach W, Ijspeert H, Lorenz MR, et al. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome. Blood. 2016;127(18):2193-202. | |
| Jagessar SA, Holtman IR, Hofman S, Morandi E, Heijmans N, Laman JD, et al. Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein. J Immunol. 2016;197(4):1074-88. | |
| Islam MB, Islam Z, Farzana KS, Sarker SK, Endtz HP, Mohammad QD, et al. Guillain-Barre syndrome in Bangladesh: validation of Brighton criteria. J Peripher Nerv Syst. 2016;21(4):345-51. | |
| IJspeert H, van Schouwenburg PA, van Zessen D, Pico-Knijnenburg I, Driessen GJ, Stubbs AP, et al. Evaluation of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and Adults. Front Immunol. 2016;7(OCT):410. | |
| IJspeert H, Van Schouwenburg PA, Van der Burg M. Strategieën voor repertoire analyse. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 161-76. | |
| IJspeert H, Rozmus J, Schwarz K, Warren RL, van Zessen D, Holt RA, et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 2016;128(5):650-9. | |
| Huang L, Langerak AW, Baan CC, Litjens NH, Betjes MG. Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients. Clin Exp Immunol. 2016;186(2):239-48. | |
| Hope JL, Pulendran B, Schoenberger SP, Katsikis PD. 1st International Conference on Human &Translational Immunology. Nat Immunol. 2016;18(1):1-4. | |
| Hoorn EJ, Taams NE, Hurskainen T, Salih M, Weening JJ, Jonkman MF, et al. Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease. Am J Kidney Dis. 2016;67(2):302-6. | |
| Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis. Neurology. 2016;87(9 Suppl 2):S67-73. | |
| Heeringa JJ, van Zelm MC. Is there a pathogenic role for IgE in psoriasis? Br J Dermatol. 2016;175(1):16-7. | |
| Heeringa JJ, Hajdarbegovic E, Thio HB, van Zelm MC. Systemic B-cell abnormalities in patients with atopic dermatitis? J Allergy Clin Immunol. 2016;138(1):317-8. | |
| Halstead SK, Kalna G, Islam MB, Jahan I, Mohammad QD, Jacobs BC, et al. Microarray screening of Guillain-Barre syndrome sera for antibodies to glycolipid complexes. Neurol Neuroimmunol Neuroinflamm. 2016;3(6):e284. | |
| Haarman BC, Riemersma-Van der Lek RF, Burger H, Drexhage HA, Nolen WA. The dysregulated brain: consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis. Bipolar Disord. 2016;18(8):696-701. | |
| Haarman BC, Riemersma-Van der Lek RF, Burger H, de Groot JC, Drexhage HA, Nolen WA, et al. Diffusion tensor imaging in euthymic bipolar disorder – A tract-based spatial statistics study. J Affect Disord. 2016;203:281-91. | |
| Haarman BC, Burger H, Doorduin J, Renken RJ, Sibeijn-Kuiper AJ, Marsman JB, et al. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun. 2016;56:21-33. | |
| Grosse L, Hoogenboezem T, Ambree O, Bellingrath S, Jorgens S, de Wit HJ, et al. Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun. 2016;54:38-44. | |
| Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, et al. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology (Berl). 2016;233(9):1679-88. | |
| Gracias DT, Boesteanu AC, Fraietta JA, Hope JL, Carey AJ, Mueller YM, et al. Phosphatidylinositol 3-Kinase p110delta Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections. J Immunol. 2016;196(3):1186-98. | |
| Girard-Madoux MJ, Ober-Blobaum JL, Costes LM, Kel JM, Lindenbergh-Kortleve DJ, Brouwers-Haspels I, et al. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine. Oncotarget. 2016;7(22):32015-30. | |
| Ghanbari M, Ikram MA, de Looper HW, Hofman A, Erkeland SJ, Franco OH, et al. Genome-wide identification of microRNA-related variants associated with risk of Alzheimer’s disease. Sci Rep. 2016;6:28387. | |
| Ghanbari M, Darweesh SK, de Looper HW, van Luijn MM, Hofman A, Ikram MA, et al. Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease. Hum Mutat. 2016;37(3):292-300. | |
| Gervin K, Page CM, Aass HC, Jansen MA, Fjeldstad HE, Andreassen BK, et al. Cell type specific DNA methylation in cord blood: A 450K-reference data set and cell count-based validation of estimated cell type composition. Epigenetics. 2016;11(9):690-8. | |
| Garcia-Montero AC, Jara-Acevedo M, Alvarez-Twose I, Teodosio C, Sanchez-Munoz L, Muniz C, et al. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression. Blood. 2016;127(6):761-8. | |
| Fokkink WJ, Haarman AE, Tio-Gillen AP, van Rijs W, Huizinga R, van Doorn PA, et al. Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS. Ann Clin Transl Neurol. 2016;3(7):547-51. | |
| Flores-Montero J, de Tute R, Paiva B, Perez JJ, Bottcher S, Wind H, et al. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Cytometry B Clin Cytom. 2016;90(1):61-72. | |
| Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. J Clin Immunol. 2016;36(2):103-6. | |
| Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, et al. Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci. Pediatr Blood Cancer. 2016;63(10):1704-12. | |
| Dunham J, Lee LF, van Driel N, Laman JD, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11(1):73-83. | |
| Driessen GJ, IJspeert H, Wentink M, Yntema HG, van Hagen PM, van Strien A, et al. Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency. J Allergy Clin Immunol. 2016;138(6):1744-7 e5. | |
| Drexhage HA, Dik WA, Leenen PJ, Versnel MA. The Immune Pathogenesis of Type 1 Diabetes: Not Only Thinking Outside the Cell but Also Outside the Islet and Out of the Box. Diabetes. 2016;65(8):2130-3. | |
| Dik WA, Virakul S, van Steensel L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves’ ophthalmopathy. Exp Eye Res. 2016;142:83-91. | |
| Dik WA, Paridaens D, Dalm VASH, Peeters RP, Van Hagen PM. Graves’ orbitopathie: pathogenese en behandeling. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 11-28. | |
| Denys B, Van der Velden V, Boeckx N. Hematologische maligniteiten – leukemie. In: Bossuyt X, editor. Wegwijs in laboratorium-diagnose. Leuven: Acco; 2016. p. 101-14. | |
| Deckers IE, van der Zee HH, Prens EP. Severe fatigue based on anaemia in patients with hidradenitis suppurativa: report of two cases and a review of the literature. J Eur Acad Dermatol Venereol. 2016;30(1):174-5. | |
| de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. J Proteome Res. 2016;15(6):1853-61. | |
| Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2016;7(JAN):697. | |
| Damasceno D, Andres MP, van den Bossche WB, Flores-Montero J, de Bruin S, Teodosio C, et al. Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells. Clin Transl Immunology. 2016;5(9):e100. | |
| Dalm VASH, Van der Burg M, Van Hagen PM. Humorale immuundeficiënties: kliniek en diagnostiek. In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 57-73. | |
| Chan MK, Cooper JD, Bot M, Birkenhager TK, Bergink V, Drexhage HA, et al. Blood-based immune-endocrine biomarkers of treatment response in depression. J Psychiatr Res. 2016;83:249-59. | |
| Carey AJ, Gracias DT, Thayer JL, Boesteanu AC, Kumova OK, Mueller YM, et al. Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice. J Immunol. 2016;196(6):2602-13. | |
| Cao Y, Jansen ID, Sprangers S, Stap J, Leenen PJ, Everts V, et al. IL-1beta differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets. J Leukoc Biol. 2016;100(3):513-23. | |
| Cantaert T, Schickel JN, Bannock JM, Ng YS, Massad C, Delmotte FR, et al. Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint. J Clin Invest. 2016;126(11):4289-302. | |
| Burgerhout K. Postpartum Psychosis : Treatment, follow-up and immunological parameters [Ph.D. thesis]: Erasmus University Rotterdam; 2016. | |
| Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, et al. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann Rheum Dis. 2016;75(8):1567-73. | |
| Both T, Zillikens MC, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, et al. Bone Mineral Density in Sjogren Syndrome Patients with and Without Distal Renal Tubular Acidosis. Calcif Tissue Int. 2016;98(6):573-9. | |
| Beth SA, Jansen MA, Elfrink ME, Kiefte-de Jong JC, Wolvius EB, Jaddoe VW, et al. Generation R birth cohort study shows that specific enamel defects were not associated with elevated serum transglutaminase type 2 antibodies. Acta Paediatr. 2016;105(10):e485-91. | |
| Berk KAC, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, et al. Effect van gewichtsverlies door het volgen van een dieet op markers van endotheel dysfunctioneren en inflammatie bij behandelde diabetes type 2 patiënten. Voeding & Visie. 2016;29:8-13. | |
| Berk KA, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, et al. Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes. Clinical Nutrition ESPEN. 2016;15:101-6. | |
| Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambree O, de Wit H, et al. Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder. J Affect Disord. 2016;202:1-9. | |
| Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, Ambree O, de Wit H, et al. Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. J Neuroimmune Pharmacol. 2016;11(2):248-58. | |
| Baldeon Rojas L, Weigelt K, de Wit H, Ozcan B, van Oudenaren A, Sempertegui F, et al. Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. Diabetol Metab Syndr. 2016;8:6. | |
| Avellino R, Havermans M, Erpelinck C, Sanders MA, Hoogenboezem R, van de Werken HJ, et al. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood. 2016;127(24):2991-3003. | |
| Alves CH, Farrell E, Vis M, Colin EM, Lubberts E. Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review. Clin Rev Allergy Immunol. 2016;51(1):27-47. | |
| Alemdehy MF, De Looper HWJ, Kavelaars FG, Sanders MA, Hoogenboezem R, Löwenberg B, et al. MicroRNA-155 induces AML in combination with the loss of C/EBPA in mice. Leukemia. 2016;30(11):2238-41. | |
| Akar HH, Patiroglu T, Hershfield M, van der Burg M. Combined immunodeficiencies: twenty years experience from a single center in Turkey. Cent Eur J Immunol. 2016;41(1):107-15. | |
| Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016 September 2016. 186 p. |
PUBLICATIONS 2015
| Ambree O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, et al. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression. Int J Neuropsychopharmacol. 2015;19(3):pyv103. |